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Abstract  
This thesis describes the development of a general synthetic approach for the 
diastereoselective synthesis of a wide range of α-functionalised sulfoximines via 
lithiation-trapping reactions. In addition, studies for the synthesis of 2,2- and 2,5/2,6-
disubstituted cyclic sulfoximines are reported.  
The synthesis of cyclic and acyclic sulfoximines with different N-substituents is described 
in Chapter 2.1. Chapter 2.2 explores the scope and diastereoselectivity of lithiation-
trapping reactions of 5- and 6-membered ring sulfoximines with a range of electrophiles 
(including benzophenone, benzaldehyde, benzyl bromide and methyl iodide) and N-
substituents (TBDPS, Boc, Me and CN). Our results show high α-diastereoselectivity 
with the N-TBDPS group, giving mostly cis diastereomers in high yields. Good yields 
and diastereoselectivity were also observed for the lithiation-trapping reactions of N-Boc, 
N-Me and N-CN sulfoximines. It is proposed that the sterically bulky TBDPS group is 
able to block one face of the sulfoximine preventing electrophilic attack on one side. 
Therefore, the trapped sulfoximine adopts a configuration where the new α-substituent is 
cis to the sulfoximine oxygen.  
 
In Chapter 2.3, the synthesis of disubstituted sulfoximines is reported. The two routes 
detail the diastereoselective synthesis of 2,2- and 2,5/2,6-disubstituted sulfoximines. 
The approach to 2,2-disubstituted sulfoximines was far less successful than that to the 
2,5/2,6-disubstituted sulfoximines. 
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1. Introduction 
1.1 Introduction to Sulfoximines 
There is growing interest in synthetic chemistry using sulfoximines 1 (Figure 1.1) due to 
recent developments in the use of sulfoximines in both the pharmaceutical1 and 
agrochemical2 industries. The first example of the characterisation of a sulfoximine was 
reported in 1950.3 With reference to synthetic chemistry, sulfoximines 1 are much less 
studied than their corresponding sulfones 2 and sulfoxides 3 (Figure 1.1). Commonly 
referred to as the mono-aza analogues of sulfones, sulfoximines 1 have a nitrogen in place 
of one of the oxygen atoms in sulfones 2 but share many of the properties of both sulfones 
and sulfoxides. 
 
Figure 1.1 Structure of sulfoximines 1, sulfones 2 and sulfoxides 3 
Due to the presence of a nitrogen atom in sulfoximines 1, a range of different types of 
sulfoximines are possible, depending on the structure of the R3 group. The main classes 
of sulfoximines contain NH, N-alkyl, N-aryl, N-SiR3, N-SO2R and N-CN groups.
4 
Electron withdrawing groups such as N-SO2R and N-CN increase the polarity of the 
sulfoximine unit, whilst electron donating groups such as N-alkyl, N-aryl and N-SiR3 
decrease the polarity. In a similar way to sulfoxides 3, the sulfur atom in sulfoximines 1 
is a stereogenic centre providing its two substituents are not identical (R1 ≠ R2).  
The sulfoximine unit is electron withdrawing and, as a result, the proton on nitrogen in 
NH sulfoximines and the α-protons on carbon of N-substituted sulfoximines can be 
deprotonated by bases. Bordwell has carried out measurements of pKa values (DMSO, 25 
°C) for numerous functional groups including the α-protons of N-substituted 
sulfoximines, sulfones and sulfoxides.5 Some example pKa values are shown in Figure 
1.2. For sulfoximines, the N-substituent has a large impact on the pKa value of the α-
protons. For example, sulfoximine 4 has a methyl group on nitrogen and a pKa of 33 but 
replacing the methyl with the electron withdrawing tosyl group in sulfoximine 5 results 
in a lower pKa of 24.5. In contrast, the α-protons of sulfoxide 6 have a pKa of 33 whilst 
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the corresponding sulfone 7 has a lower pKa of 29, presumably due to the electron 
withdrawing ability of the additional oxygen atom bonded to sulfur.  
 
Figure 1.2 pKas of α-protons of sulfoximines 4 and 5, sulfoxide 6 and sulfone 7 
Interestingly, a number of pharmaceutical companies have begun to include the 
sulfoximine functional group in their drug development programmes. Potential 
pharmaceuticals bearing the sulfoximine functional group often benefit from increased 
polarity and solubility in comparison to their sulfone analogues. A comparison of aqueous 
solubility and logD at pH 7.4 between sulfone 8 and two sulfoximines 9 and 10 is shown 
in Table 1.1.6 Sulfone 8 showed a low solubility of <0.2 μM and a high logD of 3.2. Using 
small molecule X-ray crystallography, the insolubility of the sulfone was shown to be a 
result of intermolecular interactions of the sulfone group stabilising the solid-state.7 In 
comparison, the corresponding NH sulfoximine 9 displayed a significantly higher 
solubility (7.0 μM) and was less lipophilic (logD of 2.5). The analogous N-Me 
sulfoximine 10 also displayed high solubility (5.0 μM) when compared to sulfone 8 
despite having almost the same lipophilicity (logD of 3.3). High solubility and low 
lipophilicity are beneficial features when developing potential pharmaceuticals as they 
make the compounds more likely to pass through the earlier stages of clinical testing. 
                                                                                                                      
Entry Compound R LogD Aqueous Solubility/μM 
1 8 O 3.2 0.2 
2 9 NH 2.5 7.0 
3 10 NMe 3.3 5.0 
Table 1.1 Log D and aqueous solubility of sulfone 8 and sulfoximines 9 and 10 
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Bayer investigated sulfonamide ZK 304709 as a potential CDK inhibitor.8 ZK 304709 
was found to have low lipophilicity (logD of 0.3 at pH 7.5) and low thermodynamic 
solubility in water (19 mM). During phase 1 studies of the sulfonamide, the low solubility 
proved to be an issue and the studies were terminated. As a result, a sulfoximine analogue 
was synthesised and this led to the development of enantiopure nanomolar pan-CDK 
inhibitor BAY 1000394 (Figure 1.3).9 This compound displayed high thermodynamic 
solubility in water (423 μM) which was significantly greater than that of sulfonamide ZK 
304709. The solubility of the sulfoximine was also shown to increase in organic solvents 
and at a low pH. Another sulfoximine compound which has shown promise as a potential 
cancer treatment is the enantiopure ATR inhibitor AZD673810,11 developed by 
AstraZeneca (Figure 1.3). Clinical trials have shown it to be effective at treating gastric 
cancer cells,12 although research is still ongoing. In addition, the racemic sulfoximine 
Sudexanox13,14 (Figure 1.3) underwent clinical trials as an oral antiasthmatic drug, with 
promising results.  
 
Figure 1.3 Clinical candidates bearing the sulfoximine functional group 
Sulfoximines have also been utilised in agrochemistry as insecticides.2 The mixture of 
diastereomeric N-CN sulfoximines, commonly known as Sulfoxaflor,15 and other related 
sulfoximines 1116 and 1217 (Figure 1.4) have proved to be more efficient than traditional 
insecticides.18 Use of a cyano group as the N-substituent was found to give increased 
insecticidal activity when compared to the corresponding nitro sulfoximines. As a result, 
there has been a significant effort to synthesise sulfoximines for this purpose, especially 
those bearing the CN functionality. 
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Figure 1.4 Potential insecticides bearing the sulfoximine functional group 
Sulfoximines have also been used as chiral resolving agents and as chiral ligands in 
asymmetric catalysis.4 For example, Johnson developed a method using an α-lithiated 
sulfoximine to resolve chiral ketones.19 Work by Bolm20 demonstrated the catalytic 
asymmetric reduction of ketones such as 13 using 0.1 eq. of enantiopure β-
hydroxysulfoximine (S)-14. Alcohol (S)-15 was isolated in 88% yield and 90% ee 
(Scheme 1.1). Using this method, a range of ketones were reduced in high % ee. Chiral 
enantiopure sulfoximines have also been utilised as ligands in palladium-catalysed 
asymmetric allylic substitution reactions.21  
 
Scheme 1.1 
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1.2 Synthesis of Sulfoximines  
1.2.1 Synthesis of NH sulfoximines 
A range of methods have been reported for the synthesis of NH sulfoximines. Routes to 
NH sulfoximines are of interest as the free nitrogen atom enables further functionalisation 
of this position. The first reported approach to an NH sulfoximine 17 started from 
sulfoxide 16 and involved reaction with sodium azide and sulfuric acid (Scheme 1.2). 
Under these conditions, it is likely that highly toxic and explosive HN3 is generated so 
this is not a desirable method. In addition, partial racemisation of enantioenriched 
sulfoximines can occur during the imination process.22  
 
Scheme 1.2 
An alternate route to NH sulfoximines from sulfoxides uses O-
mesitylsulfonylhydroxylamine (MSH) as an electrophilic source of the amino group. It 
was found that reaction of enantioenriched sulfoxides with MSH proceeded with retention 
of configuration to give the corresponding enantioenriched sulfoximines. As an example, 
sulfoxide (R)-18 of 98% ee was converted into sulfoximine (R)-19 of 97% ee in 80% 
yield (Scheme 1.3).23 Altering the substituents on the sulfoxide gave sulfoximines in high 
yields with high % ees in most cases.  
 
Scheme 1.3 
An efficient route to arylated and cyclic sulfoximines 20-24 from the corresponding 
sulfoxides was reported using O-(2,4-dinitrophenyl)hydroxylamine (DPH) in 
tetrafluoroethylene (Scheme 1.4).24 The reaction was catalysed by Rh2(esp)2 and 
proceeded via a rhodium nitrene intermediate. Good yields were obtained for the majority 
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of substrates tested, including those substituted at the meta position (20, 88%) or para 
position (21, 90%). In contrast, substrates substituted at the ortho position were 
synthesised in poor yields (22, 32%) presumably due to steric hindrance. Cyclic 
sulfoximine 23 and diphenyl sulfoximine 24 were also synthesised in high yields. This 
method provides an easy route to a wide range of sulfoximines in good yields using mild 
conditions but involves the use of an expensive rhodium catalyst. 
 
Scheme 1.4 
The majority of methods for the direct transfer of an imino group to sulfoxides use harsh 
reaction conditions or expensive reagents and exhibit some limitations as a result. Work 
by Luisi, Bull and co-workers detailed a simple way of converting sulfoxides into 
sulfoximines using mild conditions.25 Three sets of reaction conditions were investigated 
using inexpensive ammonium carbamate as a source of ammonia and 
(diacetoxyiodo)benzene (PIDA) as an oxidising agent (Scheme 1.5). Using reaction 
conditions A, sulfoxide 18 was converted into sulfoximine 19 in 90% yield. A limitation 
of the reaction was the insolubility of ammonium carbamate in toluene and, in order to 
overcome this, the reaction was heated at 35 °C for 16 h. It was found that ammonium 
carbamate readily dissolved when the reaction was performed at rt in acetonitrile 
(conditions B) or methanol (conditions C) due to the increased polarity of these solvents 
in comparison to toluene. Reaction conditions C were preferred as the reaction only took 
30 min and sulfoximine 19 was synthesised in 96% yield. The scope of the reaction was 
investigated using conditions C, giving a diverse range of sulfoximines 25-28, 23 and (S)-
19 in high yields (Scheme 1.5). In addition, the reaction was shown to proceed with 
retention of stereochemistry when performed on an enantioenriched sulfoxide. For 
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example, sulfoximine (S)-19 was synthesised with a 97:3 er in 89% yield from the 
corresponding sulfoxide of 97:3 er.  
 
Scheme 1.5 
A mechanistic investigation on this formation of sulfoximines from sulfoxides was 
carried out by Luisi, Bull and co-workers. Analysis of the reaction by mass spectrometry 
under flow conditions briefly detected intermediates 29 and 30 and, as a result, two 
possible pathways were proposed (Scheme 1.6). In pathway 1, the sulfur lone pair of 
sulfoxide 3 attacks the nitrogen atom of intermediate 29 and subsequent elimination of 
iodobenzene would form sulfoximine 31. Alternatively, sulfoxide 3 could attack the 
iodine of intermediate 29 and then form sulfoximine 31 through a reductive elimination 
sequence. In pathway 2, attack on the nitrogen atom of a different cationic intermediate 
(30) by the sulfur lone pair of sulfoxide 3 would result in iodonium species 32 which 
forms sulfoximine 31 on work-up. Unfortunately, it was not possible to distinguish 
between pathways 1 and 2. Poorer yields for the reaction were observed when R1 or R2 
in the sulfoxide was an electron-withdrawing group, showing that the nucleophilicity of 
the sulfoxide was important for the success of this reaction. 
 
Scheme 1.6 
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Following on from this work, Bull and Luisi investigated the direct conversion of sulfides 
into sulfoximines.26 PIDA was used as the oxidising agent whilst ammonium carbamate, 
ammonium acetate and ammonia in methanol solution were used as sources of ammonia. 
The conversion of sulfides into sulfoximines was performed in toluene, acetonitrile and 
methanol. Methanol was the preferred solvent as the reaction time was the shortest and 
the yield was the highest (Scheme 1.7). It was discovered by varying the equivalents of 
PIDA that a minimum of two equivalents were required for complete reaction. Based on 
previous mechanistic studies, it is believed that one equivalent of PIDA promoted oxygen 
transfer whilst the second generated the key intermediates 29 or 30 (see Scheme 1.6). In 
addition, decreasing the amount of ammonium carbamate from four equivalents to one 
had no effect on the yield. The reaction conditions shown in Scheme 1.7 were selected 
and the scope of the reaction was investigated. Using the one-pot synthesis, a wide range 
of sulfoximines 33-35, 23 and 19 bearing alkyl and aryl groups, as well cyclic 
sulfoximines were synthesised in high yields.  
 
Scheme 1.7 
Recently, Reboul investigated the mechanism for this metal-free preparation of 
sulfoximines from sulfides (Scheme 1.8).27 First, it was shown that methanol underwent 
a fast ligand exchange reaction with PIDA to produce acetic acid which accelerated the 
decomposition of ammonium carbamate to ammonia. It is thought that ammonia attacked 
the iodine atom of PIDA, replacing the acetoxy groups to give iodonitrene intermediate 
36. Then, imination of sulfide 37 by iodonitrene 36, leads to the corresponding iodonium 
sulfilimine 32. It is believed that 32 rearranged to give 38 which can then proceed to 
sulfoximine 31 by two main pathways. Nucleophilic attack of 38 by methoxide or acetate 
and loss of iodobenzene would give methoxy and acetoxy sulfanenitrile intermediates 39 
and 40 respectively. Intermediates 39 and 40 were characterised by 1H, 13C and 15N NMR 
spectroscopic and HRMS analysis. Nucleophilic attack on methoxy sulfane nitrile 39 by 
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methanol would give sulfoximine 31. It was proposed that acetoxy sulfanenitrile 40 could 
undergo nucleophilic attack by methanol or sulfoximine 31. If intermediate 40 was 
attacked by sulfoximine 31, NH sulfoximine 31 and N-acetyl sulfoximine 41 would be 
formed. The acetyl group of intermediate 40 could also be attacked by methanol to give 
sulfoximine 31 and methyl acetate. Ultimately, from the mechanistic work, it was 
concluded that conversion of iodonitrene 36 into sulfoximine 31 could proceed by all 
three of the pathways discussed. 
 
Scheme 1.8 
 
1.2.2 Synthesis of N-functionalised sulfoximines 
There are two main approaches to N-functionalised sulfoximines. One approach involves 
synthesis of NH sulfoximines and then different methods are used to introduce the N-
functionality. Alternatively, the N-functionalised amine can be introduced directly 
starting from a sulfoxide or sulfide.  
Sulfoximines containing N-alkyl groups can be easily prepared from NH sulfoximines 
using an alkylation reaction. A common method for alkylating NH sulfoximines using 
mild conditions is shown in Scheme 1.9. Reaction of sulfoximine 42 with potassium 
hydroxide and an alkyl bromide (rt, 6 h) gave N-alkyl substituted sulfoximines 43, 44 and 
45 in 81–92% yields.28 
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Scheme 1.9 
It is currently not possible to directly introduce a N-SiR3 group to a sulfoxide or sulfide. 
Instead, it is necessary to go via the NH sulfoximine. For example, the imino group of 
dimethyl sulfoximine 46 was readily N-silylated (Scheme 1.10).29 Treatment of 
sulfoximine 46 with HMDS (125 °C, 2 h) gave N-TMS sulfoximine 47 in 61% yield. 
Alternatively, silylation of sulfoximine 46 using imidazole and TBDPSCl (60 °C, 48 h) 
gave N-TBDPS sulfoximine 48 in 69% yield.  
 
Scheme 1.10 
N-Aryl sulfoximines can be directly synthesised from the NH sulfoximine. Bolm 
investigated palladium-catalysed cross-coupling reactions as routes to N-aryl 
sulfoximines from NH sulfoximines.30 Pd(dba)2 and BINAP were used to give a 
Pd(0)/BINAP complex which was able to catalyse the reaction of sulfoximine (S)-49 with 
aryl bromide 50 (Scheme 1.11). The reaction was heated to 80 °C for 8 h resulting in N-
aryl sulfoximine (S)-51 in 84% yield, a process which proceeded with retention of 
stereochemistry. 
 
Scheme 1.11 
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The alternative approach to N-functionalised sulfoximines is synthesis directly from the 
corresponding sulfide or sulfoxide. For example, reaction of sulfoxides with either t-butyl 
hypochlorite or sulfuryl chloride followed by reaction with anilines gave N-aryl 
sulfoximines (Scheme 1.12).31 The imination reaction was believed to proceed via chloro 
intermediate 52. Both alkyl and aryl substituted sulfoxides were reacted with a range of 
substituted anilines giving sulfoximines 53–57 generally in high yields. Anilines 
substituted with an electron withdrawing group gave sulfoximines with significantly 
higher yields than those substituted with an electron donating group or with no 
substitution. 
 
Scheme 1.12 
Imination of sulfoxides with substituted azides enables the transfer of an NR group, such 
as N-Boc or N-SO2R, to give N-functionalised sulfoximines. Reaction of sulfoximines 
with t-butyloxycarbonyl azide, promoted by a substoichiometric amount of iron(II) 
chloride, gave N-Boc sulfoximines 58–61 in 45–70% yields (Scheme 1.13).32  
 
Scheme 1.13 
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One method for synthesising N-SO2R sulfoximines, reported by Tye,
33 used copper-
catalyzed imination of sulfoxides with iminoiodane reagents. As an example, sulfoxide 6 
was iminated with PhINTs, PhINNs and PhINSES to give N-Ts, N-Ns and N-SES 
sulfoximines 5, 62 and 63 in 59%, 69% and 68% yields respectively (Scheme 1.14). It is 
possible to remove the Ns and SES group from sulfoximines 62 and 63 to give the NH 
sulfoximines in good yields.  
 
Scheme 1.14 
N-Me sulfoximines can be synthesised directly from the corresponding sulfide using a 
one-pot reaction. An interesting example of this is shown in the synthesis of the potential 
ATR inhibitor 65. Imination of sulfide 64 with methylamine and bromine, followed by 
oxidation using potassium carbonate and potassium permanganate gave N-Me 
sulfoximine 65 in 64% yield (Scheme 1.15).34 
 
Scheme 1.15 
Routes to N-CN sulfoximines are of interest due to the potential insecticidal applications 
of sulfoximines bearing the cyano group. Reaction of sulfide 66 with PIDA and 
cyanimide gave imine 67, and subsequent oxidation using mCPBA and potassium 
carbonate gave N-CN sulfoximine 68 in 69% yield over two steps (Scheme 1.16).35 Other 
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commonly used conditions for the imination step substitute PIDA for a halogen source 
such as NCS, NBS or iodine and potassium tert-butoxide.36 Both approaches provide an 
easy route to N-CN sulfoximines in good yields. 
 
Scheme 1.16 
Thus, there are currently a wide range of synthetic methods available for the synthesis of 
sulfoximines. Due to the mild reaction conditions and the opportunity to convert NH 
sulfoximines into their N-substituted analogues, the methods to NH sulfoximines 
described by Luisi and Bull appear to be the current best approach. 
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1.3 α-Functionalisation of Sulfoximines by Lithiation-Trapping 
The electron-withdrawing ability of the sulfoximine unit enables the removal of a proton 
on the α-carbon of N-substituted sulfoximines using strong bases. As described in Chapter 
1.1, measurements of pKa values of the α-protons of N-substituted sulfoximines were 
carried out by Bordwell (DMSO, 25 °C).5 The N-substituent of sulfoximines has a large 
impact on the pKa value of the α-protons. For example, the α-protons of N-Me sulfoximine 
4 have a pKa of 33 whilst the α-protons of N-Ts sulfoximine 5 have a pKa of 24.5 (see 
Figure 1.2). Given this α-proton pKa range of 24-33 pKa units, strong bases such as n-BuLi 
and LDA are typically used. The lithiation-trapping reactions of acyclic sulfoximines 
have been well explored and there is a wide range of examples. In this chapter, a selection 
of results are presented to show the scope and limitations of the lithiation-trapping of 
sulfoximines.  
Lithiation-trapping reactions of sulfoximines are most commonly achieved using n-BuLi 
in THF at ‒78 °C for the deprotonation step, followed by trapping with an electrophile. 
A representative example is shown in Scheme 1.17. N-Me sulfoximine 69 was lithiated 
using n-BuLi in THF at ‒78 °C for 30 min. Trapping with benzyl bromide gave α-
benzylated sulfoximine 70 in 98% yield.37 
 
Scheme 1.17 
In related reactions, n-BuLi at ‒78 °C was used to lithiate at the α-position of N-TBDPS 
sulfoximine 48 and N-CN sulfoximine 71. Subsequent trapping with benzyl bromide 72 
gave N-TBDPS sulfoximine 73 in 70% yield and N-CN sulfoximine 74 in 75% yield 
(Scheme 1.18).38 In these examples, the N-substituent did not affect the yield of the 
products. This is a rare case of a high yielding lithiation-trapping reaction of an N-CN 
sulfoximine.  
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Scheme 1.18 
A review of the literature showed that α-functionalised N-CN sulfoximines are often 
obtained in low yields when synthesised by lithiation-trapping reactions.35,39 A typical 
example is shown in Scheme 1.19. N-CN sulfoximine 75 underwent lithiation by n-BuLi 
at ‒78 °C in THF for 20 min followed by trapping with electrophile 76 to give sulfoximine 
77 in only 6% yield.39 
 
Scheme 1.19 
Alkyl halides are one of the most commonly used electrophiles in lithiation-trapping 
reactions of sulfoximines. For example, N-TMS sulfoximine 78 was lithiated at ‒78 °C 
in THF using n-BuLi. Then, addition of HMPA followed by reaction with alkyl bromide 
79 gave sulfoximine 80 in 63% yield (Scheme 1.20).40 In this reaction, HMPA was 
presumably used to deaggregate oligomers of the lithiated sulfoximine and improve 
reactivity. Use of HMPA may have been necessary to achieve a good yield of sulfoximine 
80 since alkyl halide 79 is a less activated electrophile than benzyl bromide (see Schemes 
1.17 and 1.18). 
 
Scheme 1.20 
Chapter One: Introduction 
 
16 
 
An interesting type of cyclic sulfoximine are those in which the sulfoximine nitrogen 
atom is incorporated into the ring. For example, 5- and 6-membered ring sulfoximines 85 
and 86 can be synthesised from enantiomerically enriched acyclic sulfoximine (S)-49 by 
a three-step procedure (Scheme 1.21).41 Deprotonation of the nitrogen of sulfoximine (S)-
49 was performed using potassium hydride in DME. Treatment with tetrabutylammonium 
bromide and THP-protected bromoethanol or chloropropanol gave N-alkylated acetals. 
Then, cleavage using 2 M HCl(aq) gave N-functionalised sulfoximines 81 and 82 in 77% 
yield and 72% yield respectively. Addition of a tosyl group to sulfoximines 81 and 82 
was achieved by treatment with Et3N and p-toluenesulfonyl chloride in CH2Cl2 to give 
sulfoximine tosylates 83 and 84 in 92% yield. In the final step, deprotonation at the α-
position of sulfoximines 83 and 84 using potassium tert-butoxide and n-BuLi in THF 
allowed cyclisation to give 5- and 6-membered ring sulfoximines 85 and 86.  
 
Scheme 1.21 
LDA has also been used to deprotonate the α-position of sulfoximines and an example is 
shown in Scheme 1.22. N-TBDPS sulfoximine 87 was deprotonated at the α-position 
using LDA and subsequent trapping with methyl benzoate gave sulfoximine 88 in 92% 
yield.42 Unusually, after addition of the ester the reaction mixture was heated at reflux for 
8 h, although the authors did not comment on this aspect of the reaction conditions. 
 
Scheme 1.22 
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β-Keto sulfoximines can also be synthesised in good yields by lithiation-trapping 
reactions with Weinreb amides and esters (Table 1.2). For example, lithiation of N-
TBDPS sulfoximine 87 using n-BuLi in THF at ‒78 °C and subsequent trapping with 
bromo-substituted Weinreb amide 89 gave sulfoximine 90 in 84% yield (entry 1).43 
Sulfoximine 90 could also be synthesised in a slightly higher yield of 92% by trapping 
with ethyl ester 91 under the same conditions (entry 3). Chloro-substituted Weinreb 
amide 92 and ethyl ester 93 were compatible with this reaction giving sulfoximine 94 in 
high yields (entries 2 and 4), although trapping with iodo-substituted ethyl ester 95 was 
not successful and gave no sulfoximine 96 (entry 5). 
 
Entry Electrophile R X Product Yield (%)a 
1 89 N(OMe)Me Br 90 84 
2 92 N(OMe)Me Cl 94 82 
3 91 OEt Br 90 92 
4 93 OEt Cl 94 89 
5 95 OEt I 96 0 
 
Table 1.2 Lithiation-trapping of sulfoximine 87 with α-halogenated Weinreb amides and 
esters 
Trapping of sulfoximines with secondary alkyl halides can result in a second stereocentre 
at the β-position (Scheme 1.23). Deprotonation of N-TBDPS sulfoximine 48 at the α-
position was carried out using n-BuLi in THF at ‒78 °C and subsequent trapping with 
alkyl bromide 97 gave α-alkylated sulfoximines anti-98 (39% yield) and syn-98 (17% 
yield).38 The moderate diastereoselectivity in this reaction arises from match/mismatch 
effects in the trapping with this chiral electrophile. Sulfoximines syn-98 and anti-98 were 
converted into known compounds and a comparison of the 1H NMR spectra of these 
products with those reported in the literature enabled assignment of the relative 
stereochemistry.44 
a % yield after purification by chromatography. 
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Scheme 1.23 
Lithiation-trapping reactions of sulfoximines with a variety of ketones, such as 
benzophenone, have been explored.45 Structurally more complex ketones such as 99 
containing a macrocycle have also been explored. For example, N-Me sulfoximine (S)-
69 of 85% ee was lithiated using n-BuLi and trapped with enantiomerically enriched 
macrocyclic ketone 99 (Scheme 1.24).46 The reaction proceeded with a high level of 
stereocontrol giving a 314:1 ratio of hydroxy sulfoximines syn-100 and anti-100 in 99% 
yield with respect to ketone 99. An investigation of lithiation-trapping reactions with ring 
sizes from 6-16 showed that reactions with 7-membered rings and larger proceeded with 
high yields and good stereoselectivity.  
 
Scheme 1.24 
The trapping of lithiated sulfoximines with aldehydes has also been reported. In certain 
cases, good stereocontrol for the introduction of a stereocentre at the β-position was 
observed. For example, lithiation of N-TBDPS sulfoximine 87 using n-BuLi in THF at 0 
°C and trapping with benzaldehyde at ‒78 °C gave a 91:9 mixture of alcohols syn-101 
and anti-101 (Scheme 1.25). The stereocontrol at the β-position is high and use of the 
sterically bulky TBDPS group as the N-substituent is necessary. When smaller silyl N-
substituents such as TMS were used in lithiation-trapping reactions with aldehydes, lower 
diastereoselectivity was observed.47  
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Scheme 1.25 
Diastereoselectivity at the β-position is not limited to trapping with aldehydes as imines 
can also be successfully used. As an example, lithiation of N-TBDPS sulfoximine 87 
using n-BuLi in THF at 0 °C and subsequent trapping with imine 102 at ‒45 °C gave a 
94:6 mixture of amines anti-103 and syn-103 in 68% yield (Scheme 1.26).48 This reaction 
proceeded with high diastereoselectivity but much lower diastereoselectivity was 
observed with an N-Me substituent. 
 
Scheme 1.26 
The use of sequential lithiation-trapping has been reported for the synthesis of a 
trisubstituted sulfoximine 107. Thus, N-TMS sulfoximine 78 was lithiated using n-BuLi 
and trapped with methyl iodide to give sulfoximine 104. Subsequent repetition of this 
reaction gave first disubstituted sulfoximine 105 then trisubstituted sulfoximine 106, 
which was deprotected using methanol to give NH sulfoximine 107 in 52% overall yield 
(Scheme 1.27).49 This reaction demonstrates that di- and trisubstituted sulfoximines can 
be synthesised with ease in high yields using lithiation-trapping reactions. The reactions 
were performed at 0 °C which is unusually high as a lower temperature of ‒78 °C is often 
used for lithiation-trapping reactions. Previous literature shows that the first methylation 
would have been successful at ‒78 °C,50 although a higher temperature is likely to be 
necessary for the second and third lithiations. 
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Scheme 1.27 
There has been a significant amount of work on the lithiation-trappings of N-substituted 
methyl sulfoximines and the previous examples in this chapter provide a representative 
sample. However, exploration of more complex sulfoximines remains somewhat 
neglected. A comprehensive set of examples is provided in the following schemes.  
The α-fluorination of N-Ts alkyl sulfoximines 108–110 has been investigated. Lithiation 
using n-BuLi and trapping with NFSI gave fluorinated sulfoximines 111–113 as mixtures 
of diastereomers in yields of 54-71% (Scheme 1.28).51 Unfortunately, there was no 
comment by the authors on the ratio of the diastereomers in these reactions.  
 
Scheme 1.28 
α-Fluorinated sulfoximines are able to undergo lithiation-trapping reactions to further 
functionalise the α-position. For example, α-fluoro N-Ts sulfoximine 114 was lithiated 
using n-BuLi in THF at ‒78 °C and trapped with methyl iodide to give sulfoximine syn-
111 (Scheme 1.29).52 Sulfoximine syn-111 was isolated in 75% yield as a single 
diastereomer after recrystallisation.  
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Scheme 1.29 
Double trapping at the α-position of sulfoximines such as N-Me sulfoximine 115 has also 
been reported. In this case, N-Me sulfoximine 115 was lithiated using two equivalents of 
n-BuLi (THF, ‒78 °C). The authors propose that a dianion is formed. Then, trapping with 
1,4-diiodobutane and 1,5-diiodopentane resulted in cyclisation to give sulfoximines 116 
and 117 in 76% and 81% yield respectively (Scheme 1.30).53 Trapping with shorter chain 
haloalkanes resulted in lower yields of the cyclisation products presumably due to 
increased strain in the small ring systems. 
 
Scheme 1.30 
The lithiation of sulfoximines and trapping with imines can be diastereoselective at both 
the α- and β-position. For example, N-TBDPS sulfoximine 118 was lithiated with n-BuLi 
in THF at ‒78 °C and subsequently trapped with imine 119.54 Preferential lithiation at the 
benzylic position gave sulfoximine syn,syn-120 in 86% yield with a 95:5 dr (Scheme 
1.31). The reaction displayed high diastereoselectivity when the imine was precomplexed 
with boron trifluoride-diethyl ether. When the reaction was performed without BF3•Et2O, 
sulfoximine syn,syn-120 was obtained in 60% yield with a 79:21 dr. 
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Scheme 1.31 
The lithiation-trapping of some cyclic sulfoximines has been explored using a range of 
alkyl halides. An example is the lithiation of 5-membered ring sulfoximine 85 using n-
BuLi in THF and subsequent trapping with benzyl bromide to give sulfoximine cis-121 
as a single diastereomer in 85% yield (Scheme 1.32).41 Similarly, the lithiation-trapping 
of 6-membered ring sulfoximine 86 with benzyl bromide gave sulfoximine cis-122 as a 
single diastereomer in 71% yield. Additional lithiation-trappings of 6-membered ring 
sulfoximine 86 were performed with methyl iodide, isopropyl iodide and 2,4,6-
trimethylbenzyl chloride giving α-substituted sulfoximines in good to high yields with 
high diastereoselectivity. It is proposed that the fixed conformation of the sulfoximine 
ring and a pyramidalised α-carbon allow the bulky phenyl group to block one face of the 
sulfoximine. This results in attack of the electrophile from the opposite face giving 
sulfoximines with the α-functional group cis to the sulfoximine oxygen. 
 
Scheme 1.32 
The effect of a second lithiation-trapping reaction at the α-position of cyclic sulfoximine 
cis-122 was then investigated (Scheme 1.33). Treatment of sulfoximine cis-122 with n-
BuLi in THF followed by trapping with methyl iodide resulted in stereoselective addition 
of the methyl group at the α-position trans to the phenyl group. Disubstituted sulfoximine 
trans-123 was synthesised as a single diastereomer in 96% yield. The opposite 
diastereomer, sulfoximine cis-123, was obtained using the same methodology. Thus, 
lithiation-trapping of sulfoximine cis-124 with benzyl bromide gave disubstituted 
sulfoximine cis-123 as a single diastereomer in 42% yield. These reactions demonstrate 
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that multiple substitutions can occur at the α-position of cyclic sulfoximines by a 
lithiation-trapping sequence. In addition, they proceed with full diastereoselectivity and 
offer a way of isolating both diastereomers of sulfoximine 123. 
 
 
Scheme 1.33 
There are a few examples of the lithiation-trapping reactions of cyclic N-CN sulfoximines 
since the α-functionalised products have potential applications as insecticides. Lithiation 
of N-CN sulfoximine 68 with LDA and trapping with electrophile 76 gave sulfoximine 
125 as a mixture of diastereomers in only 9% yield (Scheme 1.34).35 The authors did not 
comment on the diastereoselectivity or the low yield of the reaction. 
 
Scheme 1.34 
In another reaction, N-CN sulfoximine 68 was lithiated using n-BuLi and trapped with 
electrophile 126 to give monosubstituted sulfoximine 127 in 7.3% yield (Scheme 1.35).2 
In addition to this, a large quantity of unwanted disubstituted sulfoximine 128 was formed 
but no yield was given. The unintentional synthesis of disubstituted sulfoximines is of 
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particular interest as this was not observed in the previous reactions discussed. There was 
no comment on the diastereoselectivity of these reactions. 
  
Scheme 1.35 
Work by Degennaro describes a comprehensive study on the diastereoselectivity of 
lithiation of 4-membered ring N-Boc sulfoximine 129 and trapping with a range of 
electrophiles (Scheme 1.36).55 Optimisation of the reactions found organolithiums LDA 
and LHMDS were ineffective at deprotonation of the sulfoximine at the α-position, whilst 
use of stronger bases such as n-BuLi, n-HexLi and s-BuLi were successful. For example, 
lithiation of N-Boc sulfoximine 129 with s-BuLi in 2-MeTHF at ‒78 °C and trapping with 
benzophenone gave sulfoximine cis-130 in 68% yield. In addition, 2,4-disubstituted 
sulfoximine cis,cis-131 was obtained in 10% yield. The reaction was repeated using n-
HexLi as the lithiating agent in place of s-BuLi, obtaining exclusively sulfoximine cis-
130 in 88% yield. A possible explanation for the synthesis of disubstituted sulfoximine 
cis,cis-131 is via the formation of a dianion. This is likely due to the excess 0.3 
equivalents of s-BuLi used and the fact that it is a stronger base than n-HexLi. n-HexLi 
was used for future reactions as it gave the highest yield of sulfoximine cis-130 and no 
disubstituted sulfoximine cis,cis-131. The diastereoselectivity of the reactions was 
impressive, showing full cis stereocontrol at the α-position 
 
Scheme 1.36 
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Using the n-HexLi conditions in Scheme 1.36, a range of electrophiles were reacted 
successfully at the α-position of N-Boc sulfoximine 129 to give products with low to 
excellent yields (Figure 1.6). Of the electrophiles tested, benzyl bromide, phenyl 
isocyanate, methyl iodide and cyclopentanone all gave sulfoximines cis-132-135 with the 
α-substituent in a cis relationship to the oxygen with >95:5 dr in yields of 30-83% (Figure 
1.6). Trapping with cyclopentanone gave sulfoximine cis-135 in a relatively low yield of 
30%, which may be due to the competing α-deprotonation of cyclopentanone by the 
lithiated sulfoximine to form the enolate. 
 
Figure 1.6 α-Functionalised products of lithiation-trapping reactions of N-Boc 
sulfoximine 129 
When N-Boc sulfoximine 129 was lithiated using n-HexLi and trapped with Weinreb 
amide 136, a 65:35 mixture of keto-sulfoximines cis-137 and trans-137 was obtained in 
only 20% yield (Scheme 1.37). We suggest that a likely explanation for the poor 
diastereoselectivity of this reaction is that the acidic α-proton of the β-keto sulfoximine 
leads to epimerisation during the work-up. The low yield of this reaction was unexpected 
as Weinreb amides typically give good yields for lithiation-trapping reactions. 
  
Scheme 1.37 
As a final example, lithiation of N-Boc sulfoximine 129 using n-HexLi and trapping with 
Ph2MeSiCl gave a 65:35 mixture of sulfoximines cis-138 and trans-138 in 45% yield 
(Scheme 1.38). In this case, it is unlikely that sulfoximines cis-138 and trans-138 can 
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undergo epimerisation in the work-up so the reason for the poor diastereoselectivity is 
unknown. 
 
Scheme 1.38 
In summary, the lithiation-trapping of acyclic sulfoximines using a range of N-alkyl 
groups and electrophiles is well established. However, there are comparatively fewer 
examples with cyclic sulfoximines. With both acyclic and cyclic sulfoximines, there are 
isolated examples of α-diastereoselectivity but, apart from Degennaro’s results with N-
Boc 4-membered ring sulfoximine 129, there are no systematic studies of α-
diastereoselectivity with different electrophiles. 
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1.4 Project Outline 
There is increased interest in the use of the sulfoximine functional group in medicinal 
chemistry and agrochemistry. In terms of lithiation-trapping reactions, the current 
literature focuses on acyclic sulfoximines. Therefore, in order to broaden the synthetic 
scope of the methodology, we planned to investigate the lithiation-trapping of 5- and 6-
membered cyclic sulfoximines 139 to obtain α-substituted cyclic sulfoximines 140 
(Scheme 1.39). Functionalisation of the α-position with a range of electrophiles would 
allow us to investigate the diastereoselectivity of the reaction. We also planned to use a 
number of substituents on the nitrogen atom such as TBDPS, Boc, Me and CN to add 
further diversification to the molecule and to investigate their effect on the 
diastereoselectivity of the reaction. The results of these studies are discussed in Chapter 
2.1. 
 
Scheme 1.39 
Using the conditions of the initial studies set out in Scheme 1.39, we next planned to 
further functionalise α-substituted sulfoximines 141 and 143 to give 2,2-disubstituted 
products 142 as well as 2,5- and 2,6-disubstituted products 144 (Scheme 1.40). To access 
the 2,2-disubstituted products 142, lithiation at the most acidic position α to the ketone 
would be used to control the regiochemistry. Thus, lithiation of sulfoximine 141 should 
give sulfoximine 142. Lithiation-trapping of sulfoximines 143 should give disubstituted 
products 144 with regioselectivity controlled by steric factors. The results of our studies 
in both of these reactions are described in Chapter 2.2 
 
Scheme 1.40
Chapter Two: Results and Discussion 
 
28 
 
2. Results and Discussion 
2.1 Synthesis of Sulfoximines 
For our planned lithiation-trapping studies, it was decided to synthesise cyclic 
sulfoximines with different N-substituents such as N-TBDPS, N-Boc, N-Me and N-CN. 
Based on the literature presented in Chapter 1.2, the methods by Luisi, Bull and co-
workers for direct synthesis of NH sulfoximines from sulfides26 and sulfoxides25 were 
selected as the key step in the planned route to the N-TBDPS, N-Boc and N-Me 
sulfoximines (Scheme 2.1). These methods were preferable as they were metal-free, did 
not require potentially explosive reagents such as azides and were performed under mild 
conditions. The NH sulfoximine could then be easily functionalised with different 
substituents to give the N-TBDPS, N-Boc and N-Me sulfoximines. In contrast, we 
planned to synthesise the N-CN sulfoximines by a one-pot procedure directly from the 
sulfoxides as this avoided the use of particularly toxic cyanogen bromide.56 
 
Scheme 2.1 
To start, 5-membered ring N-TBDPS cyclic sulfoximine 146 was synthesised. The first 
route explored used Luisi and Bull’s original method.25 Treatment of sulfoxide 145 with 
PIDA (3.0 eq.) and ammonium carbamate (4.0 eq.) at rt for 30 min gave NH sulfoximine 
23 (Scheme 2.2). The crude product was reasonably pure by 1H NMR spectroscopy, with 
the signals matching those stated in the literature.25 For the introduction of the TBDPS 
group, a method that was reported for an acyclic sulfoximine was selected. Thus, reaction 
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of NH sulfoximine 23 with TBDPSCl (1.25 eq.) and imidazole (2.0 eq.) in DMF at 90 °C 
gave novel N-TBDPS sulfoximine 146 in 50% overall yield after chromatography. 
Analysis of the 1H NMR spectrum of N-TBDPS sulfoximine 146 showed a 9H singlet at 
δH 1.08 which indicated the successful addition of the TBDPS group. 
 
Scheme 2.2 
An alternative route to 5-membered ring N-TBDPS sulfoximine 146 was explored using 
Luisi and Bull’s method starting from the corresponding sulfide.26 Treatment of sulfide 
66 with PIDA (2.5 eq.) and ammonium carbamate (2.0 eq.) at rt for 3 h gave crude NH 
sulfoximine 23 which was sufficiently pure for use in the next step. Subsequent TBDPS 
protection using the same method as used previously gave N-TBDPS sulfoximine 146 in 
60% overall yield (Scheme 2.3). A comparison of the two routes to N-TBDPS sulfoximine 
146 showed that less equivalents of PIDA and ammonium carbamate were required when 
starting from the sulfide compared to the sulfoxide and that a longer reaction time of 3 h 
was needed for the sulfide route. Sulfide 66 was significantly cheaper to purchase than 
sulfoxide 23 and therefore it was preferable to synthesise the NH sulfoximine from the 
sulfide and this method was selected for all the other examples. 
 
Scheme 2.3 
The syntheses of five N-TBDPS protected sulfoximines using this two-step approach are 
summarised in Table 2.1. The best yields were obtained for the 5- and 6-membered ring 
N-TBDPS sulfoximines 146 and 147 (entries 2 and 3). Unexpectedly, the 4-membered 
ring N-TBDPS sulfoximine 148 was obtained in a low 19% yield (entry 1). Intermediate 
yields were observed for the acyclic diethyl and phenylethyl N-TBDPS sulfoximines 149 
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and 150 (entries 4 and 5). The NMR spectroscopic data of all NH sulfoximines matched 
the literature in each case.26,57,58,59 All N-TBDPS sulfoximines 146–150 were not 
previously reported in the literature and analysis of their 1H NMR spectra showed a 9H 
singlet around δH 1.0-1.2 which indicated the successful addition of the TBDPS group.  
 
Entry R1 R2 Compound Yield/%a 
1 -(CH2)3- 
-(CH2)4- 
-(CH2)5- 
148 19 
2 146 60 
3 147 53 
4 Et Et 149 32 
5 Ph Et 150 38 
a % yield after purification by chromatography. 
Table 2.1 Synthesis of N-TBDPS sulfoximines 146–150 
The synthesis of N-Boc sulfoximines was explored using our standard procedure to form 
the 5-membered ring NH sulfoximine 23 from sulfide 66, and a procedure for the addition 
of a Boc group to an acyclic sulfoximine (Scheme 2.4).60 Addition of potassium tert-
butoxide and Boc2O to NH sulfoximine 23 gave 5-membered ring N-Boc sulfoximine 153 
in 60% yield over two steps. The spectroscopic data for this compound was consistent 
with those reported in the literature.57 The same method was applied to the 6-membered 
ring sulfide 152 resulting in a 43% yield of N-Boc sulfoximine 154, a compound that has 
not been reported previously in the literature. For the synthesis of N-Me sulfoximines, 
our standard procedure was used to afford NH sulfoximines 23 and 152. We then opted 
to use Eschweiler-Clarke conditions for the N-methylation due to literature precedent.37 
Treatment of NH sulfoximines 23 and 152 with paraformaldehyde and formic acid gave 
N-Me sulfoximines 155 and 156 in 55% and 50% yield respectively (Scheme 2.4). The 
spectroscopic data for N-Me sulfoximine 155 was consistent with those reported in the 
literature37 whilst N-Me sulfoximine 156 has not been previously reported.  
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Scheme 2.4 
N-CN sulfoximines can be synthesised from NH sulfoximines but methods typically 
require toxic reagents such as cyanogen bromide.61 In order to avoid this, we followed a 
procedure by Dannenberg which used relatively mild conditions to synthesise N-CN 5-
membered ring sulfoximine 68 directly from sulfoxide 145.56 Treatment of sulfoxide 145 
with cyanamide, potassium tert-butoxide and N-chlorosuccinimide in water resulted in 
N-CN sulfoximine 68 in 50% yield (Scheme 2.5). The NMR spectroscopic data for this 
compound were consistent with literature values.56 
 
Scheme 2.5 
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2.2 α-Lithiation and Trapping of Sulfoximines 
With a range of N-substituted cyclic and acylic sulfoximines in hand, the α-lithiation-
trapping reactions were investigated. The plan was to explore the effect of different ring 
sizes, different N-substituents and different electrophiles on the yield and 
diastereoselectivity of the lithiation-trapping reactions. 
2.2.1 α-Lithiation and Trapping of N-TBDPS Sulfoximines 
To begin with, we explored the lithiation-trapping of 5-membered ring N-TBDPS 
sulfoximine 146. It was decided to use n-BuLi as the lithiating agent, THF as the solvent 
and a temperature of ‒78 °C for the reaction based on related literature examples (see 
Chapter 1.3). Benzophenone was selected as the first electrophile as it should undergo 
fast trapping and reaction of the lithiated sulfoximine would introduce only one additional 
stereocentre. Based on a procedure reported for dimethyl sulfoximine 48,38 N-TBDPS 
sulfoximine 146 was lithiated using n-BuLi in THF at ‒78 °C for 20 min and trapped with 
benzophenone to give N-TBDPS sulfoximine cis-157 in 66% yield after purification by 
column chromatography (Scheme 2.6).  
 
 
 
 
Scheme 2.6 
Analysis by 1H NMR spectroscopy of both the crude and purified product showed that 
only one diastereomer of the sulfoximine was obtained. Diagnostic signals in the 1H NMR 
spectrum of N-TBDPS sulfoximine cis-157 are shown in Figure 2.1. A 1H signal at δH 
4.32 (dd, J = 16.5, 7.5 Hz) was assigned to the α-proton adjacent to the benzyl alcohol. 
This signal was significantly further downfield than the 2H multiplet at δH 2.67-2.51 due 
to the other two α-protons. A 1H singlet at δH 5.11 was assigned to the OH group. 
 
Figure 2.1 1H NMR spectroscopic data for N-TBDPS sulfoximine cis-157 
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The cis-stereochemistry of sulfoximine cis-157 was determined by X-ray crystallography 
(Figure 2.2). The X-ray structure clearly showed that the oxygen bonded to sulfur is cis 
to the α-substituent, with the nitrogen in a trans orientation. The proximity of the 
sulfoximine oxygen to the OH group indicates the presence of an intramolecular hydrogen 
bond. 
 
Figure 2.2 X-ray structure of N-TBDPS 5-membered ring sulfoximine cis-157 
In an effort to improve the yield of sulfoximine cis-157, we followed a procedure for the 
lithiation-trapping of an acyclic sulfoximine which used LHMDS for the deprotonation 
step.60 Sulfoximine 146 was lithiated using LHMDS in THF at ‒78 °C for 20 min and 
subsequent trapping with benzophenone gave sulfoximine cis-157 in 59% yield (Scheme 
2.7). In an attempt to improve the yield, the lithiation time was increased from 20 min to 
1 h. However, this had little effect as sulfoximine cis-157 was formed in 53% yield with 
a 1 h lithiation time.  
 
Scheme 2.7 
It was then realised that sulfoximine 146 appeared to be rather hygroscopic. Therefore, 
extra steps were taken for drying the compound, including removing the water by 
azeotroping with toluene and drying on the high vacuum immediately before use. With 
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these precautions in place, the reaction with n-BuLi shown in Scheme 2.7 was repeated 
and this gave sulfoximine cis-157 in 84% yield. The extra drying steps led to a higher 
yield of sulfoximine cis-157 and this method was therefore preferred and used for all 
subsequent lithiation-trapping reactions. Lithiation-trapping reactions were typically 
performed on a 0.5 or 1.0 mmol scale. 
For comparison, the lithiation-trapping of 6-membered ring N-TBDPS sulfoximine 147 
using n-BuLi and benzophenone was carried out. In this case, sulfoximine cis-158 was 
obtained in 76% yield after chromatography (Scheme 2.8). Analysis by 1H NMR 
spectroscopy of both the crude and purified product showed that only one diastereomer 
was formed in this reaction.  
 
Scheme 2.8                   
The stereochemistry of sulfoximine cis-158 was confirmed by X-ray crystallography 
(Figure 2.3). In the chair conformation of the 6-membered ring, the oxygen of the 
sulfoximine is axial and the adjacent α-substituent is equatorial confirming their cis 
relationship. In this case, there is an intramolecular hydrogen bond between the 
sulfoximine nitrogen and the OH group, contrasting with the 5-membered ring 
sulfoximine cis-157 (see Figure 2.2).  
 
 
 
 
 
  
 
Figure 2.3 X-ray structure of N-TBDPS 6-membered ring sulfoximine cis-158 
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To explore whether the observed cis-diastereoselectivity in the trapping applied to other 
ring sizes, we investigated the diastereoselectivity of the lithiation-trapping of 4-
membered ring N-TBDPS sulfoximine 148. This would also provide an interesting 
comparison with the related 4-membered ring N-Boc sulfoximine 129 which displayed a 
high level of cis-diastereoselectivity across a range of electrophiles (see Chapter 1.3).55 
Thus, N-TBDPS sulfoximine 148 was lithiated with n-BuLi and trapped with 
benzophenone to give an 85:15 mixture of sulfoximine cis-159 and the unexpected 
double-trapped sulfoximine cis,cis-160 (by 1H NMR spectroscopy). After 
chromatography, the two products were obtained as an inseparable 85:15 mixture of 
sulfoximines cis-159 (57% yield) and cis,cis-160 (10% yield) (Scheme 2.9). The 
stereochemistry of sulfoximine cis-159 was assigned by analogy with the previously 
described 5- and 6-membered ring results. For the double-trapped sulfoximine cis,cis-
160, the symmetrical features in the 1H and 13C NMR spectra and the fact it would likely 
come from sulfoximine cis-159 led us to propose the assigned stereochemistry. 
 
Scheme 2.9 
Diagnostic signals in the 1H NMR spectrum of N-TBDPS sulfoximine cis,cis-160 are 
shown in Figure 2.4. A 2H signal at δH 5.15 (dd, J = 10.0, 10.0 Hz) was assigned to the 
α-protons adjacent to the benzyl alcohol. A 1H signal at δH 2.92 (dt, J = 12.5, 10.0 Hz) 
was assigned to one of the two diastereotopic protons in the ring. The 2H singlet at δH 
4.82 was assigned to the two OH groups.  
 
 
 
 
 
 
Figure 2.4 1H NMR spectroscopic data for N-TBDPS sulfoximine cis,cis-160 
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Analysis of the 13C NMR spectrum of monosubstituted sulfoximine cis-159 showed a 
signal at δC 86.4 which was assigned to the SCH group. The signal at δC 65.8 was assigned 
to the SCH2 group and the signal at δC 10.2 was assigned to the CH2 in the ring. The 13C 
NMR spectrum of double-trapped sulfoximine cis,cis-160 had one signal at δC 83.7 
assigned to the two equivalent SCH groups. There was no signal indicating an SCH2 group 
and the signal at δC 13.9 was assigned to the CH2 in the ring. A comparison of these two 
signals gave further evidence that sulfoximine cis,cis-160 was disubstituted and had a 
plane of symmetry. This plane of symmetry means that the sulfoximine could have either 
cis,cis- or trans,trans-stereochemistry. However, we believe that benzophenone adds 
trans to the N-TBDPS group as this was the case for both the 5- and 6-membered ring 
sulfoximines cis-157 and cis-158.  
In order to explain the formation of the disubstituted sulfoximine cis,cis-160, we propose 
that the 4-membered ring N-TBDPS sulfoximine 148 forms a small amount of dianion 
161 during lithiation which is then double-trapped with benzophenone (Scheme 2.10). 
The formation of a dianion from sulfoximines is known (see Scheme 1.30, sulfoximine 
115) although, this was achieved by using 2 equivalents of n-BuLi at a high temperature 
of 0 °C. Since no disubstituted product was observed when 5- and 6-membered ring N-
TBDPS sulfoximines 146 and 147 underwent lithiation-trapping with benzophenone, it 
appears that the 4-membered ring sulfoximine 148 is more susceptible to dianion 
formation. Presumably, the 0.1 equivalents excess of n-BuLi in the reaction mixture is 
thought to contribute to the formation of the dianion. 
 
Scheme 2.10 
In order to explain the preferred formation of the cis-sulfoximines cis-157, cis-158 and 
cis-159, we surveyed the literature for information on the structure of the lithiated 
sulfoximine from either X-ray crystallography or solution NMR spectroscopic studies. 
Work by Gais and co-workers reported the characterisation of lithiated allyl N-TMS 
sulfoximine 161 by X-ray crystallography (Figure 2.5).62 The angle between the sulfur-
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α-carbon bond and the α-carbon-β-carbon bond was 124.3° which is close to the value 
expected for an sp2 hybridised carbanion. Additional bond angle calculations showed that 
the α-carbon is in an essentially planar environment. The structure of related lithiated N-
TMS sulfoximine 162 (Figure 2.5) was determined by X-ray crystallography and solution 
NMR spectroscopic studies in THF.63 In the proton-coupled 13C NMR spectrum, the α-
carbon signal appeared as a doublet at δC 40.6 with a JCH coupling of 15.0 Hz. This 
indicated that lithiated sulfoximine 162 is highly solvated by THF with some planarity 
around the α-carbon atom and little or no C‒Li contact.  
 
  
 
Figure 2.5 Lithiated sulfoximines 161–163 and 69 
Analysis of lithiated N-Me sulfoximine 69 (Figure 2.5) by X-ray crystallography showed 
that the α-carbon-sulfur bond displayed double bond character as it was shorter than that 
expected for a single bond.64 It was suspected that the α-carbon-sulfur bond of lithiated 
N-Me sulfoximine 163 (Figure 2.5) also displayed similar double bond character. 
Variable temperature 13C NMR spectroscopic studies of lithiated sulfoximine 163 showed 
a rapid exchange of the diastereotopic methyl groups at temperatures down to ‒103 °C. 
Therefore, if the two methyl groups in sulfoximine 163 were replaced with non-identical 
groups, the resultant lithiated sulfoximine would be configurationally unstable at the 
anionic carbon atom. This configurational instability also suggests that there is no C‒Li 
bond.   
Putting all of this structural information on lithiated sulfoximines together, we suggest 
that the model shown in Figure 2.6 can explain the diastereoselectivity of the lithiation-
trapping reactions of cyclic N-TBDPS sulfoximines. It is proposed that electrophilic 
trapping occurs from an sp2 hybridised carbanion with no C‒Li contact. The sterically 
bulky TBDPS group is able to block one face of the sulfoximine preventing electrophilic 
attack on one side. As a result, the trapped sulfoximine adopts a configuration where the 
new α-substituent is cis to the sulfoximine oxygen.  
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Figure 2.6 Model for electrophilic trapping 
Due to the high yields and diastereoselectivity, the lithiation-trapping reactions of 5-
membered ring and 6-membered ring N-TBDPS sulfoximines 146 and 147 were then 
explored using a range of electrophiles. Lithiation-trapping of 5-membered ring 
sulfoximine 146 with benzaldehyde gave a crude product which contained an 85:15 
mixture (by 1H NMR spectroscopy) of sulfoximines cis,anti-164 and cis,syn-164. After 
purification by chromatography, sulfoximines cis,anti-164 and cis,syn-164 were isolated 
in 66% and 10% yield respectively (Scheme 2.11). Analysis of the minor product cis,syn-
164 by X-ray crystallography identified its stereochemistry (Figure 2.7). The oxygen 
bonded to sulfur is cis to the α-substituent whilst the nitrogen is in a trans orientation. 
Both the sulfoximine oxygen and the alcohol oxygen are held closely together due to 
intramolecular hydrogen bonding between the two. Given that other electrophile 
trappings occur trans to the N-TBDPS group, the major product was believed to be 
cis,anti-164 and was assigned by analogy.  
 
Scheme 2.11 
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Figure 2.7 X-ray structure of N-TBDPS sulfoximine cis,syn-164 
In the 1H NMR spectrum of cis,anti-164, the PhCH signal appeared as a 1H singlet at δH 
5.12 as any coupling to the SCH was too small to be resolved, whereas the 1H NMR 
spectrum of cis,syn-164 displayed the PhCH signal as a 1H doublet at δH 4.89 (J = 9.5 
Hz). The 13C NMR spectra of both products showed signals at similar δC values. For 
example, cis,syn-164 had signals at δC 70.1 for SCH, δC 68.6 for PhCH and δC 57.3 for 
SCH2 whereas cis,anti-164 had signals at δC 70.5 for SCH, δC 75.5 for PhCH and δC 56.2 
for SCH2. 
The lithiation-trapping of 6-membered ring sulfoximine 147 with benzaldehyde gave a 
similar result. An 85:15 mixture of sulfoximines cis,anti-165 and cis,syn-165 was formed 
(from the 1H NMR spectrum of the crude product). In this case, the diastereomers were 
not separable and an 85:15 mixture was isolated in 73% yield after chromatography 
(Scheme 2.12). The stereochemistry of the products was assigned by analogy with 5-
membered ring sulfoximines cis,anti-164 and cis,syn-164. The stereochemical 
assignment was supported by the fact that the 1H NMR spectra of sulfoximines cis,anti-
165 and cis,syn-165 displayed key similarities with those of sulfoximines cis,anti-164 and 
cis,syn-164. The PhCH signal of cis,anti-165 appeared as a 1H singlet at δH 5.89 and the 
PhCH signal of cis,syn-165 appeared as a 1H doublet at δH 5.34 (J = 9.0 Hz). Hence, the 
PhCH signals of cis,syn-165 and cis,syn-164 appear as 1H doublets with similar J values 
(9.0, 9.5 Hz) and are slightly further upfield than the 1H singlets for the PhCH signals of 
cis,anti-165 and cis,anti-164. 
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Scheme 2.12 
At this stage, we decided to explore alkylating reagents for the trapping of the lithiated 
sulfoximines. Lithiation-trapping of 5-membered ring sulfoximine 146 with benzyl 
bromide gave sulfoximine cis-166 as a single diastereomer in 73% yield (Scheme 2.13). 
The stereochemistry of cis-166 was assigned by analogy with sulfoximine cis-157. 
Analysis of sulfoximine cis-166 by 1H and 13C NMR spectroscopy showed no additional 
signals indicating that only one diastereomer was obtained and no disubstituted 
sulfoximine cis,cis-167 was synthesised. In contrast, trapping of 6-membered ring 
sulfoximine 147 with benzyl bromide gave the disubstituted sulfoximine cis,cis-169 in 
33% yield in addition to sulfoximine cis-168 in 31% yield (Scheme 2.13).  
 
Scheme 2.13 
Analysis of sulfoximine cis,cis-169 by 1H NMR spectroscopy showed that the compound 
is symmetrical. There were two 2H dd signals at δH 3.42 (J = 13.5, 2.5 Hz) and δH 2.51 
(J = 12.5, 12.5 Hz) due to the four PhCH2 protons. The 2H multiplet signal at δH 2.96-
2.83 showed that there were two α-protons. Additional evidence came from the 13C NMR 
spectrum where only one CH signal and three CH2 signals were observed (Figure 2.8). 
The CH signal was significantly downfield at δC 67.6 and corresponded to the two SCH 
carbons. One CH2 signal at δC 31.6 was assigned to the two PhCH2 carbons whilst the two 
remaining CH2 signals at δC 29.0 and δC 24.8 were assigned to the three CH2 groups in 
the ring. If the sulfoximine was not symmetrical, we would have observed three additional 
signals, one for SCH, one for PhCH2 and one for a CH2 in the ring. As the data proved 
that the sulfoximine is symmetrical, we knew that the stereochemistry had to be either 
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cis,cis or trans,trans. The stereochemistry of both sulfoximines cis-157 and cis-158 were 
proven by X-ray crystallography and therefore we reasoned that benzyl bromide would 
add to sulfoximine 147 trans to the N-TBDPS group to give sulfoximine cis,cis-169. 
 
Figure 2.8 13C NMR spectroscopic data for N-TBDPS sulfoximine cis,cis-169 
Our proposed pathway for the formation of the disubstituted product cis,cis-169 is shown 
in Scheme 2.14. Initially, we believe that the desired reaction occurs i.e. the carbanion of 
deprotonated sulfoximine 170 attacks benzyl bromide to form cis-168. If benzyl bromide 
was slow to trap then it is likely that there would be deprotonated sulfoximine 170 still 
present. This could deprotonate sulfoximine cis-168 at the other α-position to give cis-
171 and regenerate the starting material 147. The carbanion of deprotonated sulfoximine 
cis-171 could then trap a second benzyl bromide to form cis,cis-169. We believe dianion 
formation, as proposed in Scheme 2.10 with the 4-membered ring sulfoximine 148, is less 
likely as formation of the disubstituted product would be dependent on the initial lithiation 
step. We observed no disubstituted product when these same conditions were used in the 
lithiation-trapping of 5- and 6-membered ring sulfoximines 146 and 147 with 
benzophenone (Scheme 2.14). Analysis of the 1H NMR spectrum of the crude product 
showed that a small amount of starting material was present although the exact amount 
could not be calculated due to overlapping signals. The presence of this starting material 
supports our proposed pathway.  
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Scheme 2.14 
The synthesis of disubstituted sulfoximine cis,cis-169 led us to investigate whether 
disubstituted products would result after trapping sulfoximines with other alkylating 
agents. We therefore investigated the lithiation-trapping of sulfoximines 146 and 147 with 
methyl iodide and dimethyl sulfate. The results are summarised in Table 2.2.  
 
Entry n Starting material Electrophile Mono-product (%)a Di-product (%)a 
1b 1 146 MeI cis-172, 56 cis,cis-173, 0 
2d 1 146 MeI cis-172, 45 cis,cis-173, 3 
3b 2 147 MeI cis-174, 47 cis,cis-175, 12 
4c 1 146 Me2SO4 cis-172, 45 cis,cis-173, 7  
5b 2 147 Me2SO4 cis-174, 52 cis,cis-174, 9 
a % yield after purification by chromatography. b 0.5 mmol scale. c 1.0 mmol scale. d 5.0 
mmol scale. 
Table 2.2 Results of lithiation-trapping reactions with methylating agents 
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The relative configuration of 5-membered ring sulfoximine cis-172 was confirmed by X-
ray crystallography (Figure 2.9) and the relative configuration of 5-membered ring 
sulfoximine cis,cis-173 was assigned by analogy. The X-ray crystal structure of 
sulfoximine cis-172 showed that the oxygen bonded to sulfur is cis to the α-substituent, 
with the nitrogen in a trans orientation.  
 
 
 
 
 
 
 
Figure 2.9 X-ray structure of N-TBDPS sulfoximine cis-172 
The relative configuration of 6-membered ring sulfoximine cis,cis-175 was confirmed by 
X-ray crystallography (Figure 2.10) and the relative configuration of 6-membered ring 
sulfoximine cis-174 was assigned by analogy. The X-ray crystal structure of sulfoximine 
cis,cis-175 showed that both α-substituents are cis to the oxygen bonded to sulfur, with 
the nitrogen in a trans orientation. The 6-membered ring adopts a chair conformation 
where N-TBDPS and the two α-methyl groups sit in equatorial positions whereas the 
oxygen bonded to sulfur is axial. 
 
 
 
 
 
 
 
 
Figure 2.10 X-ray structure of N-TBDPS sulfoximine cis,cis-175 
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Analysis of the 1H NMR spectrum of disubstituted cis,cis-173 showed a 6H doublet at δH 
1.09 (J = 7.0 Hz) showing that there were two equivalent methyl groups. The 13C NMR 
spectrum showed that there was only one signal at δC 59.3 for the two SCH carbons, one 
signal at δC 28.1 for the two CH2 carbons in the ring and one signal at δC 12.7 for the two 
α-methyl groups. Therefore, the sulfoximine must be symmetrical. The 1H and 13C NMR 
spectra of cis,cis-175 also displayed the same evidence of symmetry. 
The lithiation-trapping of 5-membered ring sulfoximine 146 with methyl iodide gave 
exclusively 5-membered ring sulfoximine cis-172 in 56% yield (Table 2.2, entry 1). 
However, when this reaction was repeated on a 5 mmol scale, we obtained sulfoximine 
cis-172 in 45% yield and disubstituted sulfoximine cis,cis-173 in 3% yield (entry 2). It is 
likely a small amount of the disubstituted product formed in the small-scale reaction 
although it was not visible by 1H NMR spectroscopy and we were unable to isolate it. 
Lithiation-trapping of 6-membered ring sulfoximine 147 with methyl iodide gave the 
monosubstituted sulfoximine cis-174 in 47% yield and disubstituted sulfoximine cis,cis-
175 in 12% yield (entry 3).  
The use of dimethyl sulfate was also explored. Lithiation-trapping of 5-membered ring 
sulfoximine 146 with dimethyl sulfate gave mono-substituted methyl sulfoximine cis-172 
in 45% yield and disubstituted sulfoximine cis,cis-173 in 7% yield (entry 4). It was found 
that lithiation-trapping of 6-membered ring sulfoximine 147 with dimethyl sulfate also 
gave the disubstituted sulfoximine cis,cis-175 (9% yield) together with monosubstituted 
sulfoximine cis-174 (52% yield) (entry 5).                                                                  
By comparing all of the results in Table 2.2, it is clear that use of either methyl iodide or 
dimethyl sulfate gave similar yields of both monosubstituted and disubstituted 
sulfoximines. A comparison of the 5- and 6-membered ring systems showed that 6-
membered ring disubstituted sulfoximine cis,cis-175 was synthesised in a slightly higher 
yield than 5-membered ring disubstituted sulfoximine cis,cis-173 when either 
methylating reagent was used. The structural similarity of the methylating reagents and 
benzyl bromide suggests that they are likely to behave in the same way in lithiation-
trapping reactions. As a result, we propose that disubstituted sulfoximines cis,cis-173 and 
cis,cis-175 are synthesised via the mechanism shown in Scheme 2.14. The moderate 
yields of the methylation reactions and formation of disubstituted sulfoximines is 
expected to be a result of slow trapping by the methylating reagents at low temperatures 
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(‒78 °C).65 To establish this, we plan to monitor the reactions using in situ ReactIR™ in 
the future. 
The lithiation-trapping of 5-membered ring sulfoximine 146 with trimethylsilyl chloride 
was also explored and we found that it gave exclusively silyl sulfoximine cis-176 in 79% 
yield (Scheme 2.15). We assigned the stereochemistry of sulfoximine cis-176 by analogy 
with the other examples studied thus far. The 1H NMR spectrum showed a 2H multiplet 
at δH 2.60-2.53 for two SCH protons and the other SCH proton was a 1H dd (J = 12.0, 
7.5 Hz) slightly further upfield at δH 2.42. In our previous lithiation-trapping reactions, 
the α-substituent was electron withdrawing resulting in a large downfield shift of the 
remaining α-proton in the 1H NMR spectrum and a large downfield shift of the SCH 
signal in the 13C NMR spectrum. In this case, silicon is electron donating and these shifts 
are not observed. For example, the 13C NMR spectrum of cis-176 showed a signal δC 57.1 
for SCH and a signal at δC 56.5ppm for SCH2. 
 
Scheme 2.15 
Sulfoximines with a ketone functionality, β-keto sulfoximines, can be synthesised by 
lithiation-trapping reactions with either esters or Weinreb amides (Table 1.2 and Scheme 
1.37). As disubstitution is possible when trapping with esters, we started with Weinreb 
amides. Following a literature procedure,66 phenyl and pyridine Weinreb amides 136 and 
179 were synthesised from benzoyl chloride 177 and nicotinoyl chloride hydrochloride 
178 using N,O-dimethyl hydroxylamine hydrochloride and Et3N. Phenyl and pyridine 
Weinreb amides 136 and 179 were obtained in 74% and 57% yield respectively (Scheme 
2.16).  
 
 
 
Scheme 2.16 
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Lithiation-trapping of 5-membered ring sulfoximine 146 with phenyl Weinreb amide 136 
gave a 75:25 ratio of diastereomeric ketones cis-180 and trans-180 (by 1H NMR 
spectroscopy of the crude product). The sulfoximines were separated by chromatography 
to give ketones cis-180 and trans-180 in 60% and 20% yield respectively (Scheme 2.17). 
In this case, the stereochemistry of the two products is assumed to be as depicted. We 
found that the diastereomeric ratio changed each time that the reaction was performed, 
giving a 55:45 mixture in one instance and a 65:35 mixture in another. A similar outcome 
was observed with 6-membered ring sulfoximine 147. Thus, lithiation-trapping of 
sulfoximine 147 gave the crude product which contained a 75:25 mixture of ketones cis-
181 and trans-181 (by 1H NMR spectroscopy). After chromatography, sulfoximines cis-
181 and trans-181 were isolated in 57% and 16% yield respectively (Scheme 2.17). 
 
Scheme 2.17 
The stereochemistry of the β-keto sulfoximines were assigned by assuming that the major 
products had cis configurations. Analysis of 5-membered ring sulfoximines cis-180 and 
trans-180 by 1H NMR spectroscopy showed their spectra to have 1H dd signals for cis-
180 and trans-180 at δH 4.73 (J = 8.0, 6.0 Hz) and δH 4.97 (J = 7.5, 7.5 Hz) respectively. 
These were significantly further downfield than the other protons on the ring (δH 2.00-
3.00) due to the introduction of the ketone functionality. Analysis of 6-membered ring 
sulfoximines cis-181 and trans-181 by 1H NMR spectroscopy showed that their spectra 
contained 1H multiplet signals for cis-181 and trans-181 at δH 4.55-4.50 and δH 4.85-4.78 
respectively, which are similar shifts to those of the 5-membered ring sulfoximines. 
At this time, phenyl Weinreb amide 136 was the only electrophile to demonstrate poor α-
diastereoselectivity. To explain this outcome, we suggest that tetrahedral intermediate 
cis-182 forms and, upon quenching, this gives β-keto sulfoximine cis-180 (Scheme 2.18). 
However, due to the acidity of the α-proton, epimerisation readily occurs via enolisation 
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to give the observed ratio of β-keto sulfoximines cis-180 and trans-180. Epimerisation 
could occur to different amounts to explain the different ratios obtained. 
 
Scheme 2.18 
Following on from this work, the lithiation-trapping of 5-membered ring sulfoximine 146 
with pyridine Weinreb amide 179 was explored. This gave an 85:15 ratio of β-keto 
sulfoximine cis-183 and double-trapped β-keto sulfoximine trans,cis-184 (by 1H NMR 
spectroscopy). The sulfoximines were separated by column chromatography to give 
sulfoximines cis-183 and trans,cis-184 in 71% and 6% yield respectively (Scheme 2.19). 
The stereochemistry of sulfoximine cis-183 was assumed based on the previous 
examples. Analysis of sulfoximine cis-183 by 1H NMR spectroscopy showed a 1H dd at 
δ 4.92 (J = 7.5, 7.5 Hz) for the α-proton which had shifted significantly downfield due to 
the addition of the ketone. No additional signals were present in the 1H or 13C NMR 
spectra indicating that the trans diastereomer was not formed. It is not clear why 
epimerisation did not occur in this case. The 2,5-disubstituted sulfoximine was assigned 
as trans,cis-184 as the 1H NMR spectrum showed two 1H dd signals for the α-protons at 
δH 5.10 (J = 8.0, 8.0 Hz) and δH 4.54 (J = 8.0, 3.5 Hz). Additional evidence came from 
the 13C NMR spectrum. Two signals at 69.4 ppm and 68.9 ppm were observed for the two 
SCH groups and two signals at 23.6 ppm and 23.3 ppm were seen for the two CH groups 
in the ring. Therefore, the sulfoximine was not symmetrical.  
 
Scheme 2.19 
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The formation of the disubstituted sulfoximine was surprising and we propose two 
possible routes for its synthesis. Sulfoximine 146 could form a dianion due to the 0.1 
equivalents excess of n-BuLi however, there is currently no evidence for this as our 
previous reactions with sulfoximine 146 have shown disubstitution to occur only with 
alkylating agents. An alternative route is shown in Scheme 2.20. Reaction of the lithiated 
sulfoximine with Weinreb amide 179 would give sulfoximine cis-185. It is then possible 
that the excess n-BuLi could lithiate sulfoximine cis-185 to give carbanion cis-186 which 
could be trapped a second time with Weinreb amide 179. It may be expected that diketone 
cis,cis-184 should form but it is possible that epimerisation occurs to give the observed 
trans,cis-184. 
 
Scheme 2.20 
As the addition of the pyridine Weinreb amide 179 to sulfoximine 146 gave exclusively 
β-keto sulfoximine cis-183, we wondered if high stereoselectivity would prevail with 
other carbonyl additions. However, lithiation-trapping of 5-membered ring sulfoximine 
146 with tert-butyl isocyanate gave amido sulfoximines 187a and 187b as a 55:45 mixture 
of diastereomers (by 1H NMR spectroscopy). Amido sulfoximine 187a was isolated in 
29% yield, whilst amido sulfoximine 187b was isolated in 39% yield (Scheme 2.21). 
Presumably, epimerisation in the work-up of the amido sulfoximines 187a and 187b 
could account for such poor diastereoselectivity. A small quantity of by-product 188 was 
detected by mass spectrometry. This was thought to form from reaction of the initially 
formed amido anion with a second equivalent of electrophile.  
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Scheme 2.21 
Use of methyl chloroformate as the electrophile also led to poor α-diastereoselectivity. 
Trapping 5-membered ring sulfoximine 146 with methyl chloroformate gave a 70:30 
mixture of ester sulfoximines cis-189 and trans-189 (by 1H NMR spectroscopy) (Scheme 
2.22). It is assumed that the major product was cis-189. The formation of the products 
was confirmed by mass spectrometry and 1H NMR spectroscopy. However, a significant 
amount of starting material remained which was not quantifiable. After several attempts 
at purification by chromatography, the products were not isolated cleanly. 
 
Scheme 2.22 
In terms of yield, lithiation and trapping with an imine was not very successful. When the 
lithiation-trapping of 5-membered ring sulfoximine 146 with N-benzylidene methylamine 
was attempted, a single unassigned diastereomeric amino sulfoximine 190 was obtained 
in only 11% yield (Scheme 2.23). In addition, 66% of the starting material 146 was 
recovered. Repetition of the reaction did not increase the yield of amino sulfoximine 190. 
Analysis of the 1H NMR spectrum of amino sulfoximine 190 showed the signal for the 
α-proton to be a 1H multiplet at δH 3.22–3.13 and the signal for PhCH to be a 1H doublet 
at δH 3.88 (J = 10.0 Hz). The 13C NMR spectrum showed only one set of signals, 
indicating that amino sulfoximine 190 was isolated as a single diastereomer. Based on 
other examples in this chapter, it is likely that the α-substituent is cis to the sulfoximine 
oxygen but we were unable to assign the configuration at the amino stereocentre. The low 
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yield may be caused by the lithiated sulfoximine acting as a base and deprotonating the 
N-methyl protons on the imine. 
 
Scheme 2.23 
In order to widen the electrophile scope, we considered whether it would be possible to 
introduce an aromatic group at the α-position of sulfoximines. There is some literature 
precedent for the α-arylation of sulfones and sulfoximines using different approaches. For 
example, Zhou reported the palladium-catalysed Negishi α-arylation of cyclic sulfones 
with aryl bromides which gave α-arylated sulfones in moderate to high yields. Lithiation 
of 5-membered ring cyclic sulfone 191 with LHMDS in THF was followed by 
transmetallation with zinc(II) chloride. Then, Negishi coupling with bromobenzene using 
palladium(II) acetate and X-Phos gave arylated sulfone 192 in 53% yield (Scheme 
2.24).67 An alternate route to arylated sulfone 192 using organocopper chemistry was 
reported by Luisi. Sulfone 191 was lithiated with n-BuLi in THF and transmetallated to 
an organocuprate using CuCN·2LiCl. Subsequent reaction with the iodonium salt Ph2IPF6 
gave arylated sulfone 192 in 70% yield (Scheme 2.24).68 Luisi’s route is higher yielding 
and does not require an expensive palladium catalyst but many more aryl bromides are 
available compared to iodonium salts. 
 
Scheme 2.24 
The palladium-catalysed α-arylation of acyclic sulfoximines has been explored. The first 
reported example showed that aryl groups could be added to sulfoximines in good yields 
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by first introducing an ester functional group, followed by cross-coupling with an aryl 
bromide and removal of the ester. For example, cross-coupling of N-benzamide 
sulfoximine 193 with bromobenzene was achieved using palladium(II) acetate, 
tricyclohexylphosphine and sodium tert-butoxide.69 Heating the mixture at reflux for 1 h 
gave arylated sulfoximine 194 in 79% yield (Scheme 2.25). Hydrolysis of sulfoximine 
194 with sodium hydroxide in methanol removed the ester group to give α-arylated 
sulfoximine 195 in 98% yield.  
 
Scheme 2.25 
Following on from this work, a one-pot reaction was reported to give α-arylated 
sulfoximines in good yields without the need for addition and removal of an ester. 
Reaction of N-PMB protected dimethyl sulfoximine 196 with bromobenzene, 
palladium(II) acetate, X-Phos and lithium tert-butoxide in cyclopentyl methyl ether gave 
α-arylated sulfoximine 197 in 76% yield (Scheme 2.26).70 The use of other N-protecting 
groups (e.g. TBDPS, Bz and Ts) was much less successful. 
 
Scheme 2.26 
As a first attempt, we decided to explore whether Luisi’s organocuprate method would 
be suitable for the α-arylation of cyclic sulfoximines. Lithiation of 5-membered ring 
sulfoximine 146 with n-BuLi in THF was followed by addition of 1.0 equivalent of 
CuCN·2LiCl. After stirring at ‒35 °C for 30 min, Ph2IPF6 was added. The mixture was 
stirred at rt for 16 h and, after chromatography, phenyl sulfoximine 198 was isolated as a 
single diastereomer in 41% yield (Scheme 2.27). Analysis of phenyl sulfoximine 198 by 
1H NMR spectroscopy showed a 1H dd signal at δH 4.04 (J = 12.0, 7.5 Hz) for the α-
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proton adjacent to the phenyl group. The remaining two α-protons appeared as a 2H 
multiplet further upfield at δH 3.09-2.93. The relative stereochemistry of phenyl 
sulfoximine 198 was determined by X-ray crystallography. This method for α-arylation 
is promising as it shows full α-diastereoselectivity.  
 
Scheme 2.27 
As the 5- and 6-membered ring N-TBDPS sulfoximines 146 and 147 displayed such good 
diastereoselectivity when undergoing lithiation-trapping reactions, we considered 
whether high diastereoselectivity would be possible with acyclic N-TBDPS sulfoximines. 
In this context, there were some examples in Chapter 1.3 showing good α-
diastereoselectivity (see Schemes 1.29 and 1.31). Diethyl sulfoximine 149 was selected 
to undergo lithiation-trapping with benzophenone. Using our standard reaction 
conditions, α-substituted sulfoximine 199 was synthesised as a single diastereomer which 
was isolated in 73% yield after chromatography (Scheme 2.28). Both the 1H and 13C NMR 
spectra showed only one set of signals, indicating that a single diastereomer was formed. 
Key signals in the 1H NMR spectrum showed a 1H quartet at δH 4.18 (J = 7.0 Hz) assigned 
to the α-proton adjacent to the benzyl alcohol and a 3H doublet at δH 1.45 (J = 7.0 Hz) 
assigned to the methyl group adjacent to the substituted α-carbon atom. The relative 
stereochemistry of α-substituted sulfoximine 199 has not been determined.  
 
 
 
 
 
Scheme 2.28 
The lithiation-trapping of phenyl ethyl sulfoximine 150 using benzophenone was also 
investigated. In this case, α-substituted sulfoximine 200 was synthesised as an 85:15 
mixture of diastereomers (by 1H NMR spectroscopy of the crude product). After 
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chromatography, only the major diastereomer was isolated in 70% yield (Scheme 2.29). 
It is possible that the minor diastereomer was not isolated due to degradation on the 
column. Analysis of the 1H NMR spectrum of the crude product showed two 1H quartets 
at δH 4.44 (J = 7.0 Hz) and δH 4.23 (J = 7.0 Hz) for the α-protons adjacent to the alcohol 
of the major and minor diastereomers respectively. In addition, two 3H doublets were 
observed at δH 1.43 (J = 7.0 Hz) and δH 1.47 (J = 7.0 Hz) for the methyl group of the 
major and minor diastereomers respectively. Analysis of the 1H NMR spectrum of the 
purified sulfoximine showed only signals for the major diastereomer.   
 
Scheme 2.29 
To explain the high diastereoselectivity in the lithiation-trapping of acyclic sulfoximines 
149 and 150, it is proposed that one of the two pathways shown in Figure 2.11 is the 
major one. Both pathways proceed via a sp2 hybridised α-carbon as proposed for the 
cyclic sulfoximines (see Figure 2.6). Reaction with benzophenone from conformation A 
would occur opposite the bulky TBDPS group to give sulfoximine syn-201. Alternatively, 
reaction from conformation B would give sulfoximine anti-201. In order to distinguish 
between these two options, the stereochemistry of the major diastereomeric products 
would need to be established. 
 
Figure 2.11 Models for electrophilic trapping 
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Overall, focusing on the results with 5- and 6-membered ring N-TBDPS cyclic 
sulfoximines 146 and 147, we have observed high levels of cis α-diastereoselectivity with 
a wide range of electrophiles. This includes benzophenone, benzaldehyde, benzyl 
bromide, methyl iodide, dimethyl sulfate and trimethylsilyl chloride. In some cases, lower 
diastereoselectivity was observed with products containing an α-carbonyl group, which 
we propose is due to epimerisation of the β-keto sulfoximine products. Our brief 
exploration of N-TBDPS acyclic sulfoximines 149 and 150 also displayed a high level of 
α-diastereoselectivity with benzophenone although, at this time, we do not know the 
stereochemistry of the major diastereomers. The α-substituted cyclic and acyclic 
sulfoximines were isolated in moderate to high yields, with the exception of ester 
sulfoximine 189 and amino sulfoximine 187. In addition, reactions of cyclic sulfoximines 
with benzyl bromide, methyl iodide and dimethyl sulfate gave varying amounts of 
disubstituted products which lowered the overall yield of the desired α-substituted 
products. 
 
2.2.2 α-Lithiation and Trapping of N-Boc Sulfoximines 
Given the success of the lithiation-trapping of N-TBDPS cyclic sulfoximines 146 and 
147, we decided to explore the corresponding N-Boc 5- and 6-membered ring 
sulfoximines 153 and 154. Investigating the lithiation-trapping reactions of these 
sulfoximines would provide a direct comparison between the N-Boc and N-TBDPS 
groups. In addition, our results could be compared with those from Degennaro’s study on 
N-Boc 4-membered ring sulfoximine 129 (see Chapter 1.3). For our own planned studies, 
four different electrophiles were chosen. Benzophenone, benzyl bromide and methyl 
iodide were selected as they were used in both our work on N-TBDPS cyclic sulfoximines 
146 and 147 and in Degennaro’s study on 4-membered ring N-Boc sulfoximine 129. 
Benzaldehyde was also tested to establish the effect of the N-Boc group on the 
diastereoselectivity at the hydroxy stereocentre. 
The first electrophile to be investigated was benzophenone. We decided to use our 
standard lithiation conditions of n-BuLi at −78 °C for 20 min for comparison reasons and 
because they are very similar to Degennaro’s conditions (see Scheme 1.36). Lithiation of 
5-membered ring N-Boc sulfoximine 153 with n-BuLi and trapping with benzophenone 
gave sulfoximine cis-202 in 71% yield (Scheme 2.30). The relative stereochemistry of 
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sulfoximine cis-202 was assigned by its separate synthesis from N-TBDPS sulfoximine 
cis-157 of known configuration, as described below. Analysis by 1H NMR spectroscopy 
showed a 1H signal at δH 4.74 (dd, J = 9.0, 9.0 Hz) which was assigned to the α-proton 
adjacent to the benzyl alcohol. A 1H singlet at δH 4.11 was assigned to the OH group. 6-
Membered ring sulfoximine 154 behaved in the same way. Lithiation of 6-membered ring 
sulfoximine 154 with n-BuLi and trapping with benzophenone gave sulfoximine cis-203 
in 75% yield (Scheme 2.30). The relative stereochemistry of sulfoximine cis-203 was 
assumed by analogy with 5-membered ring sulfoximine cis-202. Analysis by 1H NMR 
spectroscopy showed a 1H signal at δH 4.81 (dd, J = 9.5, 3.5 Hz) which was assigned to 
the α-proton adjacent to the benzyl alcohol. A 1H singlet at δH 5.05 was assigned to the 
OH group. The high yields and diastereoselectivity of these reactions were promising 
results, as changing the N-substituent appeared to have no effect on the reaction.  
 
Scheme 2.30 
The relative stereochemistry of 5-membered ring N-Boc sulfoximine cis-202 was proven 
as shown in Scheme 2.31. Deprotection of 5-membered ring N-TBDPS sulfoximine cis-
157, whose stereochemistry was established by X-ray crystallography (see Figure 2.2), 
was achieved using TBAF to give NH sulfoximine cis-204 in 90% yield. Subsequent 
protection of NH sulfoximine cis-204 using potassium tert-butoxide and Boc2O gave N-
Boc sulfoximine cis-202 in 95% yield. A comparison of the 1H and 13C NMR spectra of 
sulfoximine cis-202 synthesised by lithiation-trapping and via the route shown in Scheme 
2.31 showed that their spectra were identical, enabling the stereochemistry assignment. 
 
Scheme 2.31 
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Attempts to prove the relative stereochemistry of 6-membered ring N-Boc sulfoximine 
cis-203 in a similar way were unsuccessful. An initial attempt at deprotection of 
sulfoximine cis-158 using TBAF at rt for 48 h did not give any NH sulfoximine cis-205. 
Instead, this reaction returned unfunctionalised sulfoximine 152 in 63% yield (Scheme 
2.32). The reaction was repeated with a decreased reaction time of 24 h but 
unfunctionalised sulfoximine 152 was once again the only product (60% yield). 
 
Scheme 2.32 
Our mechanistic proposal for the formation of NH sulfoximine 152 is shown in Scheme 
2.33. It is thought that the TBDPS deprotection proceeds as expected to give deprotonated 
NH sulfoximine cis-206 which could be in equilibrium with alkoxide cis-207. Then, a 
retro-aldol-type process could occur from alkoxide cis-207 to ultimately give NH 
sulfoximine 152 after protonation, probably from some water in the TBAF solution. It is 
not clear why the 6-membered ring sulfoximine cis-158 is more susceptible to this 
fragmentation than 5-membered ring sulfoximine cis-157.  
 
 
 
 
Scheme 2.33 
The diastereoselectivity of lithiation-trapping reactions of N-Boc sulfoximines 153 and 
154 with benzaldehyde was then explored. Lithiation-trapping of 5-membered ring 
sulfoximine 153 with benzaldehyde gave a 50:50 mixture of sulfoximines 208a and 208b 
(from the 1H NMR spectrum of the crude product). After chromatography, sulfoximines 
208a and 208b were isolated in 31% and 34% yield respectively (Scheme 2.34). Analysis 
of the 1H NMR spectra of the sulfoximines showed a broad 1H singlet at δH 5.59 for the 
PhCH signal of 208a and a 1H doublet at δH 5.84 (J = 3.0 Hz) for the PhCH signal of 
208b. The relative stereochemistry of sulfoximines 208a and 208b is currently unknown. 
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Scheme 2.34 
The lithiation-trapping of 6-membered ring sulfoximine 154 with benzaldehyde gave a 
crude product which contained a 70:30 mixture of sulfoximines 209a and 209b (by 1H 
NMR spectroscopy). After chromatography, sulfoximines 209a and 209b were isolated 
in 48% and 23% yield respectively (Scheme 2.35). Analysis of the 1H NMR spectra of 
the sulfoximines showed a 1H singlet at δH 5.81 for the PhCH signal of 209a and a 1H 
singlet at δH 5.91 for the PhCH signal of 209b. The relative stereochemistry of 
sulfoximines 209a and 209b is currently unknown. 
 
Scheme 2.35 
Lithiation-trapping of 5-membered ring N-Boc sulfoximine 153 with benzyl bromide 
gave an 85:15 mixture (by 1H NMR spectroscopy) of sulfoximines cis-210 and trans-210 
in the crude product. In this case, the diastereomers were not separable and an 85:15 
mixture of sulfoximines cis-210 and trans-210 was isolated in 85% yield after 
chromatography (Scheme 2.36). The relative configuration of the diastereomers was 
assigned by a separate synthesis of N-Boc sulfoximine cis-210 from N-TBDPS 
sulfoximine cis-166, although the stereochemistry of each of these compounds is not 
proven unequivocally. Lithiation-trapping of 6-membered ring sulfoximine 154 displayed 
a lower level of α-diastereoselectivity, giving a 65:35 mixture of sulfoximines 211a and 
211b (from the 1H NMR spectrum of the crude product). After chromatography, a 65:35 
mixture of sulfoximines 211a and 211b was isolated in 45% yield (Scheme 2.36). 
Chapter Two: Results and Discussion 
 
58 
 
 
Scheme 2.36 
We were surprised that these two reactions did not give high α-stereocontrol. However, 
we initially wondered whether the two sets of signals could have been due to N-Boc 
rotamers. Therefore, in order to prove that the 5-membered ring N-Boc sulfoximines 210 
were diastereomers and not rotamers, the Boc group was removed. Deprotection of the 
85:15 mixture of 5-membered ring N-Boc sulfoximines 210 was achieved using TFA to 
give an 85:15 mixture of NH sulfoximines cis-212 and trans-212 in 67% yield (Scheme 
2.37). This proved that the sulfoximines were indeed diastereomers. Analysis by 1H NMR 
spectroscopy showed a 0.85H multiplet at δH 1.96-1.84 which was assigned to a CH signal 
and a 0.15H multiplet at δH 1.84-1.73 also assigned to a CH signal.  
 
Scheme 2.37 
The reactions shown in Scheme 2.38 were used to prove that the major diastereomer from 
lithiation and benzylation of N-Boc sulfoximine 153 and N-TBDPS sulfoximine 146 were 
the same. As described in Chapter 2.2.1, we have assigned the stereochemistry in N-
TBDPS sulfoximine cis-166 by analogy with other examples although it is not proven. 
Reaction of N-TBDPS 5-membered ring sulfoximine cis-166 with TBAF gave NH 
sulfoximine cis-212 in 85% yield. Subsequent reprotection of NH sulfoximine cis-212 
using potassium tert-butoxide and Boc2O, gave N-Boc sulfoximine cis-210 in 71% yield 
(Scheme 2.38). A comparison of the 1H NMR spectra of sulfoximine cis-210 and the 
85:15 mixture of sulfoximines cis-210 and trans-210 showed that the major diastereomer 
has cis stereochemistry.  
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Scheme 2.38 
The lithiation-trapping of 5-membered ring sulfoximine 153 with methyl iodide gave a 
crude product which appeared to show the presence of two diastereomers. However, the 
ratio of diastereomers could not be calculated from the 1H NMR spectrum due to 
overlapping peaks. After purification by chromatography, sulfoximines cis-213 and 
trans-213 were isolated in 57% yield but the ratio of diastereomers still could not be 
calculated from the 1H NMR spectrum. However, the 13C NMR spectrum showed two 
sets of signals in a ratio of 90:10 (Scheme 2.39). We therefore assumed that a 90:10 
mixture of sulfoximines cis-213 and trans-213 were formed, and the stereochemistry was 
assigned by analogy with the benzyl bromide result.  
  
Scheme 2.39 
Lithiation-trapping of 6-membered ring sulfoximine 154 with methyl iodide gave, after 
purification by chromatography, sulfoximine 214 in 61% yield. Due to overlapping peaks 
in the 1H NMR spectrum, the ratio of the two diastereomers could not be calculated. It 
was hoped that removal of the Boc group would shift the signals in the 1H NMR spectrum 
enough to enable calculation of the ratio. Treatment of sulfoximine 214 with TFA for 24 
h gave a 60:40 mixture (by 1H NMR spectroscopy) of NH sulfoximines 215a and 215b. 
After purification by chromatography, sulfoximines 215a and 215b were isolated in 42% 
and 34% yield respectively (Scheme 2.40).  
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Scheme 2.40 
Overall, the α-diastereoselectivity observed with N-Boc sulfoximines 153 and 154 was 
more variable than with N-TBDPS sulfoximines 146 and 147. A comparison of the 5- and 
6-membered ring N-Boc sulfoximines showed them both to have high diastereoselectivity 
with benzophenone, as observed with the analogous N-TBDPS sulfoximines 146 and 147. 
However, with benzaldehyde, benzyl bromide and methyl iodide the α-
diastereoselectivity was lower than the N-TBDPS sulfoximines. It is of interest that, for 
the N-Boc sulfoximines 146 and 147, no disubstituted products were formed with benzyl 
bromide and methyl iodide. In addition, the 5-membered ring N-Boc sulfoximine 153 
displayed higher diastereoselectivity than the 6-membered ring N-Boc sulfoximine 154. 
Our results can also be compared with Degennaro’s results on 4-membered ring N-Boc 
sulfoximine 129. Since the 4-membered ring sulfoximine 129 showed full α-
diastereoselectivity with benzophenone, benzyl bromide and methyl iodide, it appears 
that increasing the ring size decreases the diastereoselectivity of the reactions. 
 
2.2.3 α-Lithiation and Trapping of N-Me Sulfoximines 
An exploration of the lithiation-trapping reactions of N-Me 5- and 6-membered ring 
sulfoximines 155 and 156 would enable a direct comparison of the N-Me, N-Boc and N-
TBDPS groups. Therefore, we could determine the effect of the sterically less hindered 
N-Me substituent on the diastereoselectivity of the reactions. The electrophiles selected 
were benzophenone, benzyl bromide, methyl iodide and benzaldehyde due to their use 
with N-TBDPS sulfoximines 146 and 147 and N-Boc sulfoximines 153 and 154. 
Using benzophenone, we used our standard lithiation conditions of n-BuLi at −78 °C for 
20 min for direct comparison with the N-TBDPS and N-Boc results. Thus, 5-membered 
ring N-Me sulfoximine 155 was lithiated and trapped with benzophenone to give 
sulfoximine cis-216 in 82% yield (Scheme 2.41). The relative stereochemistry of 
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sulfoximine cis-216 was assigned by analogy with N-TBDPS sulfoximine cis-157. 
Analysis by 1H NMR spectroscopy displayed key diagnostic signals. For example, a 1H 
signal at δH 4.33 (dd, J = 9.5, 8.5 Hz) was assigned to the α-proton adjacent to the benzyl 
alcohol and a 1H singlet at δH 5.06 was assigned to the OH group.  
 
Scheme 2.41 
In contrast, the lithiation and trapping of 6-membered ring N-Me sulfoximine 156 with 
benzophenone gave the crude product which contained a 50:50 mixture (by 1H NMR 
spectroscopy) of sulfoximines 217a and 217b (Scheme 2.42). After purification by 
chromatography, sulfoximine 217a was isolated in 36% yield and sulfoximine 217b was 
isolated in 43% yield. The 1H NMR spectra of these sulfoximines displayed the usual 
diagnostic signals. Sulfoximine 217a showed a 1H signal at δH 3.95 (dd, J = 12.0, 3.0 Hz) 
which was assigned to the α-proton and a 1H singlet at δH 7.74 for the OH group. 
Sulfoximine 217b had a 1H signal at δH 3.99 (dd, J = 12.0, 2.0 Hz) which was assigned 
to the α-proton, although the signal for the OH group was not visible. For the reactions 
with benzophenone, 5-membered ring sulfoximine 155 displayed full α-diastereocontrol 
whilst the 6-membered ring sulfoximine 156 showed no α-diastereoselectivity. At this 
time, we cannot offer an explanation for this result. 
 
Scheme 2.42 
Surprisingly, the trend in α-diastereoselectivity was not observed with benzaldehyde. 
Lithiation-trapping of 5-membered ring sulfoximine 155 with benzaldehyde gave a 75:25 
mixture (by 1H NMR spectroscopy) of sulfoximines cis,anti-218 and cis,syn-218. After 
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purification by chromatography, sulfoximine cis,anti-218 (60% yield) and an 85:15 
mixture of sulfoximines cis,syn-218 and cis,anti-218 (20% yield) were isolated (Scheme 
2.43). Analysis of the major diastereomer cis,anti-218 by X-ray crystallography identified 
its stereochemistry (Figure 2.12). The oxygen bonded to sulfur is cis to the α-substituent 
whilst the nitrogen is in a trans orientation. Given that other electrophile trappings occur 
trans to the N-substituent, the minor product was believed to be cis,syn-218.  
 
Scheme 2.43  
 
 
 
 
 
 
 
Figure 2.12 X-ray structure of N-Me sulfoximine cis,anti-218 
The lithiation and trapping of 6-membered ring sulfoximine 156 with benzaldehyde gave 
a 75:25 mixture (by 1H NMR spectroscopy) of sulfoximines trans,syn-219 and 219a. 
Purification by chromatography gave sulfoximine trans,syn-219 in 55% yield and 
sulfoximine 219a in 8% yield (Scheme 2.44). The relative stereochemistry of sulfoximine 
trans,syn-219 was determined by X-ray crystallography. It is interesting that lithiation-
trapping of 6-membered ring sulfoximine 156 with benzaldehyde showed a degree of 
diastereoselectivity, giving only two out of four possible diastereomers, whilst the 
reaction with benzophenone (see Scheme 2.42) was not diastereoselective.  
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Scheme 2.44 
The reactions of N-Me sulfoximines 155 and 156 with alkylating agents was also studied. 
The lithiation and trapping of 5-membered ring sulfoximine 155 with benzyl bromide 
gave sulfoximine cis-220 in 38% yield (Scheme 2.45). The relative stereochemistry of 
sulfoximine cis-220 was assigned by analogy with N-TBDPS sulfoximine cis-166. It is 
unknown why the yield of this reaction is low in comparison to the other lithiation-
trapping examples with benzyl bromide. 
 
Scheme 2.45 
Next, 6-membered ring sulfoximine 156 was lithiated and trapped with benzyl bromide 
to give a 50:50 mixture (by 1H NMR spectroscopy) of sulfoximines 221a and 221b. After 
purification by chromatography, sulfoximine 221a was isolated in 30% yield and 
sulfoximine 221b was isolated in 25% yield (Scheme 2.46). With benzyl bromide, 5-
membered ring N-Me sulfoximine 155 showed complete α-diastereoselectivity whereas 
6-membered ring N-Me sulfoximine 156 showed no diastereoselectivity. 
 
Scheme 2.46 
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Finally, we tested the lithiation-trapping reactions of N-Me sulfoximines 155 and 156 
with methyl iodide. Lithiation-trapping of 5-membered ring sulfoximine 155 with methyl 
iodide gave the crude product which contained a 90:10 mixture (by 1H NMR 
spectroscopy) of sulfoximines cis-222 and trans-222. After purification by 
chromatography, the sulfoximines were isolated as a 90:10 mixture of cis-222 and trans-
222 in 63% yield (Scheme 2.47). The relative stereochemistry of sulfoximine cis-222 was 
assigned by its separate synthesis from N-TBDPS sulfoximine cis-172 of known 
configuration. This was the only case where reaction of 5-membered ring sulfoximine 
155 gave some of the trans-diastereomer. Key diagnostic signals in the 1H NMR spectrum 
showed a 3H doublet at δH 1.33 (J = 7.0 Hz) for the α-Me group of sulfoximine cis-222 
and a 3H doublet at δH 1.31 (J = 7.0 Hz) for the α-Me group of sulfoximine trans-222. 
 
Scheme 2.47 
The relative stereochemistry of 5-membered ring N-Me sulfoximine cis-222 was proven 
as shown in Scheme 2.48. TBAF was used to deprotect N-TBDPS sulfoximine cis-172, 
(stereochemistry proven by X-ray crystallography, see Figure 2.9) to give NH 
sulfoximine cis-223 in 95% yield. Subsequent reaction of NH sulfoximine cis-223 with 
paraformaldehyde in formic acid gave N-Me sulfoximine cis-222 in 81% yield (Scheme 
2.48). A comparison of the 1H and 13C NMR spectra of sulfoximine cis-222 synthesised 
via the route shown in Scheme 2.47 and the 90:10 mixture of sulfoximines cis-222 and 
trans-222 synthesised by lithiation-trapping showed that the major diastereomer in the 
mixture was sulfoximine cis-222. 
 
Scheme 2.48 
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The lithiation of 6-membered ring N-Me sulfoximine 156 and trapping with methyl iodide 
was also investigated (Scheme 2.49). The 1H NMR spectrum of the crude product showed 
a complex mixture of starting material 156, a diastereomeric mixture of monosubstituted 
sulfoximines 224 and a diastereomeric mixture of disubstituted sulfoximines 225. 
Purification by chromatography proved unsuccessful, returning an inseparable mixture. 
Due to overlapping peaks in the 1H NMR spectrum, the amount and diastereomeric ratio 
of the products could not be obtained.  
 
Scheme 2.49 
Overall, 5-membered ring N-Me sulfoximine 155 displayed a high level of α-
diastereoselectivity with all four electrophiles. This was slightly better α-
diastereoselectivity than 5-membered ring N-Boc sulfoximine 153 and similar to 5-
membered ring N-TBDPS sulfoximine 146 apart from the reaction with methyl iodide. 
Conversely, 6-membered ring N-Me sulfoximine 156 only showed high α-
diastereoselectivity with benzaldehyde; mixtures of diastereomers were obtained when 
trapping with benzophenone, benzyl bromide and methyl iodide.  
 
2.2.4 α-Lithiation and Trapping of N-CN Sulfoximines 
As a final study of cyclic sulfoximines, we chose to study the lithiation-trapping of 5-
membered ring N-CN sulfoximine 68 using our standard four electrophiles 
(benzophenone, benzaldehyde, benzyl bromide and methyl iodide). As discussed in the 
Introduction (see Chapter 1.3), the lithiation-trapping reactions of a range of acyclic and 
some cyclic N-CN sulfoximines often result in low yields. In addition, it is possible that 
lower levels of α-diastereoselectivity would be observed with the smaller N-CN 
substituent.  
Benzophenone was explored first using the standard lithiation conditions (n-BuLi, −78 
°C, 20 min). The lithiation and trapping of N-CN 5-membered ring sulfoximine 68 with 
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benzophenone gave a crude product which contained diastereomeric mixtures of 
monosubstituted sulfoximines 226 and disubstituted sulfoximines 227. The ratio of 
products could not be calculated from the 1H NMR spectrum of the crude product due to 
overlapping signals. Purification by chromatography gave a 90:10 mixture (by 1H NMR 
spectroscopy) of monosubstituted sulfoximines cis-226 and trans-226 (11% yield). In 
addition, a 70:30 mixture of disubstituted sulfoximines cis,cis-227 and trans,cis-227 was 
isolated in 12% yield (Scheme 2.50).  
 
Scheme 2.50 
Diagnostic signals in the 1H NMR spectrum of N-CN sulfoximines cis-226 and trans-226 
were a 1H signal at δH 4.69 (dd, J = 10.0, 8.0 Hz) which was assigned to the α-proton 
adjacent to the benzyl alcohol in sulfoximine cis-226 and a 1H signal at δH 4.50 (dd, J = 
10.0, 8.0 Hz) which was assigned to the analogous proton in sulfoximine trans-226. 
Analysis of the 13C NMR spectrum of the 90:10 mixture of sulfoximines cis-226 and 
trans-226 showed a major and minor set of peaks. The stereochemistry of these 
sulfoximines was assumed by analogy with our other lithiation-trapping reactions. 
The determination of the ratio of disubstituted sulfoximines cis,cis-227 and trans,cis-227 
was not straightforward due to overlapping signals and required a combined analysis of 
the 1H and 13C NMR spectra. Analysis of the 13C NMR spectrum of the mixture of 
disubstituted sulfoximines 227 showed a major and minor set of peaks corresponding to 
two diastereomers. The major diastereomer appeared to be a symmetrical compound and 
the minor one appeared to be unsymmetrical. Sulfoximine cis,cis-227, had a signal at δC 
79.8 which we assigned to the two COH groups, a signal at δC 72.1 which was assigned 
to the two SCH groups and a signal at δC 25.6 which was assigned to the two CH2 groups. 
Sulfoximine trans,cis-227, had two signals at δC 78.6 and 77.6 which were assigned to 
the two COH groups, two signals at δC 73.5 and 72.7 which were assigned to the two SCH 
groups and two signals at δC 23.7 and 22.9 which were assigned to the two CH2 groups. 
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Having established that the major disubstituted sulfoximine was cis,cis-227 and the minor 
one was trans,cis-227, analysis of the 1H NMR spectrum enabled the ratio to be 
determined. For sulfoximine trans,cis-227, the two 1H singlets at δH 4.91 and 3.87 were 
assigned to the two OH groups and the 1H signal at δH 4.37 (dd, J = 12.0, 6.0 Hz) was 
assigned to an SCH proton. The 1H NMR spectrum also showed a multiplet at δH 4.89-
4.82 which contained two SCH protons from sulfoximine cis,cis-227 and one SCH proton 
from sulfoximine trans,cis-227. Analysis of these signals gave a 70:30 ratio of cis,cis-
227 and trans,cis-227. The stereochemical assignments of the sulfoximines are an 
assumption based on the results from other lithiation-trapping reactions. 
Overall, the result of our initial reaction of N-CN sulfoximine 68 with benzophenone 
showed it to be low yielding for both the monosubstituted and disubstituted sulfoximines. 
We believe that the disubstituted sulfoximines were synthesised via the dianion route 
presented in Scheme 2.10 for 4-membered ring N-TBDPS sulfoximine 148. 
A slightly different reaction profile was obtained using benzaldehyde. The crude product 
showed a complex mixture of diastereomers. After purification by chromatography, a 
single unassigned diastereomer 228a was isolated in 20% yield. In addition, a 60:20:15:5 
mixture of sulfoximines 228b, 228c, 228d and 228a was isolated in 34% yield (Scheme 
2.51). No disubstituted products were detected. The overall yield of this reaction was an 
encouraging 54%. On the other hand, the diastereoselectivity of the reaction appeared 
poor and was further complicated by the additional hydroxyl stereocentre.  
 
Scheme 2.51 
Analysis of sulfoximine 228a by 1H NMR spectroscopy showed a 1H signal at δH 5.54 
(dd, J = 4.0, 2.0 Hz) which was assigned to the PhCH group, a 1H signal at δH 3.28 (ddd, 
J = 13.0, 10.5, 8.0 Hz) which was assigned to an α-proton and a 1H signal at δH 3.19 (d, 
J = 4.0 Hz) which was assigned to the OH group. Analysis of the mixture of diastereomers 
showed four signals which were assigned to the PhCH group and, from the integrations, 
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we were able to calculate the ratio of the diastereomers. The signal at δH 4.98 (dd, J = 
10.0, 4.0 Hz) was assigned to sulfoximine 228b, the signal at δH 5.10 (dd, J = 10.0, 4.0 
Hz) was assigned to sulfoximine 228c, the signal at δH 5.55 (dd, J = 3.5, 2.5 Hz) was 
assigned to sulfoximine 228d and the signal at δH 5.52 (dd, J = 4.0, 2.0 Hz) was assigned 
to sulfoximine 228a. 
Lithiation-trapping with benzyl bromide gave a crude product a mixture of diastereomers 
of monosubstituted sulfoximines 229 and disubstituted sulfoximines 230. The ratio could 
not be calculated from the 1H NMR spectrum of the crude product due to overlapping 
signals. Purification by chromatography gave a 70:30 mixture (by 1H NMR spectroscopy) 
of monosubstituted sulfoximines cis-229 and trans-229 in 32% yield. An unknown ratio 
(due to overlapping signals in the 1H NMR spectrum) of disubstituted sulfoximines 
cis,cis-230 and trans,cis-230 was isolated in 34% yield (Scheme 2.52). The overall yield 
of α-trapped products was 66%. 
 
Scheme 2.52 
The 1H NMR spectrum of the mixture of monosubstituted sulfoximines 229 had a minor 
signal at δH 2.90 (dd, J = 15.0, 11.0 Hz) and a major signal at δH 2.80 (dd, J = 14.0, 10.0 
Hz), which were each assigned to one of the PhCH protons. From this, we were able to 
calculate a 70:30 ratio of sulfoximines cis-229 and trans-229. The stereochemistry of 
sulfoximines cis-229 and trans-229 was assumed by analogy with our previous results. 
The ratio of disubstituted sulfoximines cis,cis-230 and trans,cis-230 could not be 
calculated from the 1H NMR spectrum due to overlapping signals. Analysis of the 13C 
NMR spectrum showed a major set of signals. A signal at δC 64.9 was assigned to the two 
SCH carbons, a signal at δC 33.8 was assigned to two PhCH2 carbons and a signal at δC 
26.5 was assigned to the two CH2 groups in the ring. The 
13C NMR spectrum showed 
symmetry and therefore we believe these signals to be due to sulfoximine cis,cis-230. In 
addition, there was a minor set of signals: signals at δC 68.2 and 65.1 were each assigned 
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to an SCH carbon, signals at δC 34.6 and 34.0 were each assigned to a PhCH2 carbon and 
signals at δC 28.0 and 27.8 were each assigned to the CH2 groups in the ring. These results 
indicated that the sulfoximine was not symmetrical and it therefore was assumed to be 
sulfoximine trans,cis-230. The ratio of the two disubstituted sulfoximines could not be 
determined from the 13C NMR spectrum. The stereochemical assignment of these 
sulfoximines was assumed from our previous results and whether the sulfoximine was 
symmetrical. 
Lastly, sulfoximine 68 was lithiated and trapped with methyl iodide. This reaction gave 
a complex mixture of monosubstituted sulfoximines 231 and disubstituted sulfoximines 
232 (Scheme 2.53). Even after purification by chromatography, the ratio of the 
sulfoximines could not be calculated from the 1H NMR spectrum due to overlapping 
signals and therefore a yield could not be calculated. The formation of the 
monosubstituted and disubstituted sulfoximines 231 and 232 was confirmed by mass 
spectrometry. 
 
Scheme 2.53 
To conclude, the reactions with N-CN sulfoximine 68 have demonstrated CN to be a poor 
choice of N-substituent when compared to N-TBDPS, N-Boc and N-Me groups. The N-
CN group offers varying levels of diastereoselectivity and the products were obtained in 
low to moderate yields. In addition, disubstituted sulfoximines were synthesised in the 
reactions with benzophenone, benzyl bromide and methyl iodide, further complicating 
the reactions. 
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2.3 Synthesis of Disubstituted Sulfoximines 
The lithiation and trapping reactions of 5- and 6-membered ring N-TBDPS sulfoximines 
146 and 147 showed promise, proceeding with high yields and high diastereoselectivity 
with the majority of electrophiles tested. As a result, we wanted to utilise these products 
in further reactions and decided to explore whether a second lithiation-trapping reaction 
of an α-functionalised sulfoximine could be used to add a second substituent at either of 
the two α-carbon atoms. Two possible routes were proposed for the regioselective 
functionalisation of α-substituted sulfoximines. In the first approach, we hoped to develop 
a route for the synthesis of 2,2-disubstituted sulfoximines 234 starting from β-keto 
sulfoximines cis-233 (Scheme 2.54). In order to achieve deprotonation at the 2-position, 
the acidity of the α-proton on the 2-position would need to be higher than the α-protons 
at the 5/6-position. This would be achieved by the presence of the carbonyl group at the 
α-position in β-keto sulfoximines cis-233 and would allow regioselective enolate 
formation and addition of the substituent to generate the 2,2-disubstituted products 234. 
In our previous reactions, electrophiles typically add to sulfoximines trans to the bulky 
N-TBDPS group and, therefore, we believe that the second electrophile would add to give 
disubstituted sulfoximine 234 with the stereochemistry indicated in Scheme 2.54. 
 
Scheme 2.54 
The second approach to be investigated would provide a route to introduce a substituent 
in the 5/6-position depending on whether we started with the 5- or 6-membered ring α-
substituted sulfoximine. We propose to start with an α-substituted sulfoximine cis-235 
(e.g. R = Me) and predict that lithiation-trapping using n-BuLi should give 2,5/2,6-
disubstituted sulfoximines cis,cis-236 (Scheme 2.55). This is because lithiation at the 2-
position will be sterically hindered. Thus, lithiation will occur at the more accessible 5/6-
position. In our previous lithiation-trapping reactions of 5- and 6-membered ring N-
TBDPS sulfoximines (see Chapter 2.2.1), the electrophile typically adds trans to the 
sterically bulky N-TBDPS group. We expect a similar effect with the addition of a second 
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electrophile to give 2,5- and 2,6-disubstituted sulfoximines cis,cis-236. It was important 
to select an α-substituted sulfoximine starting material with minimal functionality (e.g. R 
= Me in cis-235) for the disubstitution reaction in order to prevent unwanted side 
reactions. The next two chapters summarise our results with each of these two proposed 
approaches to disubstituted sulfoximines. 
 
Scheme 2.55 
 
2.3.1 Synthesis of 2,2-Disubstituted Sulfoximines 
We first investigated enolate formation and trapping with pyridine-containing β-keto 
sulfoximine cis-183. In order to prevent nucleophilic attack on the ketone by the lithiating 
agent, a more sterically hindered base than n-BuLi was used. LHMDS was selected and 
we expected it to deprotonate sulfoximine cis-183 at the 2-position to form the enolate. 
Deprotonation of sulfoximine cis-183 using LHMDS and trapping with benzyl bromide 
did not give any sulfoximine 237 and none of the starting sulfoximine cis-183 was 
recovered (Scheme 2.56). We were unsure why the reaction was unsuccessful so decided 
to repeat the reaction with benzaldehyde as the electrophile. Deprotonation of sulfoximine 
cis-183 with LHMDS and trapping with benzaldehyde did not give any of sulfoximine 
238 (Scheme 2.56). However, we found that the LHMDS had partially epimerised the 
starting material cis-183 giving a 75:25 mixture (from the 1H NMR spectrum of the crude 
product) of sulfoximines cis-183 and trans-183. This suggested that at least some enolate 
formation had occurred. 
 
 
 
 
Scheme 2.56 
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We decided to investigate a different substrate for the 2,2-disubstitution reactions and 
selected keto sulfoximines cis-180 and trans-180. Benzyl bromide was chosen as the first 
electrophile for direct comparison with the reactions of keto sulfoximine cis-183 (see 
Scheme 2.56). Deprotonation of sulfoximine cis-180 using LHMDS and trapping with 
benzyl bromide gave a crude product which contained a 70:20:10 mixture (by 1H NMR 
spectroscopy) of monosubstituted sulfoximine trans-180, disubstituted sulfoximine 
trans,cis-239 and monosubstituted sulfoximine cis-180. Purification by chromatography 
gave sulfoximine trans-180 in 47% yield and a 50:50 mixture (by 1H NMR spectroscopy) 
of sulfoximines cis-180 (8% yield) and trans,cis-239 (8% yield) (Scheme 2.57). None of 
the desired 2,2-disubstituted sulfoximine was formed.  
 
Scheme 2.57 
Analysis of the 1H NMR spectrum of sulfoximine trans,cis-239 showed two signals at δH 
5.16 (dd, J = 8.0, 8.0 Hz) and 4.62 (dd, J = 8.0, 3.5 Hz) which were assigned to the two 
SCH protons. There was also a 9H singlet at δH 0.80 which was assigned to the CMe3 
group. Analysis by 13C NMR spectroscopy showed two sets of signals at δC 69.0 and 68.7 
which were assigned to the SCH groups and two sets of signals at δC 24.0 and 23.7 which 
were assigned to the CH2 groups. In addition, one signal at δC 26.2 was assigned to the 
CMe3 carbons and one signal at δC 19.3 was assigned to the CMe3 carbon. This evidence 
proves that an unsymmetrical sulfoximine was synthesised and supports our 
stereochemical assignment of as trans,cis-239.   
The synthesis of 2,5-disubstituted sulfoximine trans,cis-239 as a by-product of this 
reaction was surprising. A proposed route for its synthesis is shown in Scheme 2.58. 
Although this does not fit with the likely pKa values, we propose that some of sulfoximine 
cis-180 could be lithiated at the 5-position to give carbanion cis-240. This may be possible 
because the proton at the 2-position is sterically hindered and LHMDS is a sterically 
hindered base. Then, carbanion cis-240 could subsequently attack the carbonyl of keto 
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sulfoximine cis-180 with carbanion 241 as a leaving group. Finally, epimerisation may 
occur to give diketone trans,cis-239. 
 
Scheme 2.58 
At this point, we were unsure whether the issue was enolate formation or whether the 
enolate did form but was unreactive in the reaction with benzyl bromide. Therefore 
KHMDS was explored. Deprotonation of a 75:25 mixture of sulfoximines cis-180 and 
trans-180 using KHMDS and trapping with benzyl bromide gave none of the 2,2-
disubstituted sulfoximine 242 (Scheme 2.59) By 1H NMR spectroscopy of the crude 
product, the starting material was returned as sulfoximine trans-180. This is an interesting 
result and clearly establishes that the enolate must have formed. The stereochemistry 
could be explained as follows. Deprotonation occurred to give the enolate and 
stereoselective protonation in the work-up, with the proton adding opposite the N-TBDPS 
group, would then give keto sulfoximine trans-180. 
 
Scheme 2.59 
We therefore moved on to explore a different electrophile, methyl iodide, starting with 
LHMDS as the base. Deprotonation of a 75:25 mixture of sulfoximines cis-180 and trans-
180 and trapping with methyl iodide gave 2,2-disubstituted sulfoximine 243 as a single 
diastereomer of unknown stereochemistry in only 6% yield. Starting sulfoximine trans-
180 was isolated in 56% yield. In addition, a 60:40 mixture of starting sulfoximine cis-
180 (17% yield) and 2,5-disubstituted sulfoximine trans,cis-239 (11% yield) and was 
obtained (Scheme 2.60).  
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Scheme 2.60 
The 1H NMR spectrum of 2,2-disubstituted sulfoximine 243 showed two 1H multiplets 
at δH 3.24-3.14 and 2.92-2.82 which were each assigned to an SCH proton. A 3H singlet 
at δH 1.74 was assigned to the methyl group. The 13C NMR DEPT spectrum showed a 
signal at δC 74.1 which was assigned to SCMe. In addition, a signal at δC 57.8 was 
assigned to the SCH2 carbon and a signal at δC 36.6 was assigned to the methyl group. 
Analysis of both the 1H and 13C NMR spectra of 2,2-disubstituted sulfoximine 243 
showed that the methyl group had added at the 2-position and not the 5-position. Diketone 
trans,cis-239 was presumably formed via the process shown in Scheme 2.58. The 
formation of 2,2-disubstituted sulfoximine 243 and a significant amount of keto 
sulfoximine trans-180 suggested that enolate formation was occurring successfully. 
In order to fully explore the 2,2-disubstitution reaction, we investigated a range of bases: 
LHMDS, KHMDS, NaHMDS, NaH and LDA. The results are summarised in Table 2.3. 
LHMDS was the most successful base, giving disubstituted sulfoximine 243 as a single 
diastereomer in 6% yield (entry 1). We tested the reaction with KHMDS which gave 2,2-
disubstituted sulfoximine 243 in a slightly lower yield of 5%. A 70:30 mixture (by 1H 
NMR spectroscopy) of starting sulfoximine cis-180 (20% yield) and 2,5-disubstiuted 
sulfoximine trans,cis-239 (8% yield) was also obtained. Starting sulfoximine trans-180 
was isolated in 58% yield (entry 2). Reaction with NaHMDS was poor and gave 2,2-
disubstituted sulfoximine 243 in only 1% yield. In addition, a 65:25:10 mixture (by 1H 
NMR spectroscopy) of sulfoximines trans-180 (52% yield), cis-180 (20% yield) and 
trans,cis-239 (8%) was isolated (entry 3). Deprotonation with NaH gave 2,2-disubstituted 
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sulfoximine 243 in 4% yield as well as a 65:25:10 mixture (by 1H NMR spectroscopy) of 
sulfoximines trans-180 (55% yield), cis-180 (21% yield) and trans,cis-239 (8%) (entry 
4). With LDA, no disubstituted sulfoximines were observed and the staring material was 
returned as an 85:15 mixture (by 1H NMR spectroscopy of the crude product) of 
sulfoximines trans-180 and cis-180 (entry 5). 
 
Entry Base 243/%a trans-180/%a cis-180/%a trans,cis-239/%a 
1 LHMDS 6 56 17b 11b 
2 KHMDS 5 58 20c 8c 
3 NaHMDS 1 52d 20d 8d 
4 NaH 4 55d 21d 8d 
5e LDA 0 - - 0 
 
 
 
 
 
Table 2.3 Effect of different bases on the 2,2-disubstituion of sulfoximine cis/trans-180 
With all bases except LDA, a small amount of 2,5-disubstituted sulfoximine trans,cis-
239 and a large quantity of starting sulfoximines cis-180 and trans-180 were isolated. 
LHMDS proved to be the most effective base giving 2,2-disubstituted sulfoximine 243 in 
6% yield, although there was little variance in the results when different bases were used.  
We have yet to confirm the stereochemistry of the product, although the results of our 
a % yield after purification by chromatography. b Isolated as a 60:40 mixture (by 1H NMR 
spectroscopy) of sulfoximines cis-180 and trans,cis-239. c Isolated as a 70:30 mixture (by 
1H NMR spectroscopy) of sulfoximines cis-180 and trans,cis-239. d Isolated as a 65:25:10 
mixture (by 1H NMR spectroscopy) of sulfoximines trans-180, cis-180, and trans,cis-
239. e Products not purified as no sulfoximine 243 was synthesised, 85:15 mixture of 
sulfoximines trans-180 and cis-180 observed (by 1H NMR spectroscopy). 
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other lithiation-trapping reactions support the proposal that the methyl group is cis to the 
oxygen of the sulfoximine. 
Overall, our results showed that deprotonation of sulfoximines cis/trans-180 occurred to 
give the enolate. Therefore, the main issue of the reaction must be in the trapping step. 
Future work could focus on investigating different α-substituents and electrophiles. 
 
2.3.2 Synthesis of 2,5- and 2,6-Disubstituted Sulfoximines 
Finally, we explored the synthesis of 2,5- and 2,6-disubstituted sulfoximines. A methyl 
group was chosen as the α-substituent, as its lack of functionality decreases the chances 
of side reactions occurring. Thus, methylated 5-membered ring N-TBDPS sulfoximine 
cis-172 was lithiated using n-BuLi (‒78 °C, 20 min) and trapped with benzophenone to 
give sulfoximine cis,cis-244 in 71% yield (Scheme 2.61). Evidence from both the 1H and 
13C NMR spectra showed that benzophenone addition had occurred at the 5-position. Key 
signals in the 1H NMR spectrum were two 1H signals at δH 4.43 (dd, J = 8.5, 8.5 Hz) and 
δH 2.78-2.66 (m) assigned to the two SCH protons as well as a 3H doublet at δH 0.95 (J = 
7.0 Hz) assigned to the methyl group. The 13C NMR spectrum showed two signals at δC 
71.7 and 62.3 which were assigned to the two SCH carbons. A signal at δC 78.5 was 
assigned to the COH and a signal at δC 13.5 was assigned to the methyl group. These data 
showed that both the benzyl alcohol and the methyl group were attached to different α-
carbon atoms. 
 
Scheme 2.61 
In a similar way, lithiation-trapping of methylated 6-membered ring N-TBDPS 
sulfoximine cis-174 with benzophenone gave sulfoximine cis,cis-245 in 81% yield 
(Scheme 2.61). The 1H and 13C NMR spectra displayed the key diagnostic signals 
observed with 5-membered ring sulfoximine cis,cis-244. Analysis of the 1H NMR 
spectrum of 6-membered ring sulfoximine cis,cis-245 showed two 1H signals at δH 3.88 
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(dd, J = 12.0, 1.5 Hz) and δH 2.94-2.82 (multiplet) for the two SCH protons and a 3H 
doublet at δH 0.49 (J = 7.0 Hz) assigned to the methyl group. Key signals in the 13C NMR 
spectrum included two signals at δC 74.7 and 64.4 which were assigned to the two SCH 
carbons. A signal at δC 82.2 was assigned to the COH and a signal at δC 12.7 was assigned 
to the methyl group. The stereochemistry of 5- and 6-membered ring sulfoximines cis,cis-
244 and cis,cis-245 was assigned by analogy with lithiation-trappings of other N-TBDPS 
sulfoximines. Both reactions proceeded with high diastereoselectivity and 
regioselectivity giving each product as a single diastereomer in high yields. 
The diastereoselectivity of the reaction with benzyl bromide was explored next. 
Lithiation-trapping of 5-membered ring methylated sulfoximine cis-172 with benzyl 
bromide gave sulfoximine cis,cis-246 in 86% yield. Similarly, 6-membered ring 
methylated sulfoximine cis-174 gave sulfoximine cis,cis-247 in 85% yield (Scheme 
2.62). The stereochemistry of the sulfoximines was assigned by analogy with lithiation-
trappings of other N-TBDPS sulfoximines. Both reactions were diastereoselective and 
sulfoximines cis,cis-246 and cis,cis-247 were synthesised in high yields. In a previous 
reaction, disubstitution of 6-membered ring N-TBDPS sulfoximine 147 was observed 
when trapping with benzyl bromide (see Scheme 2.13). However, when starting with 
methyl sulfoximines cis-172 and cis-174, there was no evidence of further lithiation-
trapping with benzyl bromide. Presumably, this is because 6-membered ring sulfoximine 
cis-174 is more sterically hindered at the 2-position due to the methyl substituent.  
 
Scheme 2.62 
Lastly, trapping with benzaldehyde was investigated. Lithiation-trapping of 5-membered 
ring methyl sulfoximine cis-172 with benzaldehyde gave a crude product which contained 
a 60:25:15 mixture (from the 1H NMR spectrum) of sulfoximines cis,cis,anti-248, 
cis,cis,syn-248 and 1-phenyl-1-pentanol 249 (resulting from n-BuLi reacting with 
benzaldehyde). After purification by chromatography, an inseparable 85:15 mixture of 
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sulfoximine cis,cis,anti-248 (64% yield) and 1-phenyl-1-pentanol 249 (10% yield) was 
isolated; sulfoximine cis,cis,syn-248 was also isolated in 22% yield (Scheme 2.63).  
 
Scheme 2.63 
The stereochemistry of sulfoximines cis,cis,anti-248 and cis,cis,syn-248 was assigned by 
analogy with N-TBDPS sulfoximine cis,syn-164 (stereochemistry assigned by X-ray 
crystallography, see Figure 2.7). Analysis of the 1H NMR spectra showed that 
sulfoximine cis,cis,anti-248 had a 1H broad singlet at δH 5.07 which was assigned to the 
PhCHOH proton and sulfoximine cis,anti-164 also had a 1H singlet at δH 5.12 which was 
assigned to the PhCHOH (Figure 2.13). Similarly, the 1H NMR spectrum of sulfoximine 
cis,cis,syn-248 displayed a 1H signal at δH 4.83 (dd, J = 9.5, 3.0 Hz) which was assigned 
to the PhCHOH proton, whilst sulfoximine cis,anti-165 had a 1H doublet at δH 4.89 (d, J 
= 9.5 Hz) which was assigned to the PhCHOH proton (Figure 2.13). The similarities in 
the chemical shifts of the peaks assigned to the PhCHOH proton support our 
stereochemical assignment of sulfoximines cis,cis,anti-248 and cis,cis,syn-248. Overall, 
the reaction proceeded with high diastereoselectivity and the products were synthesised 
in high yields.  
 
Figure 2.13 Diagnostic signals in the 1H NMR spectra of anti- and syn-hydroxy 
sulfoximines 
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Thus, a regioselective and diastereoselective route to 2,5- and 2,6-disubstituted 
sulfoximines has been successfully developed. In particular, we have developed a simple 
two-step approach allowing two different substituents to be attached. 
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3. Conclusions and Future Work 
In summary, we have developed a highly diastereoselective route to α-functionalised 
cyclic sulfoximines via lithiation-trapping reactions. The reactions are straightforward 
and proceed via lithiation using n-BuLi (‒78 °C, 20 min) and subsequent trapping with 
an electrophile. Using the N-TBDPS group, we were able to synthesise a range of α-
functionalised cyclic and acyclic sulfoximines as single diastereomers in high yields. A 
lower level of diastereoselectivity was observed in three reactions which contained an α-
carbonyl group, presumably as these groups allowed epimerisation to occur. However, 
diastereomerically pure sulfoximines could still be isolated in high yields. A selection of 
our best results are shown in Figure 3.1. 
 
Figure 3.1 Products of lithiation-trapping reactions of N-TBDPS sulfoximines  
An exploration of the reactions of N-Boc, N-Me and N-CN 5- and 6-membered ring 
sulfoximines with four electrophiles (benzophenone, benzyl bromide, benzaldehyde and 
methyl iodide) was also carried out. These reactions generally gave sulfoximines with 
high diastereoselectivity and good yields. Of the sulfoximines tested, it was observed that 
reactions with 6-membered ring N-Me sulfoximine 156 and 5-membered ring N-CN 
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sulfoximine 68 gave products with a lower level of diastereoselectivity, but good yields 
were still obtained with some electrophiles. The key finds are summarised in Figure 3.2. 
 
Figure 3.2 Products of lithiation-trapping reactions of N-Boc, N-Me and N-CN 
sulfoximines  
Our attempts at the synthesis of 2,2-disubstituted sulfoximines for the synthesis of 2,2-
disubstituted sulfoximines were not successful, as the highest yield achieved was 6%. 
Further optimisation of this chemistry will be required. In contrast, the synthesis of 2,5- 
and 2,6-disubstituted sulfoximines was highly successful as we were able to control the 
regiochemistry and stereochemistry of the reaction to give cis,cis-sulfoximines in high 
yields (Figure 3.3).  
 
Figure 3.3 Results of 2,5- and 2,6-disubstitution reactions 
In future work, we want to confirm our proposed stereochemical assignments for some 
more of the sulfoximines. This will be achieved by either X-ray crystallography or their 
separate synthesis from sulfoximines of known configuration. We also plan to expand the 
scope of our work to include 4–7 membered cyclic sulfoximines. We also envisage 
exploring the use of Negishi cross-coupling reactions in the diastereoselective arylation 
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of sulfoximines at the α-position. Using Negishi conditions (n-BuLi, ZnCl2 and 
Pd(OAc)2), the α-arylation reactions are likely to be sterically controlled by the bulky NR 
group, forcing the α-substituent trans to the NR group to give sulfoximine cis-249 
(Scheme 3.1). It may also be possible to override the steric control by putting a Pd-
chelating group on the nitrogen of sulfoximine 139. As a result, Pd-mediated arylation 
may proceed via chelation control to give sulfoximine trans-249.  
 
Scheme 3.1 
These methods of steric and chelation control could also be utilised in the synthesis of β-
arylated sulfoximines and a proposed method for their synthesis is shown in Scheme 3.2. 
β-keto sulfoximines 250 can be readily converted into enol triflates 251 and subsequently 
arylated using Suzuki-Miyaura cross-coupling to give β-arylated unsaturated 
sulfoximines 252. Hydrogenation proceeding via steric control will add the hydrogen 
trans to the sterically bulky NR group resulting in sulfoximine trans-253. Hydrogen 
addition via chelation control will likely be delivered cis to the NR group, giving 
sulfoximine cis-253. 
Scheme 3.2 
Other future plans could include the synthesis of bicyclic and spirocyclic sulfoximines 
which can be achieved by a number of different routes. An example of spirocycle 
synthesis is shown in Scheme 3.3. Using LHMDS, Pd(0) and tri-tert-butylphosphine 
arylation of sulfoximine 254 would occur at the α-position. Subsequent attack of the 
carbonyl by the aryl amine would give spirocyclic sulfoximine 255. The stereochemistry 
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of sulfoximine 255 is assumed to be as depicted, based on the results presented in this 
thesis. 
 
Scheme 3.3 
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4. Experimental 
4.1 General Information 
All-non aqueous reactions were carried out under oxygen free Ar or N2 using flame-
dried glassware. THF was freshly distilled from sodium and benzophenone. 
Alkyllithiums were titrated against N-benzylbenzamide before use. Electrophiles 
(dimethyl sulfate, methyl iodide and benzaldehyde) used in lithiation reactions were 
distilled over CaH2 before use. Electrophiles (benzophenone, benzyl bromide, TMSCl, 
Weinreb amide 136, Weinreb amide 179, tert-butyl isocyanate, methyl chloroformate 
and N-benzylidene methylamine) were used without further purification. Brine refers to 
a saturated solution. Water is distilled water.  
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using commercially available 
Merck F254 aluminium backed silica plates. Proton (400 MHz) and carbon (100.6 MHz) 
NMR spectra were recorded on a Jeol ECX-400 instrument using an internal deuterium 
lock. For samples recorded in CDCl3, chemical shifts are quoted in parts per million 
relative to CHCl3 (δH 7.26) and CDCl3 (δC 77.0, central line of triplet). Carbon NMR 
spectra were recorded with broad band proton decoupling and assigned using DEPT 
experiments. Coupling constants (J) are quoted in Hertz. Melting points were carried out 
on a Gallenkamp melting point apparatus. Infrared spectra were recorded on an ATI 
Mattson Genesis FT-IR spectrometer. Electrospray high and low resonance mass spectra 
were recorded at room temperature on a Bruker Daltronics microOTOF spectrometer.  
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4.2 General Procedure 
General Procedure A: Lithiation-trapping of cyclic sulfoximines using n-BuLi at ‒
78 °C 
n-BuLi (2.5 M solution in hexanes, 1.1 eq.) was added dropwise to a stirred solution of 
the sulfoximine (0.5 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting 
solution was stirred at ‒78 °C for 20 min. Then, the electrophile (1.0 mmol, 2.0 eq.) (as a 
solution in THF for benzophenone) was added dropwise. The resulting solution was 
stirred at ‒78 °C for 1 h and then allowed to warm to rt. Water (5 mL) was added and the 
two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four: Experimental 
 
 
86 
 
4.3 Experimental Procedures and Characterisation Data 
1-[(tert-Butyldiphenylsilyl)imino]-1λ⁶-thiolan-1-one 146 
 
A solution of tetramethylene sulfide 66 (1.76 mL, 20.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (16.1 g, 50.0 mmol, 2.5 eq.) and ammonium carbamate (3.1 g, 
40.0 mmol, 2.0 eq.) in MeOH (40 mL) was stirred at rt for 3 h. The solvent was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave impure 
sulfoximine 23 (2.0 g) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.22; 
1H NMR (400 MHz, 
CDCl3) δ 3.17–3.10 (m, 4H, SCH) 2.31–2.18 (m, 4H CH); 13C NMR (100.6 MHz, CDCl3) 
δ 55.5 (SCH2), 24.1 (CH2). TBDPSCl (5.6 mL, 21.5 mmol, 1.25 eq.) was added dropwise 
to a stirred solution of the impure sulfoximine 23 (2.0 g, 17.2 mmol assumed, 1.0 eq.) and 
imidazole (2.3 g, 34.3 mmol, 2.0 eq.) in DMF (7.65 mL) at 0 °C under Ar. The resulting 
solution was stirred and heated at 90 °C for 48 h. The solution was allowed to cool to rt 
and then water (10 mL) was added. The two layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 9:1 and then 7:3 hexane-EtOAc as eluent 
gave N-TBDPS sulfoximine 146 (4.4 g, 60% over 2 steps) as a white solid, mp 74–76 °C; 
RF (7:3 hexane-EtOAc) 0.30; IR (ATR) 3069, 2930, 2855, 1290, 1253, 1153, 1129, 1106, 
701 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.78–7.72 (m, 4H, Ph), 7.42–7.33 (m, 6H, Ph), 
2.95–2.86 (m, 2H, SCH), 2.81–2.73 (m, 2H, SCH), 2.16–1.96 (m, 4H, CH), 1.08 (s, 9H, 
CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.4 (ipso-Ph), 135.7 (Ph), 129.2 (Ph), 127.6 
(Ph), 55.8 (SCH2), 27.2 (CMe3), 23.2 (SCH2CH2), 19.3 (CMe3); MS (ESI) m/z 358 (M + 
H)+; MS (ESI) m/z 358 (M + H)+; HRMS (ESI) m/z calcd for C20H27NOSSi (M + H)
+ 
358.1655, found 358.1657 (‒0.5 ppm error). This product appears to be hygroscopic and 
it is sometimes necessary to remove water by azeotroping with toluene. 
Lab book reference: GH-1-80 
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A solution of tetrahydrothiophene 1-oxide 145 (0.9 mL, 10.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (9.66 g, 30.0 mmol, 3.0 eq.) and ammonium carbamate (3.12 g, 
40.0 mmol, 4.0 eq.) in MeOH (20 mL) was stirred at rt for 30 min. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with CH2Cl2 and then 9:1 CH2Cl2-MeOH gave impure 
sulfoximine 23 (1.19 g) as a yellow oil. TBDPSCl (3.25 mL, 12.5 mmol, 1.25 eq.) was 
added dropwise to a stirred solution of the impure sulfoximine 23 (1.19 g, 10.0 mmol 
assumed, 1.0 eq.) and imidazole (1.36 g, 20.0 mmol, 2.0 eq.) in DMF (4.5 mL) at 0 °C 
under Ar. The resulting solution was stirred and heated at 90 °C for 48 h. The solution 
was allowed to cool to rt and then water (10 mL) was added. The two layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 9:1 and then 
7:3 hexane-EtOAc as eluent gave the N-TBDPS sulfoximine 146 (1.79 g, 50% over 2 
steps) as a white solid. 
Lab book reference: GH-1-30 
 
1-[(tert-Butyldiphenylsilyl)imino]-1λ⁶-thian-1-one 147 
 
A solution of pentamethylene sulfide 151 (0.42 mL, 4.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (3.22 g, 10.0 mmol, 2.5 eq.) and ammonium carbamate (625 mg, 
8.0 mmol, 2.0 eq.) in MeOH (8 mL) was stirred at rt for 3 h. The solvent was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 95:5 EtOAc-MeOH as eluent gave impure 
sulfoximine 152 (416 mg) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.24; 
1H NMR (400 
MHz, CDCl3) δ 3.09–3.03 (m, 4H, SCH), 2.12–2.02 (m, 4H, CH), 1.68–1.59 (m, 2H, 
CH); 13C NMR (100.6 MHz, CDCl3) δ 54.5 (SCH2), 24.3 (CH2), 24.2 (CH2). TBDPSCl 
(1.02 mL, 3.91 mmol, 1.25 eq.) was added dropwise to a stirred solution of the impure 
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sulfoximine 152 (416 mg, 3.13 mmol assumed, 1.0 eq.) and imidazole (426 mg, 6.25 
mmol, 2.0 eq.) in DMF (1.39 mL) at 0 °C under Ar. The resulting solution was stirred 
and heated at 90 °C for 63 h. The solution was allowed to cool to rt and then water (5 mL) 
was added. The two layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 and then 7:3 hexane-EtOAc as eluent gave N-TBDPS 
sulfoximine 147 (892 mg, 60% over 2 steps) as a white solid, mp 82–84 °C; RF (7:3 
hexane-EtOAc) 0.29; IR (ATR) 3073, 2929, 2855, 1323, 1289, 1145, 1107, 701 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.75 (dd, J = 7.5, 1.5 Hz, 4H, Ph), 7.40–7.31 (m, 6H, Ph), 
2.87–2.78 (m, 2H, SCH), 2.77–2.68 (m, 2H, SCH), 1.99–1.90 (m, 4H, CH), 1.57–1.44 
(m, 2H, CH), 1.07 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.9 (ipso-Ph), 135.7 
(Ph), 129.1 (Ph), 127.5 (Ph), 56.3 (SCH2), 27.3 (CMe3), 24.7 (CH2), 24.4 (CH2), 19.4 
(CMe3); MS (ESI) m/z 372 (M + H)
+ HRMS (ESI) m/z calcd for C21H29NOSSi (M + H)
+ 
372.1812, found 372.1814 (‒0.4 ppm error). This product appears to be hygroscopic and 
it is sometimes necessary to remove water by azeotroping with toluene. 
Lab book reference: GH-1-20 
 
1-[(tert-Butyldiphenylsilyl)imino]-1λ⁶-thietan-1-one 148 
 
A solution of trimethylene sulfide (0.72 mL, 10.0 mmol, 1.0 eq.), (diacetoxyiodo)benzene 
(8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 20.0 mmol, 2.0 eq.) in 
MeOH (20 mL) was stirred at rt for 3 h. The solvent was evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on silica 
with EtOAc and then 9:1 EtOAc-MeOH gave the impure sulfoximine (900 mg) as a 
yellow oil, RF (9:1 EtOAc-MeOH) 0.31; 
1H NMR (400 MHz, CDCl3) δ 4.17 (m, 4H, 
SCH2), 2.31–2.17 (m, 2H, SCH2CH2), 2.08 (s, 1H, NH); 13C NMR (100.6 MHz, CDCl3) 
δ 66.6 (SCH2), 7.7 (SCH2CH2). TBDPSCl (2.79 mL, 10.72 mmol, 1.25 eq.) was added 
dropwise to a stirred solution of the impure sulfoximine (900 mg, 8.58 mmol assumed, 
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1.0 eq.) and imidazole (1.17 g, 17.16 mmol, 2.0 eq.) in DMF (5 mL) at 0 °C under Ar. 
The resulting solution was stirred and heated at 90 °C for 48 h. The solution was allowed 
to cool to rt and then water (10 mL) was added to the solution. The two layers were 
separated and the aqueous layer was extracted with Et2O (3 × 20 mL). The combined 
organic layers were washed with brine (5 × 60 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromatography 
on silica with 9:1 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 148 (663 mg, 19% 
over 2 steps) as a white solid, mp 50–52 °C, RF (6:4 hexane-EtOAc) 0.47; IR (ATR) 3069, 
2957, 2855, 1306, 1214, 1145, 1104, 821, 739, 700, 606, 552, 501, 489 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.78–7.72 (m, 4H, Ph), 7.43–7.34 (m, 6H, Ph), 4.03–3.92 (m, 2H, 
SCH), 3.84–3.73 (m, 2H, SCH), 2.12–1.87 (m, 2H, SCH2CH2), 1.09 (s, 9H, CMe3); 13C 
NMR (100.6 MHz, CDCl3) δ 135.8 (ipso-Ph), 135.5 (Ph), 129.4 (Ph), 127.7 (Ph), 68.6 
(SCH2), 27.1 (CMe3), 19.2 (CMe3), 7.3 (SCH2CH2); MS (ESI) m/z 344 (M + H)
+; HRMS 
(ESI) m/z calcd for C19H25NOSSi (M + H)
+ 344.1499, found 344.1497 (+0.5 ppm error).  
Lab book reference: GH-2-55 
 
 [(tert-Butyldiphenylsilyl)imino]diethyl-λ⁶-sulfanone 149 
 
A solution of ethyl sulfide (1.08 mL, 10.0 mmol, 1.0 eq.), (diacetoxyiodo)benzene (8.05 
g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 20.0 mmol, 2.0 eq.) in MeOH 
(20 mL) was stirred at rt for 3 h. The solvent was evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 
EtOAc and then 9:1 EtOAc-MeOH gave the impure sulfoximine (0.70 g) as a yellow oil, 
RF (9:1 EtOAc-MeOH) 0.17; 
1H NMR (400 MHz, CDCl3) δ 3.06 (q, J = 7.5 Hz, 4H, 
SCH2), 2.07 (s, 1H, NH), 1.41 (t, J = 7.5 Hz, 6H, SCH2Me); 
13C NMR (100.6 MHz, 
CDCl3) δ 48.4 (SCH2), 7.1 (SCH2Me). TBDPSCl (1.89 mL, 7.25 mmol, 1.25 eq.) was 
added dropwise to a stirred solution of the impure sulfoximine (0.70 g, 5.8 mmol 
assumed, 1.0 eq.) and imidazole (0.79 g, 11.6 mmol, 2.0 eq.) in DMF (3 mL) at 0 °C 
under Ar. The resulting solution was stirred and heated at 90 °C for 48 h. The solution 
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was allowed to cool to rt and then water (5 mL) was added to the solution. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 20 mL). The combined 
organic layers were washed with brine (5 x 60 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromatography 
on silica with 9:1 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 149 (1.15 g, 32% 
over 2 steps) as a clear oil, RF (6:4 hexane-EtOAc) 0.64; IR (ATR) 3069, 2930, 2855, 
2888, 1307, 1281, 1261, 1145, 1106, 821, 783, 737, 699, 624, 613, 587, 495 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.77–7.71 (m, 4H, Ph), 7.40–7.31 (m, 6H, Ph), 2.89–2.73 (m, 
4H, SCH), 1.24 (t, J = 7.5 Hz, 6H, SCH2Me), 1.06 (s, 9H, CMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 136.9 (ipso-Ph), 135.7 (Ph), 129.1 (Ph), 127.5 (Ph), 49.7 (SCH2), 27.3 (CMe3), 
19.5 (CMe3), 7.9 (SCH2Me); MS (ESI) m/z 360 (M + H)
+; HRMS (ESI) m/z calcd for 
C20H29NOSSi (M + H)
+ 360.1812, found 360.1809 (+0.8 ppm error). 
Lab book reference: GH-2-54 
 
(tert-Butyldiphenylsilyl)[ethyl(oxo)phenyl-λ⁶-sulfanylidene]amine 150 
 
A solution of ethyl phenyl sulfide (1.35 mL, 10.0 mmol, 1.0 eq.), (diacetoxyiodo)benzene 
(8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 20.0 mmol, 2.0 eq.) in 
MeOH (20 mL) was stirred at rt for 3 h. The solvent was evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on silica 
with EtOAc and then 9:1 EtOAc-MeOH gave the impure sulfoximine (1.09 g) as a yellow 
oil, RF (9:1 EtOAc-MeOH) 0.5; 
1H NMR (400 MHz, CDCl3) δ 7.98–7.93 (m, 2H, Ph), 
7.64–7.58 (m, 1H, Ph), 7.57–7.50 (m, 2H, Ph), 3.18 (q, J = 7.5 Hz, 2H, SCH2), 2.08 (s, 
1H, NH), 1.25 (t, J = 7.5 Hz, 3H, SCH2Me). TBDPSCl (2.2 mL, 8.01 mmol, 1.25 eq.) 
was added dropwise to a stirred solution of the impure sulfoximine (1.09 g, 6.4 mmol 
assumed, 1.0 eq.) and imidazole (0.87 g, 12.8 mmol, 2.0 eq.) in DMF (4 mL) at 0 °C 
under Ar. The resulting solution was stirred and heated at 90 °C for 48 h. The solution 
was allowed to cool to rt and then water (5 mL) was added to the solution. The two layers 
were separated and the aqueous layer was extracted with Et2O (3 × 20 mL). The combined 
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organic layers were washed with brine (5 × 60 mL), dried (MgSO4) and evaporated under 
reduced pressure to give the crude product. Purification by flash column chromatography 
on silica with 95:5 hexane-EtOAc as eluent gave N-TBDPS sulfoximine 150 (1.54 g, 38% 
over 2 steps) as a clear oil, RF (6:4 hexane-EtOAc) 0.56; IR (ATR) 3069, 2930, 2855, 
1427, 1323, 1298, 1156, 1108, 740, 720, 702, 690, 499 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.98–7.91 (m, 2H, Ph), 7.89–7.77 (m, 4H, Ph), 7.58–7.50 (m, 1H, Ph), 7.50–7.33 (m, 
8H, Ph), 3.17–2.91 (m, 2H, SCH2), 1.22–1.14 (m, 12H, CMe3,SCH2Me); 13C NMR (100.6 
MHz, CDCl3) δ 142.1 (ipso-Ph), 136.56 (ipso-Ph), 136.49 (ipso-Ph), 135.67 (Ph), 135.63 
(Ph), 132.2 (Ph), 129.00 (Ph), 128.96 (Ph), 128.7 (Ph), 127.9 (Ph), 127.40 (Ph), 127.36 
(Ph), 54.7 (SCH2), 27.3 (CMe3), 19.5 (CMe3), 8.4 (SCH2Me); MS (ESI) m/z 408 (M + 
H)+; HRMS (ESI) m/z calcd for C24H29NOSSi (M + H)
+ 408.1812, found 408.1794 (+4.3 
ppm error).  
Lab book reference: GH-2-66 
 
tert-Butyl N-(1-oxo-1λ⁶-thiolan-1-ylidene)carbamate 153 
 
A solution of tetramethylene sulfide 66 (0.88 mL, 10.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 
20.0 mmol, 2.0 eq.) in MeOH (20 mL) was stirred at rt for 30 min. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with CH2Cl2 and then 9:1 CH2Cl2-MeOH gave impure 
sulfoximine 23 (824 mg) as a yellow oil. A solution of potassium tert-butoxide (1.01 g. 
9.0 mmol, 1.3 eq.) in THF (18 mL) was added to a stirred solution of impure sulfoximine 
23 (824 mg, 6.9 mmol assumed, 1.0 eq.) in THF (21 mL) at 0 °C under Ar. The resulting 
solution was stirred at 0 °C for 30 min. Then, a solution of Boc2O (3.01 g, 13.8 mmol, 
2.0 eq.) in THF (32 mL) was added and the resulting solution was stirred at 0 °C for 1 h. 
The solution was allowed to warm to rt and stirred at rt for 30 h. Saturated NH4Cl(aq) (35 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 30 mL). The combined organic layers were dried (MgSO4) and evaporated 
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under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 1:1 hexane-EtOAc and then 1:4 hexane-EtOAc as eluent 
gave N-Boc sulfoximine 153 (1.32 g, 60%) as a yellow oil, RF (1:4 hexane-EtOAc) 0.24; 
IR (ATR) 2975, 1654 (C=O), 1289, 1252, 1218, 1159, 913, 860 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 3.64–3.55 (m, 2H, SCH), 3.32–3.22 (m, 2H SCH), 2.38–2.19 (m, 4H, CH), 1.50 
(s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 159.4 (C=O), 80.9 (CMe3), 53.0 (SCH2), 
28.3 (CMe3), 23.7 (CH2); MS (ESI) m/z 242 (M + Na)
+; HRMS (ESI) m/z calcd for 
C9H17NO3S (M + Na)
+ 242.0821, found 242.0819 (+0.9 ppm error). 
Lab book reference: GH-1-57 
 
tert-Butyl N-(1-oxo-1λ⁶-thian-1-ylidene)carbamate 154 
 
A solution of pentamethylene sulfide 151 (1.04 mL, 10.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 
20.0 mmol, 2.0 eq.) in MeOH (20 mL) was stirred at rt for 3 h. The solvent was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 95:5 EtOAc-MeOH as eluent gave impure 
sulfoximine 152 (944 mg) as a yellow oil. A solution of potassium tert-butoxide (1.03 g. 
9.2 mmol, 1.3 eq.) in THF (18 mL) was added to a stirred solution of the impure 
sulfoximine 152 (940 mg, 7.0 mmol assumed, 1.0 eq.) in THF (22 mL) at 0 °C under Ar. 
The resulting solution was stirred at 0 °C for 30 min. Then, a solution of Boc2O (3.09 g, 
14.2 mmol, 2.0 eq.) in THF (33 mL) was added and the solution was stirred at 0 °C for 1 
h. The solution was allowed to warm to rt and stirred for 30 h. Saturated NH4Cl(aq) (35 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 30 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 1:1 hexane-EtOAc and then 1:4 hexane-EtOAc as eluent 
gave N-Boc sulfoximine 154 (1.01 g, 43% over 2 steps) as a white solid, mp 78–80 °C; 
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RF (1:4 hexane-EtOAc) 0.34; IR (ATR) 2978, 2931, 2872, 1658 (C=O), 1281, 1246, 1158, 
960, 893, 867 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.57–3.49 (m, 2H, SCH), 3.31–3.20 
(m, 2H, SCH), 2.17–2.02 (m, 4H, SCH2CH2), 1.74–1.60 (m, 2H, CH2), 1.49 (s, 9H, 
CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 158.8 (C=O), 80.5 (CMe3), 51.1 (SCH2), 28.3 
(CMe3), 23.8 (CH2), 23.4 (CH2); MS (ESI) m/z 256 (M + Na)
+; HRMS (ESI) m/z calcd 
for C10H19NO3S (M + Na)
+ 256.0978, found 256.0979 (‒0.5 ppm error). 
Lab book reference: GH-1-59 
 
1-(Methylimino)-1λ⁶-thiolan-1-one 155 
 
A solution of tetramethylene sulfide 66 (0.88 mL, 10.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 
20.0 mmol, 2.0 eq.) in MeOH (20 mL) was stirred at rt for 30 min. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with CH2Cl2 and then 9:1 CH2Cl2-MeOH gave impure 
sulfoximine 23 (871 mg) as a yellow oil. A solution of paraformaldehyde (263 mg, 8.8 
mmol, 1.2 eq.) and impure sulfoximine 23 (871 mg, 7.3 mmol assumed, 1.0 eq.) in formic 
acid (10.95 mL) was stirred and heated at 120 °C for 36 h. The solution was allowed to 
cool to rt and the solvent evaporated under reduced pressure. The residue was dissolved 
in 2 M H2SO4(aq) (51.1 mL) and the aqueous layer was extracted with CH2Cl2 (3 × 30 
mL). The aqueous layer was basified by the addition of 2 M NaOH(aq) until pH 12 was 
reached. The aqueous mixture was extracted with CH2Cl2 (3 × 40 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with EtOAc and 
then 9:1 EtOAc-MeOH as eluent gave N-Me sulfoximine 155 (754 mg, 57%) as an amber 
oil, RF (9:1 EtOAc-MeOH) 0.15; IR (ATR) 3398, 2944, 2802, 1224, 1147, 1100, 1074, 
905, 847 cm-1; 1H NMR (400 MHz CDCl3) δ 3.24–3.13 (m, 2H, SCH), 3.02–2.93 (m, 2H, 
SCH), 2.83 (s, 3H, NMe), 2.30–2.10 (m, 4H, CH); 13C NMR (100.6 MHz, CDCl3) δ 51.4 
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(SCH2), 30.8 (CH3), 23.8 (CH2); MS (ESI) m/z 134 (M + H)
+; HRMS (ESI) m/z calcd for 
C5H11NOS (M + H)
+ 134.0634, found 134.0631 (+2.6 ppm error). 
Lab book reference: GH-1-65 
 
1-(Methylimino)-1λ⁶-thian-1-one 156 
 
A solution of pentamethylene sulfide 151 (1.04 mL, 10.0 mmol, 1.0 eq.), 
(diacetoxyiodo)benzene (8.05 g, 25.0 mmol, 2.5 eq.) and ammonium carbamate (1.56 g, 
20.0 mmol, 2.0 eq.) in MeOH (20 mL) was stirred at rt for 3 h. The solvent was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 190:9:1 EtOAc-MeOH-NH4OH(aq) as 
eluent gave impure sulfoximine 152 (1.11 g) as a yellow oil. A solution of 
paraformaldehyde (301 mg, 10.0 mmol, 1.2 eq.) and the impure sulfoximine 152 (1.11 g, 
8.4 mmol assumed, 1.0 eq.) in formic acid (12.5 mL) was stirred and heated at 120 °C for 
36 h. The solution was allowed to cool to rt and the solvent evaporated under reduced 
pressure. The residue was dissolved in 2 M H2SO4(aq) (59 mL) and the aqueous layer was 
extracted with CH2Cl2 (3 × 30 mL). The aqueous layer was basified by the addition of 2 
M NaOH(aq) until pH 12 was reached. The aqueous mixture was extracted with CH2Cl2 
(3 × 60 mL). The combined organic layers were dried (MgSO4) and evaporated under 
reduced pressure. Purification by flash column chromatography on silica with EtOAc and 
then 9:1 EtOAc-MeOH as eluent gave N-Me sulfoximine 156 (741 mg, 50%) as a yellow 
oil, RF (9:1 EtOAc-MeOH) 0.17; IR (ATR) 2929, 2876, 2804, 1230, 1136, 1106, 867 cm
-
1 1H NMR (400 MHz, CDCl3) δ 3.15–3.06 (m, 2H, SCH), 3.04–2.96 (m, 2H, SCH), 2.80 
(s, 3H, NMe), 2.08–1.93 (m, 4H, SCH2CH2), 1.72–1.54 (m, 2H, CH2); 13C NMR (100.6 
MHz, CDCl3) δ 50.5 (SCH2), 28.6 (Me), 24.5 (CH2), 24.1 (CH2); MS (ESI) m/z 148 (M 
+ H)+; HRMS (ESI) m/z calcd for C6H13NOS (M + H)
+ 148.0791, found 148.0792 (‒0.6 
ppm error).  
Lab book reference: GH-1-75-2 
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[(1-oxo-1λ⁶-thiolan-1-ylidene)amino]formonitrile 68 
 
Potassium tert-butoxide (2.24 g, 20 mmol, 2.0 eq.) and cyanamide (840 mg, 20 mmol, 
2.0 eq.) were added sequentially to a stirred solution of tetrahydrothiophene 1-oxide 145 
(0.90 mL, 10 mmol, 1.0 eq.) in water (100 mL) at rt. The resulting solution was stirred at 
rt for 10 min. N-chlorosuccinimide (2.67 g, 20 mmol, 2.0 eq.) was added and the resulting 
solution was stirred at rt for 2 h. CH2Cl2 (100 mL) and 20% NaOH(aq) (50 mL) were added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 50 
mL). The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on silica 
with 1:1 hexane-EtOAc and then 9:1 EtOAc-hexane as eluent gave N-CN sulfoximine 68 
(716 mg, 50%) as a white solid, mp 78–80 °C (lit.36 78–79 °C); RF (EtOAc) 0.30; IR 
(ATR) 3004, 2948, 2184 (C≡N), 1448, 1408, 1280, 1228, 1176, 1091, 900, 817, 733, 600, 
539 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.59–3.49 (m, 2H, SCH), 3.35–3.23 (m, 2H, 
SCH), 2.45–2.26 (m, 4H, SCH2CH2); 13C NMR (100.6 MHz, CDCl3) δ 112.5 (C≡N), 53.0 
(SCH2), 23.6 (SCH2CH2); MS (ESI) m/z 145 (M + H)
+; HRMS (ESI) m/z calcd for 
C5H8N2OS (M + H)
+ 145.0430, found 145.0430 (0.0 ppm error). Spectroscopic data are 
consistent with those reported in the literature.56  
Lab book reference: GH-1-86-2 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(hydroxydiphenylmethyl)-1λ⁶-thiolan-1-one 
cis-157 
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Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude 
product. Purification by flash column chromatography on silica with hexane to 95:5 
hexane-EtOAc as eluent gave alcohol cis-157 (228 mg, 84%) as a white solid, mp 109–
111 °C; RF (8:2 hexane-EtOAc) 0.47; IR (ATR) 3437 (OH), 3072, 2930, 2855, 1299, 
1109, 734, 700 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.78–7.74 (m, 2H, Ph), 7.73–7.69 
(m, 2H, Ph), 7.55–7.51 (m, 2H, Ph), 7.43–7.32 (m, 6H, Ph), 7.29–7.17 (m, 7H, Ph), 7.17–
7.12 (m, 1H, Ph), 5.11 (s, 1H, COH), 4.32 (dd, J = 16.5, 7.5 Hz, 1H, SCH), 2.67–2.51 (m, 
2H, SCH), 2.22–2.11 (m, 1H, CH), 2.01–1.91 (m, 1H, CH), 1.91–1.72 (m, 2H, CH), 1.04 
(s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 145.6 (ipso-Ph), 145.4 (ipso-Ph), 136.1 
(ipso-Ph), 135.83 (ipso-Ph), 135.77 (Ph), 135.74 (Ph), 129.4 (Ph), 129.3 (Ph), 128.42 
(Ph), 128.38 (Ph), 127.8 (Ph), 127.6 (Ph), 127.3 (Ph), 126.8 (Ph), 126.5 (Ph), 125.1 (Ph), 
78.6 (COH), 70.9 (SCH), 57.8 (SCH2), 27.1 (CMe3), 27.0 (CH2), 21.3 (CH2), 19.3 
(CMe3); MS (ESI) m/z 540 (M + H)
+; HRMS (ESI) m/z calcd for C33H37NO2SSi (M + 
H)+ 540.2387, found 540.2399 (‒0.2 ppm error). The stereochemistry of cis-157 was 
assigned by X-ray crystallography. 
Crystal structure determination of cis-157 
C33H37NO2SSi, M = 539.78, monoclinic, a = 10.37330(10), b = 17.0824(2), c = 
16.0625(2) Å, β = 90.9500(10)°, U = 2845.90(6) Å3, T = 110.05(10) K, space group P21, 
Z = 4, μ(Mo-Kα) = 1.646 mm-1, 21242 reflection measured, 5437 unique (Rint = 0.0246) 
which were used in calculation. The final R1 was 0.0317 (I≥2σ) and wR2 was 0.0850 (all 
data). 
Lab book reference: GH-1-33  
 
LHMDS (0.55 mL of a 1 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. 
Benzophenone (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) was added 
dropwise and the resulting solution was stirred at ‒78 °C for 1 h. The solution was allowed 
to warm to rt and then water (5 mL) was added. The two layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were 
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dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with hexane and then 95:5 hexane-
EtOAc as eluent gave the alcohol cis-157 (158 mg, 59%) as a white solid. 
Lab book reference GH-1-26 
 
LHMDS (0.55 mL of a 1 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. 
Benzophenone (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) was added 
dropwise and the resulting solution was stirred at ‒78 °C for 1 h. The solution was allowed 
to warm to rt and then water (5 mL) was added. The two layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were 
dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with hexane to 97:3 hexane-
EtOAc as eluent gave the alcohol cis-157 (143 mg, 53%) as a white solid. 
Lab book reference: GH-1-28 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(hydroxydiphenylmethyl)-1λ⁶-thian-1-one cis-
158 
 
Using general procedure A, N-TBDPS sulfoximine 147 (186 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude 
product. Purification by flash column chromatography on silica with 95:5 hexane-EtOAc 
and then 9:1 hexane-EtOAc as eluent gave alcohol cis-158 (209 mg, 76%) as a white 
solid, mp 96–98 °C, RF (8:2 hexane-EtOAc) 0.30; IR (ATR) 3274 (OH), 3065, 2931, 
2857, 1255, 1139, 729, 701 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.73–7.70 (m, 2H, Ph), 
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7.69–7.66 (m, 2H, Ph), 7.50–7.46 (m, 2H, Ph), 7.43–7.34 (m, 8H, Ph), 7.33–7.20 (m, 6H, 
Ph), 7.12 (s, 1H, COH), 3.90 (dd, J = 12.0, 2.0 Hz, 1H, SCH), 2.58–2.47 (m, 1H, SCH), 
2.26–2.11 (m, 2H, CH), 1.90–1.61 (m, 4H, CH), 1.33–1.22 (m, 1H, CH), 1.00 (s, 9H, 
CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 144.8 (ipso-Ph), 142.1 (ipso-Ph), 136.3 (ipso-
Ph), 136.1 (Ph), 135.8 (Ph), 135.6 (ipso-Ph), 129.5 (Ph), 129.3 (Ph), 128.4 (Ph), 128.2 
(Ph), 127.8 (Ph), 127.69 (Ph), 127.67 (Ph), 127.6 (Ph), 127.5 (Ph), 127.2 (Ph), 81.5 
(COH), 72.9 (SCH), 57.9 (SCH2), 28.1 (CH2), 27.2 (CMe3), 25.9 (CH2), 24.0 (CH2), 19.2 
(CMe3); MS (ESI) m/z 554 (M + H)
+; HRMS (ESI) m/z calcd for C34H39NO2SSi (M + 
H)+ 554.2544, found 554.2556 (‒2.2 ppm error). The stereochemistry of cis-158 was 
assigned by X-ray crystallography. 
Crystal structure determination of cis-158 
C34H39NO2SSi, M = 553.81, monoclinic, a = 20.0762(3), b = 10.90514(18), c = 
81.5001(12) Å, β = 93.6761(13)°, U = 17806.4(5) Å3, T = 110.05(10) K, space group P21, 
Z = 24, μ(Mo-Kα) = 1.591 mm-1, 117774 reflection measured, 31743 unique (Rint = 
0.0496) which were used in calculation. The final R1 was 0.0729 (I≥2σ) and wR2 was 
0.2085 (all data). 
Lab book reference: GH-1-36 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(hydroxydiphenylmethyl)-1λ⁶-thietan-1-one 
cis-159 and 1-[(tert-Butyldiphenylsilyl)imino]-2,4-bis(hydroxydiphenylmethyl)-1λ⁶-
thietan-1-one cis,cis-160 
 
Using general procedure A, N-TBDPS sulfoximine 148 (172 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude 
product which contained an 85:15 mixture (by 1H NMR spectroscopy) of sulfoximines 
cis-159 and cis,cis-160. Purification by flash column chromatography on silica with 95:5 
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hexane-EtOAc as eluent gave an 85:15 mixture of sulfoximines cis-159 and cis,cis-160 
(185 mg, 149 mg (57%) of cis-159 and 36 mg (10%) of cis,cis-160) as a white solid, RF 
(8:2 hexane-EtOAc) 0.46; IR (ATR) 3459 (OH), 3068, 2930, 2856, 1449, 1427, 1333, 
1186, 1153, 1110, 740, 700, 508, 502 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.79–7.68 (m, 
3H, Ph), 7.68–7.59 (m, 2H, Ph), 7.52–7.14 (m, 14H, Ph), 7.08–6.93 (m, 1H, Ph), 5.25 
(dd, J = 9.0, 9.0 Hz, 0.85H, SCH), 5.15 (dd, J = 10.0, 10.0 Hz, 0.3H, SCH), 5.03 (s, 0.85H, 
COH), 4.82 (s, 0.3H, COH), 3.88–3.66 (m, 0.85H, SCH), 3.67 (ddd, J = 12.5, 10.5, 8.5 
Hz, 0.85H, SCH), 2.92 (dt, J = 12.5, 9.5 Hz, 0.15H, CH) 2.48–2.34 (m, 0.85H, SCHCH), 
1.84–1.70 (m, 1H, SCHCH), 1.11 (s, 7.65H, CMe3), 0.93 (s, 1.35H, CMe3); 13C NMR 
(100.6 MHz, CDCl3) δ 145.4 (ipso-Ph), 145.0 (ipso-Ph), 143.95 (ipso-Ph), 143.85 (ipso-
Ph), 135.53 (Ph), 135.51 (Ph), 135.46 (Ph), 135.44 (Ph), 129.5 (Ph), 128.5 (Ph), 128.4 
(Ph), 127.78 (Ph), 127.73 (Ph), 127.2 (Ph), 126.6 (Ph), 126.0 (Ph), 125.56 (Ph), 125.45 
(Ph), 86.4 (SCH, cis-159), 83.7 (SCH, cis,cis-160), 78.7 (COH, cis,cis-160), 78.3 (COH, 
cis-159), 65.8 (SCH2, cis-159), 27.0 (CMe3, cis-159), 26.7 (CMe3, cis,cis-160), 19.32 
(CMe3, cis,cis-160), 19.29 (CMe3, cis-159), 13.9 (CH2, cis,cis-160), 10.2 (CH2, cis-159) 
(some Ph resonances not resolved); MS (ESI) m/z 526 (M + H)+ HRMS (ESI) m/z calcd 
for C32H35NO2SSi (M + H)
+ 526.2231, found 526.2223 (+1.5 ppm error), MS (ESI) m/z 
730 (M + H)+ HRMS (ESI) m/z calcd for C45H45NO3SSi (M + H)
+ 730.2782, found 
730.2793 (‒1.6 ppm error). The stereochemistry of cis-159 and cis,cis-160 was assigned 
by analogy with related examples. 
Lab book reference: GH-2-59 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-[hydroxy(phenyl)methyl]-1λ⁶-thiolan-1-one 
cis,anti-164 and cis,syn-164 
 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained an 
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85:15 mixture (by 1H NMR spectroscopy) of alcohols cis,anti-164 and cis,syn-164. 
Purification by flash column chromatography on silica with 95:5 and then 9:1 hexane-
EtOAc as eluent gave alcohol cis,anti-164 (154 mg, 66%) as a white solid and alcohol 
cis,syn-164 (23 mg, 10%) as a white solid, mp 86–88 °C; RF (8:2 hexane-EtOAc) 0.27; 
IR (ATR) 3479 (OH), 3069, 2930, 2855, 1299, 1108, 731, 698 cm-1; 1H NMR (400 MHz, 
CDCl3) δ; 7.80–7.73 (m, 4H, Ph), 7.43–7.34 (m, 6H, Ph), 7.28–7.16 (m, 3H, Ph), 7.00 (d, 
J = 7.0 Hz, 2H, Ph), 5.12 (s, 1H, PhCHOH), 3.98 (s, 1H, PhCHOH), 3.01–2.88 (m, 3H, 
SCH), 2.30–2.18 (m, 1H, CH), 2.13–2.02 (m, 1H, CH), 1.93–1.80 (m, 1H, CH), 1.74–
1.65 (m, 1H, CH), 1.11 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ; 140.5 (ipso-Ph), 
136.19 (ipso-Ph), 136.15 (ipso-Ph), 135.70 (Ph), 135.66 (Ph), 129.51 (Ph), 129.46 (Ph), 
128.4 (Ph), 127.81 (Ph), 127.78 (Ph), 127.4 (Ph), 125.6 (Ph), 70.1 (SCH), 68.6 
(PhCHOH), 57.3 (SCH2), 27.2 (CMe3), 22.3 (CH2), 20.9 (CH2), 19.3 (CMe3); MS (ESI) 
m/z 464 (M + H)+; HRMS (ESI) m/z calcd for C27H33NO2SSi (M + H)
+ 464.2074, found 
464.2079 (‒1.2 ppm error), mp 82–84 °C; RF (8:2 hexane-EtOAc) 0.20; IR (ATR) 3468 
(OH), 3068, 2930, 2855, 1304, 1108, 700 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.80–7.74 
(m, 4H, Ph), 7.46–7.35 (m, 6H, Ph), 7.35–7.29 (m, 3H, Ph), 7.29–7.25 (m, 2H, Ph), 4.89 
(d, J = 9.5 Hz, 1H, PhCHOH), 4.07 (s, 1H, PhCHOH), 3.19 (ddd, J = 9.5, 9.5, 9.5 Hz, 
1H, SCH), 2.95–2.77 (m, 2H, SCH), 2.07–1.94 (m, 1H, CH), 1.92–1.79 (m, 1H, CH), 
1.78–1.68 (m, 1H, CH), 1.68–1.55 (m, 1H, CH), 1.11 (s, 9H, CMe3); 13C NMR (100.6 
MHz, CDCl3) δ 140.3 (ipso-Ph), 136.04 (ipso-Ph), 136.01 (ipso-Ph), 135.8 (Ph), 129.4 
(Ph), 128.7 (Ph), 128.4 (Ph), 127.8 (Ph), 127.7 (Ph), 127.1 (Ph), 75.5 (PhCHOH), 70.5 
(SCH), 56.2 (SCH2), 27.2 (CMe3), 27.0 (CH2), 20.9 (CH2), 19.3 (CMe3) (two Ph 
resonances not resolved); MS (ESI) m/z 464 (M + H)+; HRMS (ESI) m/z calcd for 
C27H33NO2SSi (M + H)
+ 464.2074, found 464.2070 (+0.9 ppm error). The 
stereochemistry of cis,syn-164 was assigned by X-ray crystallography and that of cis,anti-
164 was assigned by analogy. 
Crystal structure determination of cis,syn-164 
C27H33NO2SiS, M = 463.69, monoclinic, a = 14.6428(2), b = 11.09222(10), c = 
16.4498(2) Å, β = 113.4106(16)°, U = 2451.85(6) Å3, T = 110.05(10) K, space group P21, 
Z = 4, μ(Mo-Kα) = 1.822 mm-1, 18079 reflection measured, 4375 unique (Rint = 0.0274) 
which were used in calculation. The final R1 was 0.0327 (I≥2σ) and wR2 was 0.0893 (all 
data). 
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Lab book reference GH-1-35 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-[hydroxy(phenyl)methyl]-1λ⁶-thian-1-one 
cis,anti-165 and cis,syn-165 
 
Using general procedure A, N-TBDPS sulfoximine 147 (186 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained an 
85:15 mixture (by 1H NMR spectroscopy) of alcohols cis,anti-165 and cis,syn-165. 
Purification by flash column chromatography on silica with 95:5 and then 9:1 hexane-
EtOAc as eluent gave an 85:15 mixture of diastereomeric alcohols cis,anti-165 and 
cis,syn-165 (174 mg, 73%) as a white solid, RF (8:2 hexane-EtOAc) 0.31; IR (ATR) 3488 
(OH), 3069, 2929, 2856, 1324, 1284, 1259, 1134, 1107, 732, 699; 1H NMR (400 MHz, 
CDCl3) δ 7.79–7.78 (m, 4H, Ph), 7.42–7.30 (m, 9H, Ph), 7.26–7.30 (m, 2H, Ph), 5.89 (s, 
0.85H, PhCHOH), 5.34 (d, J = 9.0 Hz, 0.15H, PhCHOH), 3.55 (s, 1H, PhCHOH), 3.12–
3.06 (m, 0.15H, SCH), 2.86–2.77 (m, 1.7H, SCH), 2.78–2.67 (m, 0.85H, SCH), 2.58–
2.50 (m, 0.15H, SCH), 2.43–2.39 (m, 0.15H, SCH), 2.20–2.06 (m, 1H, CH), 2.05–1.91 
(m, 1H, CH), 1.90–1.72 (m, 2H, CH), 1.74–1.65 (m, 1H, CH), 1.22–1.16 (m, 1H, CH), 
1.13 (s, 7.65H, CMe3) 1.11 (s, 1.35H, CMe3); 
13C NMR (100.6 MHz, CDCl3) for cis,anti-
165 δ 140.4 (ipso-Ph), 136.47 (ipso-Ph), 136.46 (ipso-Ph), 135.69 (Ph), 135.62 (Ph), 
129.4 (Ph), 128.4 (Ph), 127.73 (Ph), 127.70 (Ph), 127.48 (Ph), 125.90 (Ph), 70.2 (SCH), 
67.8 (PhCHOH), 57.6 (SCH2), 27.3 (CMe3), 24.4 (CH2), 24.2 (CH2), 21.9 (CH2), 19.5 
(CMe3) (one Ph resonance not resolved); MS (ESI) m/z 478 (M + H)
+; HRMS (ESI) m/z 
calcd for C28H35NO2SSi (M + H)
+ 478.2231, found 478.2238 (‒1.6 ppm error). 
Diagnostic signals for cis,syn-165 δ 73.1 (SCH), 69.1 (PhCHOH), 55.6 (SCH2), 27.5 
(CMe3), 27.2 (CH2), 24.03 (CH2), 23.95 (CH2), 19.2 (CMe3). The stereochemistry of 
cis,syn-165 and cis,anti-165 was assigned by analogy with related examples. 
Lab book reference: GH-1-37 
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2-Benzyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thiolan-1-one cis-166 
 
Using general procedure A, N-TBDPS sulfoximine 146 (358 mg, 1.0 mmol, 1.0 eq.), n-
BuLi (0.44 mL of a 2.5 M solution in n-hexane, 1.1 mmol, 1.1 eq.) and benzyl bromide 
(0.24 mL, 2.0 mmol, 2.0 eq.) in THF (10 mL) gave the crude product. Purification by 
flash column chromatography on silica with hexane and then 95:5 hexane-EtOAc as 
eluent gave benzyl sulfoximine cis-166 (328 mg, 73%) as a white semi-solid, RF (9:1 
hexane-EtOAc) 0.24; IR (ATR) 3073, 2929, 2855, 1307, 1153, 1108, 702 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.80–7.71 (m, 4H, Ph), 7.43–7.32 (m, 6H, Ph), 7.28–7.17 (m, 3H, 
Ph), 7.00 (d, J = 7.0 Hz, 2H, Ph), 3.12 (dd, J = 14.0, 4.5 Hz, 1H, PhCH), 3.02–2.83 (m, 
3H, SCH), 2.61 (dd, J = 14.0, 10.5 Hz, 1H, PhCH), 2.08–1.92 (m, 2H, CH), 1.88–1.67 
(m, 2H, CH), 1.08 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 138.3 (ipso-Ph), 
136.56 (ipso-Ph), 136.54 (ipso-Ph), 135.7 (Ph), 129.3 (Ph), 129.1 (Ph), 128.7 (Ph), 127.7 
(Ph), 126.7 (Ph), 66.2 (SCH), 55.8 (SCH2), 33.8 (PhCH2), 28.9 (CH2), 27.2 (CMe3), 20.5 
(CH2), 19.3 (CMe3) (three Ph resonances not resolved); MS (ESI) m/z 448 (M + H)
+; 
HRMS (ESI) m/z calcd for C27H33NOSSi (M + H)
+ 448.2125, found 448.2126 (‒0.3 ppm 
error). The stereochemistry of cis-166 was assigned by analogy with related examples. 
Lab book reference: GH-1-18 
 
2-Benzyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thian-1-one cis-168 and 2,6-
Dibenzyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thian-1-one cis,cis-169  
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Using general procedure A, N-TBDPS sulfoximine 147 (72 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 
55:45 mixture (by 1H NMR spectroscopy) of sulfoximines cis-168 and cis,cis-169. 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc as eluent 
gave dibenzyl sulfoximine cis,cis-169 (91 mg, 33%) as a clear oil, RF (8:2 hexane-EtOAc) 
0.56; IR (ATR) 3027, 2930, 2855, 1358, 1346, 1320, 1268, 1156, 1106, 759, 739, 699, 
614, 601, 491 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.94–7.87 (m, 4H, Ph), 7.43–7.34 (m, 
6H, Ph), 7.23–7.11 (m, 6H, Ph), 6.85–6.78 (m, 4H, Ph), 3.42 (dd, J = 13.0, 2.5 Hz, 2H, 
PhCH), 2.96–2.83 (m, 2H, SCH), 2.51 (dd, J = 13.0, 12.0 Hz, 2H, PhCH), 1.76–1.59 (m, 
5H, CH), 1.19–1.08 (m, 1H, CH), 1.12 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ; 
137.7 (ipso-Ph), 136.6 (ipso-Ph), 135.8 (Ph), 129.5 (Ph), 129.2 (Ph), 128.6 (Ph), 127.7 
(Ph), 126.6 (Ph), 67.6 (SCH), 31.6 (CH2), 29.0 (CH2), 27.2 (CMe3), 24.8 (CH2), 20.0 
(CMe3); MS (ESI) m/z 552 (M + H)
+; HRMS (ESI) m/z calcd for C35H41NOSSi (M + H)
+ 
552.2751, found 552.2750 (+0.2 ppm error) and benzyl sulfoximine cis-168 (72 mg, 31%) 
as a clear oil, RF (8:2 hexane-EtOAc) 0.51; IR (ATR) 3068, 2929, 2855, 1321, 1281, 1259, 
1167, 1141, 1106, 820, 733, 698, 656, 602, 495, 462 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.84–7.76 (m, 4H, Ph), 7.43–7.33 (m, 6H, Ph), 7.32–7.17 (m, 3H, Ph), 7.05 (d, J = 7.0 
Hz, 2H, Ph), 3.60 (dd, J = 13.5, 2.5 Hz, 1H, PhCH), 2.95–2.75 (m, 2H, SCH), 2.75–2.54 
(m, 1H, SCH), 2.55 (dd, J = 13.5, 11.5 Hz, PhCH), 2.04–1.90 (m, 1H, CH), 1.90–1.77 
(m, 2H, CH), 1.77–1.62 (m, 2H, CH), 1.28–1.14 (m, 1H, CH), 1.11 (s, 9H, CMe3); 13C 
NMR (100.6 MHz, CDCl3) δ 137.9 (ipso-Ph), 136.92 (ipso-Ph), 136.90 (ipso-Ph), 135.75 
(Ph), 135.72 (Ph), 129.5 (Ph), 129.2 (Ph), 128.7 (Ph), 127.6 (Ph), 126.7 (Ph), 66.7 (SCH), 
56.4 (SCH2), 31.2 (PhCH2), 28.5 (CH2), 27.3 (CMe3), 24.6 (CH2), 24.5 (CH2), 19.5 
(CMe3) (two Ph resonances not resolved); MS (ESI) m/z 462 (M + H)
+; HRMS (ESI) m/z 
calcd for C28H35NOSSi (M + H)
+ 462.2281, found 462.2282 (‒0.1 ppm error). The 
stereochemistry of cis-168 and cis,cis-169 was assigned by analogy with related 
examples. 
Lab book reference: GH-1-96 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-methyl-1λ⁶-thiolan-1-one cis-172 and 1-[(tert-
Butyldiphenylsilyl)imino]-2,5-dimethyl-1λ⁶-thiolan-1-one cis,cis-173  
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Using general procedure A, N-TBDPS sulfoximine 146 (358 mg, 1.0 mmol, 1.0 eq.), n-
BuLi (0.44 mL of a 2.5 M solution in hexanes, 1.1 mmol, 1.1 eq.) and dimethyl sulfate 
(0.19 mL, 2.0 mmol, 2.0 eq.) in THF (10 mL) gave the crude product which contained an 
85:15 mixture (by 1H NMR spectroscopy) of sulfoximines cis-172 and cis,cis-173. 
Purification by flash column chromatography on silica with hexane and then 9:1 hexane-
EtOAc as eluent gave dimethyl sulfoximine cis,cis-173 (28 mg, 7%) as a white solid, mp 
49–51 °C; RF (9:1 hexane-EtOAc) 0.5; IR (ATR) 3069, 2930, 2854, 1313, 1248, 1145, 
1106, 702 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.75–7.71 (m, 4H, Ph), 7.38–7.29 (m, 6H, 
Ph), 2.93–2.81 (m, 2H, SCH), 2.08–1.98 (m, 2H, CH), 1.65–1.55 (m, 2H, CH), 1.09 (d, J 
= 7.0 Hz, 6H, CHMe), 1.06 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 137.6 (Ph), 
136.9 (ipso-Ph), 135.7 (Ph), 130.4 (Ph), 129.1 (Ph), 127.5 (Ph), 59.3 (SCH), 28.1 (CH2), 
27.2 (CMe3), 19.4 (CMe3), 12.7 (CHMe) (two Ph resonances not resolved); MS (ESI) m/z 
386 (M + H)+ HRMS (ESI) m/z calcd for C22H31NOSSi (M + H)
+ 386.1968, found 
386.1968 (+0.1 ppm error) and methyl sulfoximine cis-172 (166 mg, 45%) as a white 
solid, mp 64–66 °C; RF (9:1 hexane-EtOAc) 0.38; IR (ATR) 3069, 2930, 2855, 1305, 
1250, 1147, 1107, 701 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.77–7.71 (m, 4H, Ph), 7.41–
7.32 (m, 6H, Ph), 2.90–2.76 (m, 3H, SCH), 2.21–2.11 (m, 1H, CH), 2.08–1.97 (m, 1H, 
CH), 1.92–1.79 (m, 1H, CH), 1.73–1.61 (m, 1H, CH), 1.18 (d, J = 7.0 Hz, 3H, CHMe), 
1.07 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.67 (ipso-Ph), 136.62 (ipso-Ph), 
135.70 (Ph), 135.68 (Ph), 129.2 (Ph), 127.57 (Ph), 127.55 (Ph), 60.3 (SCH), 54.9 (SCH2), 
30.9 (CH2), 27.2 (CMe3), 20.5 (CH2), 19.3 (CMe3), 12.3 (CHMe) (one Ph resonance not 
resolved); MS (ESI) m/z 372 (M + H)+; HRMS (ESI) m/z calcd for C21H29NOSSi (M + 
H)+ 372.1812 found, 372.1819 (‒1.8 ppm error). The stereochemistry of cis-172 was 
assigned by X-ray crystallography and that of cis,cis-173 was assigned by analogy. 
Crystal structure determination of cis-172 
C21H29NOSSi, M = 371.60, monoclinic, a = 11.22483(13), b = 11.01708(15), c = 
16.9162(2) Å, β = 103.5456(13)°, U = 2033.75(5) Å3, T = 110.05(10) K, space group P21, 
Z = 4, μ(Mo-Kα) = 2.031 mm-1, 11190 reflection measured, 3640 unique (Rint = 0.0186) 
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which were used in calculation. The final R1 was 0.0294 (I≥2σ) and wR2 was 0.0796 (all 
data). 
Lab book reference: GH-1-15 
 
Using general procedure A, N-TBDPS sulfoximine 146 (1.79 g, 5 mmol, 1.0 eq.), n-BuLi 
(2.4 mL of a 2.3 M solution in hexanes, 5.5 mmol, 1.1 eq.) and methyl iodide (0.62 mL, 
10 mmol, 2.0 eq.) in THF (5 mL) gave the crude product. Purification by flash column 
chromatography on silica with hexane and then 9:1 hexane-EtOAc as eluent gave 
dimethyl sulfoximine cis,cis-173 (52 mg, 3%) as a white solid and methyl sulfoximine 
cis-172 (834 mg, 45%) as a white solid. 
Lab book reference: GH-1-82 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-methyl-1λ⁶-thiolan-1-one cis-172 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with hexane and then 9:1 hexane-EtOAc as eluent gave 
methyl sulfoximine cis-172 (109 mg, 56%) as a white solid.  
Lab book reference: GH-1-46 
 
1-[(tert-Butyldiphenylsilyl)imino]-2,5-dimethyl-1λ⁶-thiolan-1-one cis,cis-173 
n-BuLi (0.54 mL of a 2.3 M solution in hexanes, 1.25 mmol, 2.5 eq.) was added dropwise 
to a stirred solution of the N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.) in THF 
(5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. Then, 
methyl iodide (0.12 mL, 2.0 mmol, 4.0 eq) was added dropwise. The resulting solution 
was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Water (5 mL) was added and 
the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 30 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
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95:5 hexane-EtOAc as eluent gave dimethyl sulfoximine cis,cis-173 (148 mg, 74%) as a 
white solid, RF (8:2 hexane-EtOAc) 0.40. 
Lab book reference: GH-2-43 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-methyl-1λ⁶-thian-1-one cis-174 and 1-[(tert-
Butyldiphenylsilyl)imino]-2,6-dimethyl-1λ⁶-thian-1-one cis,cis-175  
 
Using general procedure A, N-TBDPS sulfoximine 147 (186 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained an 
80:20 mixture (by 1H NMR spectroscopy) of sulfoximines cis-174 and cis,cis-175. 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc as eluent 
gave dimethyl sulfoximine cis,cis-175 (24 mg, 12%) as a white solid, mp 164–166 °C; RF 
(8:2 hexane-EtOAc) 0.53; IR (ATR) 3069, 2931, 2855, 1329, 1280, 1107, 1181, 1154, 
702 cm-1; 1H NMR (400 MHz CDCl3) δ 7.80–7.74 (m, 4H, Ph), 7.39–7.30 (m, 6H, Ph), 
2.87–2.73 (m, 2H, SCH), 1.87–1.69 (m, 5H, CH), 1.49–1.37 (m, 1H, CH), 1.10 (d, J = 
7.0 Hz, 6H, CHMe), 1.04 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.9 (ipso-
Ph), 135.8 (Ph) 129.0 (Ph), 127.4 (Ph), 61.2 (SCH), 32.9 (CH2), 27.3 (CMe3), 25.3 (CH2), 
19.8 (CMe3), 12.1 (CHMe); MS (ESI) m/z 400 (M + H)
+; HRMS (ESI) m/z calcd for 
C23H33NOSSi (M + H)
+ 400.2131 found 400.2131 (+0.1 ppm error) and methyl 
sulfoximine cis-174 (90 mg, 47%) as a white solid, mp 158–160 °C; RF (8:2 hexane-
EtOAc) 0.44; IR (ATR) 3069, 2931, 2855, 1329, 1280, 1107, 1181, 1154, 702 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.79–7.71 (m, 4H, Ph), 7.40–7.30 (m, 6H, Ph), 2.89–2.71 (m, 
2H, SCH), 2.68–2.58 (m, 1H, SCH), 2.01–1.70 (m, 5H, CH), 1.41–1.30 (m, 1H, CH), 
1.28 (d, J = 7.0 Hz, 3H, CHMe), 1.06 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 
137.1 (ipso-Ph), 137.0 (ipso-Ph), 135.74 (Ph), 135.70 (Ph), 129.08 (Ph), 129.06 (Ph), 
127.50 (Ph), 127.48 (Ph), 60.5 (SCH), 55.9 (SCH2), 32.2 (CH2), 27.3 (CMe3), 24.8 (CH2), 
24.6 (CH2), 19.5 (CMe3), 11.8 (CHMe); MS (ESI) m/z 386 (M + H)
+; HRMS (ESI) m/z 
calcd for C22H31NOSSi (M + H)
+ 386.1968, found 386.1975 (‒1.6 ppm error). The 
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stereochemistry of cis,cis-175 was assigned by X-ray crystallography and that of cis-174 
was assigned by analogy. 
Crystal structure determination of cis,cis-175 
C23H33NOSSi, M = 399.65, monoclinic, a = 12.32310(10), b = 10.67430(10), c = 
16.70490(10) Å, β = 98.4940(10)°, U = 2173.27(3) Å3, T = 110.00(10) K, space group 
P21, Z = 4, μ(Mo-Kα) = 1.934  mm-1, 20529 reflection measured, 4167 unique (Rint = 
0.0166) which were used in calculation. The final R1 was 0.0374 (I≥2σ) and wR2 was 
0.0973 (all data). 
Lab book reference: GH-1-55 
 
Using general procedure A, N-TBDPS sulfoximine 147 (186 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and dimethyl sulfate 
(0.1 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained an 
85:15 mixture (by 1H NMR spectroscopy) of sulfoximines cis-174 and cis,cis-175. 
Purification by flash column chromatography on silica with 9:1 hexane-EtOAc as eluent 
gave dimethyl sulfoximine cis,cis-175 (18 mg, 9%) as a white solid and methyl 
sulfoximine cis-174 (101 mg, 52%) as a white solid. 
Lab book reference: GH-1-24 
 
n-BuLi (0.54 mL of a 2.3 M solution in hexanes, 1.25 mmol, 2.5 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 147 (186 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min. Then, 
methyl iodide (0.12 mL, 2.0 mmol, 4.0 eq) was added dropwise. The resulting solution 
was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Then water (5 mL) was added 
and the two layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 30 
mL). The combined organic layers were dried (MgSO4) and evaporated under reduced 
pressure to give the crude product which contained an 85:15 mixture (by 1H NMR 
spectroscopy) of sulfoximines cis,cis-175 and cis-174. Purification by flash column 
chromatography on silica with 95:5 hexane-EtOAc as eluent gave dimethyl sulfoximine 
Chapter Four: Experimental 
 
 
108 
 
cis,cis-175 (108 mg, 54%) as a white solid and methyl sulfoximine cis-174 (21 mg, 11%) 
as a white solid. 
Lab book reference: GH-2-44 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(trimethylsilyl)-1λ⁶-thiolan-1-one cis-176 
 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and TMSCl (0.13 mL, 
1.0 mmol, 2.0 eq) gave the crude product. Purification by flash column chromatography 
on silica with 9:1 and then 8:2 hexane-EtOAc as eluent gave silyl sulfoximine cis-176 
(170 mg, 79%) as a clear oil, RF (9:1 hexane-EtOAc) 0.50; IR (ATR) 3069, 3048, 2955, 
2893, 2855, 1427, 1300, 1248, 1140, 1108, 845, 821, 738, 702, 605, 500 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.78–7.71 (m, 4H, Ph), 7.41–7.31 (m, 6H, Ph), 2.60–2.53 (m, 2H, 
SCH), 2.42 (dd, J = 12.0, 7.5 Hz, 1H, SCH), 2.16–2.02 (m, 2H, CH), 2.00–1.78 (m, 2H, 
CH), 1.07 (s, 9H, CMe3), 0.22 (s, 9H, SiMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.8 
(ipso-Ph), 136.5 (ipso-Ph), 135.9 (Ph), 135.8 (Ph), 129.16 (Ph), 129.11 (Ph), 127.58 (Ph), 
127.55 (Ph), 57.1 (SCH), 56.5 (SCH2), 27.2 (CMe3), 26.1 (CH2), 24.8 (CH2), 19.4 
(CMe3), ‒1.9 (SiMe3); MS (ESI) m/z 430 (M + H)+; HRMS (ESI) m/z calcd for 
C23H35NOSSi2 (M + H)
+ 430.2051, found 430.2052 (‒0.3 ppm error). The 
stereochemistry of silyl sulfoximine cis-176 was assigned by analogy with related 
examples. 
Lab book reference: GH-2-25 
 
N-Methoxy-N-methylbenzamide 136 
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Et3N (3 mL, 21.3 mmol, 1.0 eq.) was added to a stirred solution of N,O-
dimethylhydroxylamine hydrochloride (694 mg, 7.11 mmol, 1.0 eq.) in CH2Cl2 (20 mL) 
at rt under Ar. The resulting solution was cooled to 0 °C. Then, benzoyl chloride 177 
(0.83 mL, 7.11 mmol, 1.0 eq.) was added. The resulting solution was allowed to warm to 
rt and stirred at rt for 2 h. Saturated NH4Cl(aq) (20 mL) and saturated NaHCO3(aq) (20 mL) 
were added. The two layers were separated and the aqueous layer was extracted with 
CH2Cl2 (3 × 50 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 4:1 and then 1:1 hexane-EtOAc as eluent gave Weinreb 
amide 136 (869 mg, 74%) as a yellow oil, RF (4:1 hexane-EtOAc) 0.21; IR (ATR) 2970, 
2936, 1636 (C=O), 1447, 1413, 1377, 977, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.69–
7.64 (m, 2H, Ph), 7.48–7.37 (m, 3H, Ph), 3.55 (s, 3H, OMe), 3.36 (s, 3H, NMe); 13C NMR 
(100.6 MHz, CDCl3) δ 170.1 (C=O), 134.2 (ipso-Ph), 130.7 (Ph), 128.3 (Ph), 128.1 (Ph), 
61.2 (OMe), 33.3 (NMe); MS (ESI) m/z 166 (M + H)+; HRMS (ESI) m/z calcd for 
C9H11NO2 (M + H)
+ 166.0863, found 166.0862 (+0.6 ppm error). Spectroscopic data are 
consistent with those reported in the literature.66 
Lab book reference: GH-1-1 
 
N-Methoxy-N-methylpyridine-3-carboxamide 179 
 
Et3N (6.27 mL, 45 mmol, 3.0 eq.) was added to a stirred solution of N,O-
dimethylhydroxylamine hydrochloride (1.46 g, 15.0 mmol, 1.0 eq.) in CH2Cl2 (20 mL) at 
rt under Ar. The resulting solution was cooled to 0 °C. Then, nicotinoyl chloride 
hydrochloride 178 (2.67 g, 15.0 mmol, 1.0 eq.) was added. The resulting solution was 
allowed to warm to rt and stirred at rt for 16 h. Saturated NH4Cl(aq) (40 mL) and saturated 
NaHCO3(aq) (40 mL) were added. The two layers were separated and the aqueous layer 
was extracted with CH2Cl2 (3 × 100 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with EtOAc as eluent gave Weinreb amide 179 
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(1.42 g, 57%) as a clear oil, RF (EtOAc) 0.19; IR (ATR) 2934, 1642 (C=O), 1590, 1414, 
1383, 979, 728 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.96 (d, J = 2.0 Hz, 1H, Ar), 8.69 
(dd, J = 1.5, 5.0 Hz, 1H, Ar), 8.05–8.00 (m, 1H, Ar), 7.36 (dd, J = 8.0, 5.0 Hz, 1H, Ar), 
3.56 (s, 3H, OMe), 3.40 (s, 3H, NMe); 13C NMR (100.6 MHz, CDCl3) δ 167.6 (C=O), 
151.6 (Ar), 149.5 (Ar), 136.3 (Ar), 130.0 (Ar), 123.1 (Ar), 61.4 (OMe), 33.3 (NMe); MS 
(ESI) m/z 167 (M + H)+; HRMS (ESI) m/z calcd for C8H10N2O2 (M + H)
+ 167.0815, found 
167.0820 (‒2.7 ppm error). Spectroscopic data are consistent with those reported in the 
literature.71 
Lab book reference: GH-1-78-2 
 
2-Benzoyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thiolan-1-one cis-180 and trans-180 
 
Using general procedure A, N-TBDPS sulfoximine 146 (1.86 g, 5.2 mmol, 1.0 eq.), n-
BuLi (2.49 mL of a 2.3 M solution in hexanes, 5.72 mmol, 1.1 eq.) and Weinreb amide 
136 (1.03 mL, 6.76 mmol, 1.3 eq.) in THF (50 mL) gave the crude product which 
contained a 75:25 mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-180 and 
trans-180. Purification by flash column chromatography on silica with 97:3 and then 9:1 
hexane-EtOAc as eluent gave keto-sulfoximine cis-180 (1.43 g, 60%) as a white solid, 
mp 120–122 °C, RF (6:4 hexane-EtOAc) 0.60; IR (ATR) 3068, 2929, 2855, 1683 (C=O), 
1299, 1153, 1108, 734, 702 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.94–7.90 (m, 2H, Ph), 
7.80–7.76 (m, 2H, Ph), 7.74–7.70 (m, 2H, Ph), 7.56–7.50 (m, 1H, Ph), 7.46–7.32 (m, 8H, 
Ph), 4.73 (dd, J = 8.0, 6.0 Hz, 1H, SCH), 3.01–2.92 (m, 1H, CH), 2.87–2.79 (m, 1H, CH), 
2.76–2.65 (m, 1H, CH), 2.36–2.25 (m, 1H, CH), 2.22–2.05 (m, 2H, CH), 1.08 (s, 9H, 
CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 191.9 (C=O), 136.9 (ipso-Ph), 135.9 (ipso-Ph), 
135.8 (Ph), 135.7 (Ph), 133.7 (Ph), 129.5 (Ph), 129.4 (Ph), 128.7 (Ph), 127.81 (Ph), 127.77 
(Ph), 69.1 (SCH), 56.5 (SCH2), 27.2 (CMe3), 26.0 (CH2), 21.5 (CH2), 19.5 (CMe3) (two 
Ph resonances not resolved); MS (ESI) m/z 462 (M + H)+; HRMS (ESI) m/z calcd for 
C27H31NO2SSi (M + H)
+; 462.1918, found 462.1924 (‒1.4 ppm error) and keto-
sulfoximine trans-180 (470 mg, 20%) as a white solid, mp 112–114 °C, RF (6:4 hexane-
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EtOAc) 0.53; IR (ATR) 3069, 2955, 2930, 1684 (C=O), 1307, 1255, 1217, 1175, 1157, 
1109, 702, 690, 501 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.19–8.15 (m, 2H, Ph), 7.62–
7.56 (m, 1H, Ph), 7.52–7.44 (m, 6H, Ph), 7.37–7.22 (m, 6H, Ph), 4.97 (dd, J = 7.5, 7.5 
Hz, 1H, SCH), 2.83–2.73 (m, 1H, CH), 2.73–2.65 (m, 1H, CH), 2.55 (ddd, J = 12.5, 10.0, 
7.0 Hz, 1H, SCH), 2.33–2.17 (m, 2H, CH), 2.17–2.06 (m, 1H, CH), 0.75 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 191.6 (C=O), 137.2 (ipso-Ph), 135.70 (ipso-Ph), 135.63 
(Ph), 135.59 (Ph), 133.8 (Ph), 129.6 (Ph), 129.2 (Ph), 128.8 (Ph), 127.53 (Ph), 127.46 
(Ph), 68.6 (SCH), 56.4 (SCH2), 26.8 (CMe3), 25.8 (CH2), 21.9 (CH2), 19.1 (CMe3) (two 
Ph resonances not resolved); MS (ESI) m/z 462 (M + H)+; HRMS (ESI) m/z calcd for 
C27H31NO2SSi (M + H)
+ 462.1918, found 462.1923 (‒1.2 ppm error). The 
stereochemistry of keto-sulfoximines cis-180 and trans-180 was assigned by analogy 
with related examples. 
Lab book reference: GH-2-31 
 
Using general procedure A, N-TBDPS sulfoximine 146 (326 mg, 0.91 mmol, 1.0 eq.), n-
BuLi (0.40 mL of a 2.5 M solution in hexanes, 1.0 mmol, 1.1 eq.) and Weinreb amide 
136 (0.28 mL, 1.82 mmol, 2.0 eq) in THF (10 mL) gave the crude product which 
contained a 55:45 mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-180 and 
trans-180. Purification by flash column chromatography on silica with hexane and then 
9:1 hexane-EtOAc as eluent gave keto-sulfoximine cis-180 (185 mg, 40%) as a white 
solid and keto-sulfoximine trans-180 (147 mg, 32%) as a white solid. 
Lab book reference: GH-1-12 
 
2-Benzoyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thian-1-one cis-181 and trans-181 
  
Using general procedure A, N-TBDPS sulfoximine 147 (2.02 g, 5.44 mmol, 1.0 eq.), n-
BuLi (2.60 mL of a 2.3 M solution in hexanes, 5.99 mmol, 1.1 eq.) and Weinreb amide 
136 (1.08 mL, 7.07 mmol, 1.3 eq.) in THF (50 mL) gave the crude product which 
contained a 75:25 mixture (by 1H NMR spectroscopy) of keto sulfoximines cis-181 and 
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trans-181. Purification by flash column chromatography on silica with 95:5 and then 9:1 
hexane-EtOAc as eluent gave keto-sulfoximine cis-181 (1.48 g, 57%) as a white solid, 
mp 140–142 °C, RF (6:4 hexane-EtOAc) 0.63; IR (ATR) 3069, 2929, 2855, 1677 (C=O), 
1448, 1427, 1283, 1142, 1108, 909, 821, 729, 699, 685, 601, 503 cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.80–7.73 (m, 4H, Ph), 7.58–7.54 (m, 2H, Ph), 7.54–7.49 (m, 1H, Ph), 
7.46–7.31 (m, 8H, Ph), 4.55–4.50 (m, 1H, SCH), 3.50–3.39 (m, 1H, SCH), 2.92–2.82 (m, 
1H, SCH), 2.32–2.05 (m, 4H, CH), 2.05–1.91 (m, 1H, CH), 1.62–1.51 (m, 1H, CH), 1.06 
(s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 194.3 (C=O), 136.74 (ipso-Ph), 136.71 
(ipso-Ph), 136.53 (ipso-Ph), 135.87 (Ph), 135.83 (Ph), 133.6 (Ph), 129.3 (Ph), 128.9 (Ph), 
128.6 (Ph), 127.7 (Ph), 66.4 (SCH), 54.7 (SCH2), 28.3 (CH2), 27.3 (CMe3), 25.0 (CH2), 
20.5 (CH2), 19.3 (CMe3) (two Ph resonances not resolved); MS (ESI) m/z 476 (M + H)
+; 
HRMS (ESI) m/z calcd for C28H33NO2SSi (M + H)
+ 476.2074, found 476.2080 (‒1.2 ppm 
error) and keto-sulfoximine trans-181 (423 mg, 16%) as a white solid, 136–138 °C, RF 
(6:4 hexane-EtOAc) 0.55; IR (ATR) 3069, 2929, 2855, 1679 (C=O), 1321, 1304, 1288, 
1141, 1108, 821, 731, 701, 603, 503 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.0 
Hz, 2H, Ph), 7.62 (d, J = 7.0 Hz, 2H, Ph), 7.59–7.53 (m, 3H, Ph), 7.46–7.39 (m, 2H, Ph), 
7.35–7.29 (m, 2H, Ph), 7.28–7.23 (m, 4H, Ph), 4.85–4.78 (m, 1H, SCH), 3.32 (ddd, J = 
13.5, 8.5, 5.0 Hz, 1H, SCH), 2.80–2.69 (m, 1H, SCH), 2.42–2.21 (m, 2H, CH), 2.03–1.84 
(m, 3H, CH), 1.59–1.48 (m, 1H, CH), 0.93 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) 
δ 193.7 (C=O), 136.8 (ipso-Ph), 136.6 (ipso-Ph), 136.3 (ipso-Ph), 135.70 (Ph), 135.67 
(Ph), 133.7 (Ph), 129.2 (Ph), 129.05 (Ph), 129.02 (Ph), 128.7 (Ph), 127.4 (Ph), 67.6 
(SCH), 55.1 (SCH2), 28.2 (CH2), 27.1 (CMe3), 24.4 (CH2), 20.4 (CH2), 19.3 (CMe3) (one 
Ph resonance not resolved); MS (ESI) m/z 476 (M + H)+; HRMS (ESI) m/z calcd for 
C28H33NO2SSi (M + H)
+ 476.2074, found 476.2083 (‒1.9 ppm error). The 
stereochemistry of keto-sulfoximines cis-181 and trans-181 was assigned by analogy 
with related examples. 
Lab book reference: GH-2-46 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(pyridine-3-carbonyl)-1λ⁶-thiolan-1-one cis-183 
and 1-[(tert-Butyldiphenylsilyl)imino]-2-[1-(pyridin-3-yl)ethenyl]-5-(pyridine-3-
carbonyl)-1λ⁶-thiolan-1-one trans,cis-184 
Chapter Four: Experimental 
 
 
113 
 
 
Using general procedure A, N-TBDPS sulfoximine 146 (1.00 g, 2.80 mmol, 1.0 eq.), n-
BuLi (1.34 mL of a 2.3 M solution in hexanes, 3.08 mmol, 1.1 eq.) and Weinreb amide 
179 (0.85 mL, 5.60 mmol, 2.0 eq.) in THF (28 mL) gave the crude product which 
contained an 85:15 mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-183 and 
trans,cis-184. Purification by flash column chromatography on silica with 8:2 and then 
1:1 hexane-EtOAc as eluent gave keto-sulfoximine cis-183 (920 mg, 71%) as a white 
solid, mp 128–130 °C; RF (1:1 hexane-EtOAc) 0.29; IR (ATR) 2930, 2856, 1688 (C=O), 
1586, 1427, 1298, 1255, 1172, 1158, 1108, 869, 729, 700, 604, 500, 488 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 9.32 (d, J = 2.0 Hz, 1H, Ar), 8.77 (dd, J = 5.0, 2.0 Hz, 1H, Ar), 8.39 
(ddd, J = 8.0, 2.0, 2.0 Hz, 1H, Ar), 7.53–7.49 (m, 2H, Ar), 7.49–7.44 (m, 2H, Ar), 7.41–
7.32 (m, 3H, Ar), 7.32–7.25 (m, 4H, Ar), 4.92 (dd, J = 7.5, 7.5 Hz, 1H, SCH), 2.85–2.67 
(m, 2H, SCH, CH), 2.59 (ddd, J = 12.5, 10.0, 7.0 Hz, 1H, SCH), 2.37–2.07 (m, 3H, CH), 
0.77 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 190.9 (C=O), 153.9 (Ar), 150.7 
(Ar), 136.6 (Ar), 135.5 (Ar), 135.4 (Ar), 135.34 (ipso-Ar), 135.28 (ipso-Ar), 132.4 (ipso-
Ar), 129.32 (Ar), 129.29 (Ar), 127.56 (Ar), 127.53 (Ar), 123.6 (Ar), 69.0 (SCH), 56.5 
(SCH2), 26.7 (CMe3), 25.5 (CH2), 21.8 (CH2), 19.1 (CMe3); MS (ESI) m/z 463 (M + H)
+; 
HRMS (ESI) m/z calcd for C26H30N2O2SSi (M + H)
+ 463.1870, found 463.1876 (‒1.3 
ppm error) and keto-sulfoximine trans,cis-184 (96 mg, 6%) as a white solid, mp 122–124 
°C; RF (1:1 hexane-EtOAc) 0.17; IR (ATR) 2961, 2857, 1683 (C=O), 1585, 1420, 1317, 
1236, 1164, 1109, 909, 820, 729, 698, 500 cm-1; 1H NMR (400 MHz, CDCl3) δ 9.29 (d, 
J = 2.0 Hz, 1H, Ar), 8.81 (dd, J = 4.5, 1.0 Hz, 1H, Ar), 8.71 (d, J = 2.0 Hz, 1H, Ar), 8.68–
8.64 (m, 1H, Ar), 8.39–8.35 (m, 1H, Ar), 7.67–7.62 (m, 2H, Ar), 7.54 (d, J = 7.0 Hz, 2H, 
Ar), 7.46–7.35 (m, 6H, Ar), 7.30–7.24 (m, 2H, Ar), 7.08 (dd, J = 8.0, 5.0 Hz, 1H, Ar), 
5.10 (dd, J = 8.0, 8.0 Hz, 1H, SCH), 4.54 (dd, J = 8.0, 3.5 Hz, 1H, SCH), 3.10–2.98 (m, 
1H, CH), 2.71–2.55 (m, 2H, CH), 2.46–2.35 (m, 1H, CH), 0.81 (s, 9H, CMe3); 13C NMR 
(100.6 MHz, CDCl3) δ 192.2 (C=O), 189.2 (C=O), 154.2 (Ar), 153.8 (Ar), 150.8 (Ar), 
150.1 (Ar), 136.9 (Ar), 136.2 (Ar), 135.61 (Ar), 135.52 (Ar), 135.1 (ipso-Ar), 134.4 (ipso-
Ar), 131.7 (ipso-Ar), 129.86 (Ar), 129.76 (Ar), 127.95 (Ar), 127.87 (Ar), 123.6 (Ar), 
123.4 (Ar), 69.4 (SCH), 68.9 (SCH), 26.7 (CMe3), 23.6 (CH2), 23.3 (CH2), 19.3 (CMe3) 
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(one ipso-Ar resonance not resolved); MS (ESI) m/z 568 (M + H)+; HRMS (ESI) m/z 
calcd for C32H34N3O3SSi (M + H)
+ 568.2085, found 568.2096 (‒2.1 ppm error). The 
stereochemistry of keto-sulfoximines cis-183 and trans,cis-184 was assigned by analogy 
with related examples. 
Lab book reference: GH-2-10 
 
N-tert-Butyl-1-[(tert-butyldiphenylsilyl)imino]-1-oxo-1λ⁶-thiolane-2-carboxamide 
cis-187 and trans-187  
 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and tert-butyl 
isocyanate (0.11 mL, 1.0 mmol, 2.0 eq) gave the crude product which contained a 45:55 
mixture (by 1H NMR spectroscopy) of diastereomeric amido sulfoximines cis-187 and 
trans-187. Purification by flash column chromatography on silica with 95:5 and then 9:1 
hexane-EtOAc as eluent gave amido sulfoximine 187a (65 mg, 29%) as a clear oil, RF 
(1:1 hexane-EtOAc) 0.60; IR (ATR) 3355 (NH), 3070, 2962, 2856, 1685 (C=O), 1518, 
1454, 1427, 1390, 1362, 1302, 1225, 1159, 1109, 821, 737, 702, 805, 502 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.76–7.71 (m, 4H, Ph), 7.43–7.34 (m, 6H, Ph), 5.87 (s, 1H, NH), 
3.29 (dd, J = 8.0, 8.0 Hz, 1H, SCH), 2.96–2.79 (m, 2H, SCH), 2.45–2.33 (m, 1H, CH), 
2.24–2.10 (m, 2H, CH), 2.02–1.89 (m, 1H, CH), 1.28 (s, 9H, NCMe3), 1.08 (s, 9H, 
SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 163.9 (C=O), 135.85 (ipso-Ph), 135.83 (ipso-
Ph), 135.69 (Ph), 135.68 (Ph), 129.6 (Ph), 127.8 (Ph), 68.6 (SCH), 55.3 (SCH2), 52.0 
(NCMe3), 28.7 (NCMe3), 27.2 (SiCMe3), 25.5 (CH2), 20.2 (CH2), 19.3 (SiCMe3) (two Ph 
signals not resolved); MS (ESI) m/z 457 (M + H)+; HRMS (ESI) m/z calcd for 
C25H36N2O2SSi (M + H)
+ 457.2340, found 457.2343 (‒0.8 ppm error) and amido 
sulfoximine 187b (90 mg, 39%) as a clear oil, RF (1:1 hexane-EtOAc) 0.43; IR (ATR) 
3348 (NH), 2962, 2931, 2856, 1678 (C=O), 1545, 1360, 1298, 1253, 1104, 821, 732, 702, 
604, 501, 489 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.78–7.72 (m, 4H, Ph), 7.41–7.31 (m, 
6H, Ph), 6.09 (s, 1H, NH), 3.60–3.50 (m, 1H, SCH), 2.77–2.66 (m, 2H, SCH), 2.53–2.41 
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(m, 1H, CH), 2.35–2.23 (m, 1H, CH), 2.16–1.92 (m, 2H, CH), 1.19 (s, 9H, NCMe3), 1.08 
(s, 9H, SiCMe3); 
13C NMR (100.6 MHz, CDCl3) δ 164.1 (C=O), 135.90 (ipso-Ph), 135.85 
(Ph), 135.74 (Ph), 135.68 (ipso-Ph), 129.4 (Ph), 129.3 (Ph), 127.7 (Ph), 69.0 (SCH), 54.4 
(SCH2), 52.0 (NCMe3), 28.7 (NCMe3), 27.3 (SiCMe3), 25.7 (CH2), 20.4 (CH2), 19.5 
(SiCMe3) (one Ph resonance not resolved); MS (ESI) m/z 457 (M + H)
+; HRMS (ESI) 
m/z calcd for C25H36N2O2SSi (M + H)
+ 457.2340, found 457.2338 (+0.3 ppm error).  
Lab book reference: GH-2-27 
 
Methyl 1-[(tert-butyldiphenylsilyl)imino]-1-oxo-1λ⁶-thiolane-2-carboxylate 189 
 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.), n-
BuLi (0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl 
chloroformate (0.077 mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product. 
Purification by flash column chromatography on silica with hexane and then 9:1 hexane-
EtOAc as eluent gave a 70:30 mixture (by 1H NMR spectroscopy) of diastereomeric 
sulfoximines 189, MS (ESI) m/z 416 (M + H)+; HRMS (ESI) m/z calcd for C22H29NO3SSi 
(M + H)+ 416.1710, found 416.1710 (‒1.4 ppm error). Diagnostic signals: 1H NMR (400 
MHz, CDCl3) δ 4.32 (dd, J = 7.5, 5.5 Hz, 1H, SCH), 3.93 (dd, J = 7.5, 5.5 Hz, SCH). 
Lab book reference: GH-1-49-3 
 
1-{[Diphenyl(trimethylsilyl)methyl]imino}-2-[(methylamino)(phenyl)methyl]-1λ⁶-
thiolan-1-one 190 
 
Using general procedure A, N-TBDPS sulfoximine 146 (179 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and N-benzylidene 
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methylamine (0.12 mL, 1.0 mmol, 2.0 eq) gave the crude product. Purification by flash 
column chromatography on silica with 95:5 and then 8:2 hexane-EtOAc as eluent gave a 
single diastereomeric amino sulfoximine 190 (26 mg, 11%) as a yellow oil, RF (1:1 
hexane-EtOAc) 0.40; IR (ATR) 3068, 2930, 2854, 1288, 1251, 1153, 1127, 1106, 820, 
736, 699, 650, 602, 558, 532, 500, 487 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.83–7.78 
(m, 4H, Ph), 7.43–7.37 (m, 6H, Ph), 7.35–7.31 (m, 4H, Ph), 7.31–7.26 (m, 1H, Ph), 3.88 
(d, J = 10.0 Hz, 1H, PhCHNH), 3.22–3.13 (m, 1H, SCH), 2.85–2.76 (m, 1H, SCH), 2.59–
2.49 (m, 1H, SCH), 2.23 (s, 1H, NH), 2.07 (s, 3H, HNMe), 1.86–1.76 (m, 2H, CH), 1.59–
1.41 (m, 2H, CH), 1.15 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 140.5 (ipso-Ph), 
136.4 (ipso-Ph), 136.1 (ipso-Ph), 135.9 (Ph), 135.6 (Ph), 129.4 (Ph), 128.7 (Ph), 128.4 
(Ph), 128.0 (Ph), 127.74 (Ph), 127.70 (Ph), 70.1 (SCH), 65.5 (PhCHNH), 55.9 (SCH2), 
34.2 (HNMe), 28.3 (CH2), 27.3 (CMe3), 20.7 (CH2), 19.5 (CMe3) (one Ph resonance not 
resolved); MS (ESI) m/z 477 (M + H)+; HRMS (ESI) m/z calcd for C28H36NOSSi2 (M + 
H)+ 477.2390, found 477.2393 (‒0.6 ppm error).  
Lab book reference: GH-2-24 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-phenyl-1λ⁶-thiolan-1-one cis-198 
 
Preparation of a solution of CuCN•2LiCl in THF: THF (2 mL) was added to dry LiCl (85 
mg, 2.0 mmol, 4.0 eq.) at rt under Ar and the resulting solution was stirred at rt for 30 
min. CuCN (90 mg, 1.0 mmol, 2.0 eq.) was added to the solution and the resulting solution 
was stirred at rt for 30 min to give a 0.5 M solution of CuCN•2LiCl in THF.  
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS sulfoximine 146 (179 mg, 0.5 mmol, 1.0 eq.) in THF (5 
mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 min and then 
CuCN·2LiCl (1 mL of the freshly prepared 0.5 M solution in THF, 0.5 mmol, 1.0 eq) was 
added. The resulting solution was allowed to warm to ‒35 °C and stirred at ‒35 °C for 15 
min. Then, Ph2IPF6 (213 mg, 0.5 mmol, 1.0 eq.) was added. The resulting solution was 
stirred at ‒35 °C for 15 min and then allowed to warm to rt and stirred at rt for 16 h. Then, 
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saturated NH4Cl(aq) (2 mL) was added and the two layers were separated. The aqueous 
layer was extracted with Et2O (3 × 20 mL). The combined organic layers were dried 
(MgSO4) and evaporated under reduced pressure to give the crude product. Purification 
by flash column chromatography on silica with 95:5 as eluent gave a single 
diastereomeric phenyl sulfoximine cis-198 (88 mg, 41%) as a white solid, mp 88–90 °C, 
RF (8:2 hexane-EtOAc) 0.32; IR (ATR) 3068, 2929, 2854, 1427, 1302, 1262, 1238, 1156, 
1103, 821, 736, 696, 602, 498 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.71–7.64 (m, 4H, 
Ph), 7.41–7.28 (m, 11H, Ph), 4.04 (dd, J = 12.0, 7.5 Hz, 1H, SCH), 3.09–2.93 (m, 2H, 
SCH), 2.49–2.32 (m, 2H, CH), 2.29–2.17 (m, 1H, CH), 2.12–1.97 (m, 1H, CH), 1.00 (s, 
9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 136.55 (ipso-Ph), 136.49 (ipso-Ph), 135.63 
(Ph), 135.62 (Ph), 131.7 (ipso-Ph), 129.8 (Ph), 129.1 (Ph), 128.6 (Ph), 128.5 (Ph), 127.5 
(Ph), 70.6 (SCH), 54.8 (SCH2), 28.7 (CH2), 27.1 (CMe3), 20.2 (CH2), 19.3 (CMe3) (two 
Ph resonances not resolved); MS (ESI) m/z 434 (M + H)+; HRMS (ESI) m/z calcd for 
C26H31NOSSi (M + H)
+ 434.1968, found 434.1956 (+2.9 ppm error). 
Crystal structure determination of cis-198 
C26H31NOSSi, M = 433.67, monoclinic, a = 11.90777(15), b = 21.8687(2), c = 
9.87464(13) Å, β = 110.2919(15) °, U = 2411.84(6) Å3, T = 110.00(10) K, space group 
P21, Z = 4, μ(Mo-Kα) = 1.787 mm-1, 9179 reflection measured, 4301 unique (Rint = 
0.0149) which were used in calculation. The final R1 was 0.0290 (I≥2σ) and wR2 was 
0.0769 (all data). 
Lab book reference: GH-2-63 
 
[(tert-Butyldiphenylsilyl)imino](ethyl)(1-hydroxy-1,1-diphenylpropan-2-yl)-λ⁶-
sulfanone 199 
 
Using general procedure A, N-TBDPS sulfoximine 149 (180 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude 
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product. Purification by flash column chromatography on silica with 95:5 hexane-EtOAc 
as eluent gave a single diastereomeric alcohol 199 (198 mg, 73%) as a white solid, mp 
54–56 °C; RF (8:2 hexane-EtOAc) 0.45; IR (ATR) 3388 (OH), 2931, 2856, 1450, 1427, 
1308, 1136, 1109, 740, 702, 503 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.72–7.69 (m, 2H, 
Ph), 7.66–7.62 (m, 4H, Ph), 7.58–7.54 (m, 2H, Ph), 7.40–7.26 (m, 10H, Ph), 7.21–7.15 
(m, 2H, Ph), 6.29 (s, 1H, COH), 4.18 (q, J = 7.0 Hz, 1H, SCH), 2.17 (dq, J = 14.5, 7.5 
Hz, 1H, SCH), 1.67 (dq, J = 14.5, 7.5 Hz, 1H, SCH), 1.45 (d, J = 7.0 Hz, 3H, SCHMe), 
1.04 (s, 9H, CMe3), 0.91 (t, J = 7.5 Hz, 3H, SCH2Me); 
13C NMR (100.6 MHz, CDCl3) δ 
146.0 (ipso-Ph), 145.7 (ipso-Ph), 136.2 (ipso-Ph), 135.92 (ipso-Ph), 135.79 (Ph), 135.71 
(Ph), 129.34 (Ph), 129.31 (Ph), 128.5 (Ph), 128.3 (Ph), 127.64 (Ph), 127.55 (Ph), 127.3 
(Ph), 126.9 (Ph), 126.1 (Ph), 125.2 (Ph), 79.0 (COH), 63.0 (SCH), 51.8 (SCH2), 27.3 
(CMe3), 19.6 (CMe3), 11.7 (SCHMe), 8.9 (SCH2Me); MS (ESI) m/z 542 (M + H)
+; HRMS 
(ESI) m/z calcd for C33H39NO2SSi (M + H)
+ 542.2544, found 542.2549 (‒0.9 ppm error).  
Lab book reference: GH-2-58 
 
2-{[(tert-Butyldiphenylsilyl)imino](oxo)phenyl-λ⁶-sulfanyl}-1,1-diphenylpropan-1-
ol 200 
 
Using general procedure A, N-TBDPS sulfoximine 150 (204 mg, 0.50 mmol, 1.0 eq.), n-
BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude 
product which contained an 85:15 mixture (by 1H NMR spectroscopy) of diastereomeric 
alcohols 200a and 200b. Purification by flash column chromatography on silica with 99:1 
and then 98:2 hexane-EtOAc as eluent gave a single diastereomeric alcohol 200a (206 
mg, 70%) as a white solid, mp 158–160 °C, RF (8:2 hexane-EtOAc) 0.45; IR (ATR) 3408 
(OH), 3068, 2930, 2856, 1448, 1261, 1141, 1108, 907, 732, 699, 646, 604, 566, 497 cm-
1; 1H NMR (400 MHz, CDCl3) δ 7.63–7.58 (m, 2H, Ph), 7.52 (d, J = 7.5 Hz, 2H, Ph), 
7.47–7.40 (m, 2H, Ph), 7.40–7.36 (m, 2H, Ph), 7.32–7.26 (m, 1H, Ph), 7.26–7.20 (m, 6H, 
Ph), 7.20–7.04 (m, 5H, Ph), 7.04–6.92 (m, 5H, Ph), 6.33 (s, 1H, CHOH), 4.44 (q, J = 7.0 
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Hz, 1H, SCH), 1.43 (d, J = 7.0 Hz, 3H, CHMe), 1.01 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) δ 146.2 (ipso-Ph), 144.9 (ipso-Ph), 143.1 (ipso-Ph), 135.73 (Ph), 135.70 
(Ph), 135.63 (ipso-Ph), 135.2 (ipso-Ph), 131.4 (Ph), 129.03 (Ph), 128.86 (Ph), 128.4 (Ph), 
128.2 (Ph), 127.75 (Ph), 127.71 (Ph), 127.4 (Ph), 127.1 (Ph), 126.73 (Ph), 126.72 (Ph), 
126.2 (Ph), 124.9 (Ph), 79.3 (COH), 67.9 (SCH), 27.2 (CMe3), 19.4 (CMe3), 12.5 
(SCHMe); MS (ESI) m/z 590 (M + H)+; HRMS (ESI) m/z calcd for C37H39NO2SSi (M + 
H)+ 590.2544, found 590.2540 (+0.6 ppm error). The minor diastereomeric alcohol 200b 
was not isolated. Diagnostic signals for minor diastereomeric alcohol 200b: 1H NMR 
(400 MHz, CDCl3) δ 4.23 (q, J = 7.0 Hz, 1H, SCH), 1.47 (d, J = 7.0 Hz, 3H, CHMe). 
Lab book reference: GH-2-67 
 
tert-Butyl N-[2-(hydroxydiphenylmethyl)-1-oxo-1λ⁶-thiolan-1-ylidene]carbamate 
cis-202 
 
Using general procedure A, N-Boc sulfoximine 153 (110 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc to 9:1 
hexane-EtOAc as eluent gave alcohol cis-202 (142 mg, 71%) as a white solid, mp 200–
202 °C, RF (1:1 hexane-EtOAc) 0.43; IR (ATR) 3497 (OH), 2978, 1659 (C=O), 1449, 
1366, 1280, 1247, 1152, 909, 861, 733, 702 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.76–
7.71 (m, 2H, Ph), 7.40–7.33 (m, 4H, Ph), 7.30–7.23 (m, 3H, Ph), 7.19–7.15 (m, 1H, Ph), 
4.74 (dd, J = 9.0, 9.0 Hz, 1H, SCH), 4.23–4.16 (m, 1H, SCH), 4.11 (s, 1H, COH), 3.16 
(ddd, J = 13.0, 12.0, 7.5, Hz, 1H, SCH), 2.41–2.31 (m, 1H, CH), 2.31–2.20 (m, 1H, CH), 
2.09–1.95 (m, 1H, CH), 1.90–1.82 (m, 1H, CH), 1.50 (s, 9H, CMe3); 13C NMR 
(100.6MHz, CDCl3) δ 158.4 (C=O), 144.7 (ipso-Ph), 144.4 (ipso-Ph), 128.7 (Ph), 128.6 
(Ph), 127.9 (Ph), 127.2 (Ph), 125.9 (Ph), 125.0 (Ph), 81.0 (CMe3), 78.9 (COH), 67.4 
(SCH), 53.5 (SCH2), 28.3 (CH2), 26.7 (CH2), 21.3 (CH2); MS (ESI) m/z 402 (M + H)
+; 
HRMS (ESI) m/z calcd for C22H27NO4S (M + H)
+ 402.1734, found 402.1727 (+1.7 ppm 
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error). The stereochemistry of alcohol cis-202 was assigned by synthesis from N-TBDPS 
sulfoximine cis-157. 
Lab book reference: GH-1-62-3 
 
TBAF (0.66 mL of a 1 M solution in THF, 0.66 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of the N-TBDPS sulfoximine cis-157 (178 mg, 0.33 mmol, 1.0 eq.) in 
THF (5 mL) at rt °C under Ar. The resulting solution was stirred at rt for 48 h. The solvent 
was evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with EtOAc as eluent gave NH sulfoximine cis-204 (90 
mg, 90%) as a white solid, mp 180–182 °C, RF (9:1 EtOAc-MeOH) 0.53; IR (ATR) 3429 
(NH/OH), 3323 (NH/OH), 3059, 1493, 1448, 1201, 1177, 1111, 995, 962, 909, 733, 699, 
657, 551, 511 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.75–7.69 (m, 2H, Ph), 7.51–7.45 (m, 
2H, Ph), 7.41–7.35 (m, 2H, Ph), 7.32–7.24 (m, 3H, Ph), 7.21–7.15 (m, 1H, Ph), 5.13 (s, 
1H, COH), 4.31 (dd, J = 10.5, 7.5 Hz, 1H, SCH), 3.37–3.28 (m, 1H, SCH), 3.13 (dd, J = 
13.0, 9.5, 7.5 Hz, 1H, SCH), 2.53 (s, 1H, NH), 2.52–2.42 (m, 1H, SCH), 2.23–2.13 (m, 
1H, CH), 2.13–1.97 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 145.1 (ipso-Ph), 144.6 
(ipso-Ph), 128.7 (Ph), 128.5 (Ph), 127.8 (Ph), 127.1 (Ph), 125.6 (Ph), 124.9 (Ph), 77.5 
(COH), 71.3 (SCH), 57.1 (SCH2), 27.5 (CH2), 20.6 (CH2); MS (ESI) m/z 302 (M + H)
+; 
HRMS (ESI) m/z calcd for C17H19NO2S (M + H)
+ 302.1209, found 302.1206 (+0.9 ppm 
error). A solution of potassium tert-butoxide (44 mg. 0.39 mmol, 1.3 eq.) in THF (1 mL) 
was added to a stirred solution of NH sulfoximine cis-204 (90 mg, 0.30 mmol, 1.0 eq.) in 
THF (1 mL) at 0 °C under Ar. The resulting solution was stirred at 0 °C for 30 min. Then, 
a solution of Boc2O (131 mg, 0.60 mmol, 2.0 eq.) in THF (1.5 mL) was added. The 
resulting solution was stirred at 0 °C for 1 h. The solution was allowed to warm to rt and 
stirred at rt for 72 h. Saturated NH4Cl(aq) (2 mL) was added and the two layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 8:2 and then 
1:1 hexane-EtOAc as eluent gave alcohol cis-202 (117 mg, 95%) as a white solid. 
Lab book reference: GH-2-20-2 
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tert-Butyl N-[2-(hydroxydiphenylmethyl)-1-oxo-1λ⁶-thian-1-ylidene]carbamate cis-
203 
 
Using general procedure A, N-Boc sulfoximine 154 (117 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product. 
Purification by flash column chromatography on silica with 95:5 hexane-EtOAc and then 
9:1 hexane-EtOAc as eluent gave alcohol cis-203 (156 mg, 75%) as a white solid, mp 80–
82 °C, RF (1:1 hexane-EtOAc) 0.37; IR (ATR) 3497 (OH), 3288 (OH), 2977, 1652 (C=O), 
1449, 1366, 1282, 1251, 1151, 908, 861, 731, 702 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.60–7.55 (m, 2H, Ph), 7.47–7.42 (m, 2H, Ph), 7.34–7.28 (m, 4H, Ph), 7.25–7.19 (m, 2H, 
Ph) 5.05 (s, 1H, OH), 4.81 (dd, J = 9.5, 3.5 Hz, 1H, SCH), 3.57 (ddd, J = 14.0, 8.5, 5.5 
Hz, 1H, SCH), 3.47 (ddd, J = 14.0, 5.5, 5.5 Hz, 1H, SCH), 2.16–2.03 (m, 3H, CH), 1.99–
1.84 (m, 2H, CH), 1.52–1.43 (m, 1H, CH) 1.41 (s, 9H, CMe3); 13C NMR (100.6 MHz, 
CDCl3) δ 157.9 (C=O), 145.2 (ipso-Ph), 143.9 (ipso-Ph), 128.5 (Ph), 128.4 (Ph), 127.6 
(Ph), 127.3 (Ph), 126.1 (Ph), 125.9 (Ph) 80.43 (CMe3/COH), 80.36 (CMe3/COH), 66.0 
(SCH), 53.2 (SCH2), 28.3 (CMe3), 26.6 (CH2), 23.3 (CH2), 22.8 (CH2); MS (ESI) m/z 416 
(M + H)+; HRMS (ESI) m/z calcd for C23H29NO4S (M + H)
+ 416.1890, found 416.1894 
(‒1.0 ppm error). The stereochemistry of alcohol cis-203 was assigned by analogy with 
related examples. 
Lab book reference: GH-1-61-3 
 
Attempted synthesis of 2-(Hydroxydiphenylmethyl)-1-imino-1λ⁶-thian-1-one cis-
205 
 
Chapter Four: Experimental 
 
 
122 
 
TBAF (0.24 mL of a 1 M solution in THF, 0.24 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine cis-158 (67 mg, 0.12 mmol, 1.0 eq.) in THF (2 
mL) at rt under Ar. The resulting solution was stirred at rt for 48 h. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave unsubsstituted NH sulfoximine 152 
(10 mg, 63%) as a yellow oil and none of the desired product cis-205. 
Lab book reference: GH-2-15 
 
TBAF (0.75 mL of a 1 M solution in THF, 0.75 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS sulfoximine cis-158 (207 mg, 0.37 mmol, 1.0 eq.) in THF 
(2 mL) at rt under Ar. The resulting solution was stirred at rt for 24 h. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc as eluent gave none of the desired product cis-205. 
Lab book reference: GH-2-48 
 
tert-Butyl N-{2-[hydroxy(phenyl)methyl]-1-oxo-1λ⁶-thiolan-1-ylidene}carbamate 
cis,anti-208 and cis,syn-208 
 
Using general procedure A, N-Boc sulfoximine 153 (110 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde (0.10 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 50:50 
mixture (by 1H NMR spectroscopy) of alcohols cis,anti-208 and cis,syn-208. Purification 
by flash column chromatography on silica with 9:1 and then 8:2 hexane-EtOAc as eluent 
gave alcohol 208a (51 mg, 31%) as a white solid, mp 126–128 °C, RF (1:1 hexane-EtOAc) 
0.36; IR (ATR) 3361 (OH), 2980, 1663 (C=O), 1453, 1392, 1367, 1291, 1250, 1213, 
1153, 906, 856, 701 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.40–7.33 (m, 4H, Ph), 7.33–
7.27 (m, 1H, Ph), 5.59 (br s, 1H, PhCH), 4.90 (d, J = 2.5 Hz, 1H, CHOH), 3.64–3.55 (m, 
2H, SCH), 3.30–3.21 (m, 1H, SCH), 2.30–2.22 (m, 2H, CH), 2.21–2.09 (m, 1H, CH), 
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2.02–1.90 (m, 1H, CH), 1.50 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) δ 158.7 
(C=O), 140.2 (ipso-Ph), 128.8 (Ph), 128.1 (Ph), 125.7 (Ph), 81.4 (CMe3), 70.4 
(PhCHOH), 67.6 (SCH), 53.8 (SCH2), 28.3 (CMe3), 21.8 (CH2), 21.5 (CH2); MS (ESI) 
m/z 348 (M + Na)+; HRMS (ESI) m/z calcd for C16H23NO4S (M + Na)
+ 348.1240, found 
348.1230 (‒3.0 ppm error) and alcohol 208b (56 mg, 34%) as a white solid, mp 136–138 
°C, RF (1:1 hexane:EtOAc) 0.26; IR (ATR) 3496 (OH), 2976, 2931, 1654 (C=O), 1287, 
1250, 1218, 1153, 1120, 898, 857, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.44–7.40 
(m, 2H, Ph), 7.39–7.34 (m, 2H, Ph), 7.31–7.26 (m, 1H, Ph), 5.84 (d, J = 3.0 Hz, 1H, 
PhCH), 3.83–3.76 (m, 1H, SCH), 3.74–3.66 (m, 1H, SCH), 3.21 (d, J = 3.5 Hz, 1H, 
CHOH), 3.11 (ddd, J = 13.0, 11.0, 7.0 Hz, 1H, SCH), 2.60–2.48 (m, 1H, CH), 2.33–2.24 
(m, 1H, CH), 2.03–1.89 (m, 2H, CH), 1.53 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) 
δ 159.9 (C=O), 140.0 (ipso-Ph), 128.7 (Ph), 127.9 (Ph), 125.6 (Ph), 81.2 (CMe3), 69.4 
(PhCHOH), 68.0 (SCH), 54.1 (SCH2), 28.3 (CMe3), 23.0 (CH2), 21.1 (CH2); MS (ESI) 
m/z 348 (M + Na)+; HRMS (ESI) m/z calcd for C16H23NO4S (M + Na)
+ 348.1240, found 
348.1255 (+4.4 ppm error). The cis stereochemistry of cis,anti-208 and cis,syn-208 was 
assigned by analogy with related examples. 
Lab book reference: GH-2-3 
 
tert-Butyl N-{2-[hydroxy(phenyl)methyl]-1-oxo-1λ⁶-thian-1-ylidene}carbamate 
209a and 209b 
 
Using general procedure A, N-Boc sulfoximine 154 (117 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde (0.10 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 70:30 
mixture (by 1H NMR spectroscopy) of alcohols 209a and 209b. Purification by flash 
column chromatography on silica with 8:2 and then 1:1 hexane-EtOAc as eluent gave 
alcohol 209a (82 mg, 48%) as a white solid, mp 194–196 °C, RF (1:1 hexane-EtOAc) 
0.47; IR (ATR) 3358 (OH), 2977, 2931, 1668 (C=O), 1452, 1367, 1283, 1242, 1197, 
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1152, 1098, 1065, 904, 889, 860, 707 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.43-7.34 (m, 
4H, Ph), 7.33–7.27 (m, 1H, Ph), 5.81 (s, 1H, PhCH), 4.96 (s, 1H, CHOH), 4.46 (brd, J = 
14.0 Hz, 1H, SCH), 2.99 (ddd, J = 13.5, 12.0, 3.5 Hz, 1H, SCH), 2.90 (dd, J = 12.0, 3.0 
Hz, 1H, SCH), 2.30–2.17 (m, 1H, CH), 2.15–2.06 (m, 1H, CH), 2.03–1.93 (m, 1H, CH), 
1.93–1.82 (m, 2H, CH), 1.49 (s, 9H, CMe3), 1.37–1.28 (m, 1H, CH); 13C NMR (100.6 
MHz, CDCl3) δ 158.5 (C=O), 139.9 (ipso-Ph), 128.6 (Ph), 127.9 (Ph), 126.1 (Ph), 81.0 
(CMe3), 68.3 (SCH), 67.1 (PhCHOH), 51.1 (SCH), 28.3 (CMe3), 24.4 (CH2), 23.8 (CH2), 
22.3 (CH2); MS (ESI) m/z 362 (M + Na)
+; HRMS (ESI) m/z calcd for C17H25NO4S (M + 
Na)+ 362.1396, found 362.1382 (+3.9 ppm error) and alcohol 209b (39 mg, 23%) as a 
white solid, mp 188–190 °C, RF (1:1 hexane-EtOAc) 0.39; IR (ATR) 3297 (OH), 2942, 
1670 (C=O), 1279, 1268, 1251, 1210, 1153, 904, 856, 759, 705 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.39–7.35 (m, 4H, Ph), 7.32–7.27 (m, 1H, Ph), 5.91 (s, 1H, PhCH), 3.71 (ddd, 
J = 14.5, 4.5, 4.5 Hz, 1H, SCH), 3.56 (dd, J = 10.5, 3.5 Hz, 1H, SCH), 3.38 (ddd, J = 
14.5, 10.5, 5.5 Hz, 1H, SCH), 3.15 (s, 1H, CHOH), 2.26–2.17 (m, 1H, CH), 2.17–2.08 
(m, 2H, CH), 1.99–1.89 (m, 1H, CH), 1.87–1.78 (m, 1H, CH), 1.51 (s, 9H, CMe3), 1.43–
1.31 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 158.6 (C=O), 139.6 (ipso-Ph), 128.6 
(Ph), 127.9 (Ph), 125.9 (Ph), 80.8 (CMe3), 69.0 (PhCHOH), 65.0 (SCH), 51.6 (SCH2), 
28.3 (CMe3), 23.14 (CH2), 23.05 (CH2), 21.2 (CH2); MS (ESI) m/z 362 (M + Na)
+; HRMS 
(ESI) m/z calcd for C17H25NO4S (M + Na)
+ 362.1396, found 362.1381 (‒4.4 ppm error). 
Lab book reference: GH-2-4 
 
tert-Butyl N-(2-benzyl-1-oxo-1λ⁶-thiolan-1-ylidene)carbamate cis-210 and trans-210 
 
Using general procedure A, N-Boc sulfoximine 153 (110 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide (0.12 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained an 85:15 
mixture (by 1H NMR spectroscopy) of benzyl sulfoximines cis-210 and trans-210. 
Purification by flash column chromatography on silica with 8:2 hexane-EtOAc as eluent 
gave an 85:15 mixture of benzyl sulfoximines cis-210 and trans-210 (131 mg, 85%) as a 
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clear oil, RF (1:1 hexane-EtOAc) 0.26; IR (ATR) 2975, 1653 (C=O), 1455, 1366, 1283, 
1251, 1221, 1160, 895, 863, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35–7.29 (m, 2H, 
Ph), 7.28–7.18 (m, 3H, Ph), 3.88–3.79 (m, 0.85H, SCH), 3.67–3.57 (m, 1.7H, 
SCH,CHPh), 3.72–3.36 (m, 0.6H, CH), 3.23 (ddd, J = 13.5, 10.0, 8.0 Hz, 0.85H, SCH), 
2.80 (dd, J = 14.0, 11.0 Hz, 0.15H, CHPh), 2.72 (dd, J = 14.0, 12.0, 0.85H, CHPh), 2.32–
2.12 (m, 2H, CH), 2.07–1.84 (m, 2H, CH), 1.52 (s, 9H, CMe3); 13C NMR (100.6 MHz, 
CDCl3) δ 159.7 (C=O, cis-210), 159.3 (C=O, trans-210), 137.04 (ipso-Ph, trans-210), 
136.99 (ipso-Ph, cis-210), 129.14 (Ph, cis-210), 129.05 (Ph, trans-210), 128.98 (Ph, 
trans-210), 128.94 (Ph, cis-210), 127.18 (Ph, trans-210), 127.14 (Ph, cis-210), 80.86 
(CMe3, trans-210), 80.81 (CMe3, cis-210), 65.9 (SCH, trans-210), 63.8 (SCH, cis-210), 
53.5 (SCH2, cis-210), 52.4 (SCH2, trans-210), 34.3 (PhCH2, cis-210), 33.8 (PhCH2, trans-
210), 29.65 (CH2, cis-210), 28.63 (CH2, trans-210), 28.3 (CMe3, cis-210, trans-210), 21.4 
(CH2, cis-210), 20.9 (CH2, trans-210); MS (ESI) m/z 332 (M + Na)
+ HRMS (ESI) m/z 
calcd for C16H23NO3S (M + Na)
+ 332.1291, found 332.1294 (‒1.0 ppm error). The 
stereochemistry of benzyl sulfoximine cis-210 was assigned by synthesis from N-TBDPS 
sulfoximine cis-166. 
Lab book reference: GH-1-84-2 
 
tert-Butyl N-(2-benzyl-1-oxo-1λ⁶-thian-1-ylidene)carbamate 211a and 211b 
 
Using general procedure A, N-Boc sulfoximine 154 (117 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide (0.12 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with 9:1 and then 8:2 hexane-EtOAc as eluent gave a 
75:25 mixture of benzyl sulfoximines 211a and 211b (71 mg, 45%) as a white solid, RF 
(1:1 hexane-EtOAc) 0.39; IR (ATR) 2933, 1655 (C=O), 1366, 1276, 1248, 1151, 907, 
860, 726, 701, 646, 455 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35–7.29 (m, 2H, Ph), 7.29–
7.23 (m, 1H, Ph), 7.23–7.15 (m, 2H, Ph), 3.80–3.71 (m, 0.75H, SCH), 3.66 (dd, J = 13.5, 
3.0 Hz, 0.75H, PhCH), 3.62–3.50 (m, 1.25H, SCH, PhCH), 3.40–3.30 (m, 0.75H, SCH), 
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3.22–3.13 (m, 0.25H, SCH), 3.09–2.98 (m, 0.25H, SCH), 2.85 (dd, J = 13.5, 11.5 Hz, 
0.25H, PhCH), 2.70 (dd, J = 13.5, 11.5 Hz, 0.75H, PhCH), 2.19–2.04 (m, 2H, CH), 2.03–
1.87 (m, 1H, CH), 1.87–1.74 (m, 2H, CH), 1.53 (s, 2.25H, CMe3), 1.51 (s, 6.75H, CMe3), 
1.47–1.35 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 159.1 (C=O, 211b), 158.6 
(C=O, 211a), 136.6 (ipso-Ph, 211b), 136.2 (ipso-Ph, 211a), 129.51 (Ph, 211a), 129.47 
(Ph, 211b), 128.92 (Ph, 211b), 128.88 (Ph, 211a), 127.12 (Ph, 211a, 211b), 80.48 (CMe3, 
211b), 80.39 (CMe3, 211a), 64.0 (SCH, 211b), 61.1 (SCH, 211a), 50.1 (SCH2, 211a), 
49.6 (SCH2, 211b), 31.4 (PhCH2, 211b), 31.3 (PhCH2, 211a), 28.34 (CMe3, 211b), 28.29 
(CMe3, 211a), 26.6 (CH2, 211a), 24.0 (CH2, 211b), 23.8 (CH2, 211b), 23.4 (CH2, 211b), 
23.04 (CH2, 211a), 22.97 (CH2, 211a) (one Ph resonance not resolved); MS (ESI) m/z 
324 (M + H)+; HRMS (ESI) m/z calcd for C17H25NO3S (M + H)
+ 324.1628, found 
324.1624 (+1.3 ppm error). The stereochemistry of benzyl sulfoximines 211a and 211b 
was assigned by analogy with related examples. 
Lab book reference: GH-2-12 
 
2-Benzyl-1-imino-1λ⁶-thiolan-1-one cis-212 and trans-212 
 
TFA (0.19 mL, 2.4 mmol, 9.75 eq.) was added dropwise to a stirred solution of an 85:15 
mixture of N-Boc sulfoximines cis-210 and trans-210 (79 mg, 0.25 mmol, 1.0 eq.) in 
CH2Cl2 (1.3 mL) at rt. The resulting solution was stirred at rt for 24 h. The solvent was 
evaporated under reduced pressure and the residue was dissolved in water (1.3 mL). 
Saturated Na2CO3(aq) (2.6 mL) was added and the aqueous mixture was extracted with 
CH2Cl2 (3 × 20 mL). The combined organic extracts were dried (Na2SO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with EtOAc and then 9:1 EtOAc-MeOH as eluent gave an 85:15 
mixture of NH sulfoximines cis-212 and trans-212 (35 mg, 67%) as a yellow oil, RF (9:1 
EtOAc-MeOH) 0.32; IR (ATR) 3262 (NH), 3027, 2946, 1496, 1454, 1214, 1200, 1151, 
1106, 994, 757, 702, 537 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35–7.28 (m, 2H, Ph), 
7.28–7.21 (m, 3H, Ph), 3.36–3.20 (m, 3H, SCH, PhCH), 3.19–3.07 (m, 1H, SCH), 2.83–
2.70 (m, 1H, PhCH), 2.47 (s, 1H, NH), 2.28–2.11 (m, 2H, CH), 2.11–1.96 (m, 1H, CH), 
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1.96–1.84 (m, 0.85H, CH), 1.84–1.73 (m, 0.15H, CH); 13C NMR (100.6 MHz, CDCl3) δ 
137.5 (ipso-Ph, cis-212), 137.3 (ipso-Ph, trans-212), 129.1 (Ph, cis-212), 128.93 (Ph, 
trans-212), 128.89 (Ph, trans-212), 128.86 (Ph, cis-212), 127.03 (Ph, trans-212), 127.01 
(Ph, cis-212), 65.9 (SCH, cis-212), 65.1 (SCH, trans-212), 55.8 (SCH2, cis-212), 54.6 
(SCH2, trans-212), 34.4 (PhCH2, trans-212), 34.0 (PhCH2, cis-212), 30.4 (CH2, trans-
212), 30.2 (CH2, cis-212), 21.1 (CH2, cis-212), 20.7 (CH2, trans-212); MS (ESI) m/z 210 
(M + H)+; HRMS (ESI) m/z calcd for C11H15NOS (M + H)
+ 210.0955, found 210.0947 (‒
3.6 ppm error). The stereochemistry of NH sulfoximines cis-212 and trans-212 was 
assigned by analogy with related examples. 
Lab book reference: GH-1-81-2 
 
tert-Butyl N-(2-benzyl-1-oxo-1λ⁶-thiolan-1-ylidene)carbamate cis-210 
 
TBAF (1.1 mL of a 1 M solution in THF, 1.1 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS benzyl sulfoximine cis-166 (246 mg, 0.55 mmol, 1.0 eq.) in 
THF (5 mL) at rt under Ar. The resulting solution was stirred at rt for 24 h. The solvent 
was evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 1:1 hexane-EtOAc and then EtOAc as eluent gave 
NH sulfoximine cis-212 (98 mg, 85%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.33; 
1H 
NMR (400 MHz, CDCl3) δ 7.35–7.29 (m, 2H, Ph), 7.28–7.21 (m, 3H, Ph), 3.33–3.21 (m, 
3H, SCH, PhCH), 3.14 (ddd, J = 13.0, 9.5, 8.0 Hz, 1H, SCH), 2.84–2.73 (m, 1H, PhCH), 
2.28–2.13 (m, 2H, CH), 2.10–1.96 (m, 1H, CH), 1.96–1.84 (m, 1H, CH); 13C NMR (100.6 
MHz, CDCl3) δ 137.6 (ipso-Ph), 129.1 (Ph), 128.9 (Ph), 127.1 (Ph), 66.0 (SCH), 55.8 
(SCH2), 34.1 (PhCH2), 30.3 (CH2), 21.1 (CH2). A solution of potassium tert-butoxide (68 
mg. 0.60 mmol, 1.3 eq.) in THF (1 mL) was added to a stirred solution of NH sulfoximine 
cis-210 (98 mg, 0.46 mmol, 1.0 eq.) in THF (2 mL) at 0 °C under Ar. The resulting 
solution was stirred at 0 °C for 30 min. Then, a solution of Boc2O (200 mg, 0.92 mmol, 
2.0 eq.) in THF (2 mL) was added and the resulting solution was stirred at 0 °C for 1 h. 
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The solution was allowed to warm to rt and stirred at rt for 48 h. Saturated NH4Cl(aq) (5 
mL) was added and the two layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 × 10 mL). The combined organic layers were dried (MgSO4) and evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 8:2 and then 1:1 hexane-EtOAc as eluent gave N-Boc 
benzyl sulfoximine cis-210 (101 mg, 71%) as a white solid, mp 100–102 °C, RF (1:1 
hexane-EtOAc) 0.49; IR (ATR) 2975, 1653 (C=O), 1455, 1366, 1283, 1251, 1221, 1160, 
895, 863, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.35–7.29 (m, 2H, Ph), 7.28–7.19 (m, 
3H, Ph), 3.88–3.78 (m, 1H, SCH), 3.67–3.56 (m, 2H, SCH, PhCH), 3.28–3.16 (m, 1H, 
SCH), 2.72 (dd, J = 14.0, 12.0 Hz, 1H, PhCH), 2.30–2.21 (m, 2H, CH), 2.07–1.84 (m, 
2H, CH), 1.52 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 159.7 (C=O), 137.1 (ipso-
Ph), 129.2 (Ph), 129.0 (Ph), 127.2 (Ph), 80.9 (CMe3), 63.9 (SCH), 53.6 (SCH2), 34.3 
(PhCH2), 29.7 (CH2), 28.3 (CMe3), 21.5 (CH2); MS (ESI) m/z 332 (M + Na)
+; HRMS 
(ESI) m/z calcd for C16H23NO3S (M + Na)
+ 332.1291, found 332.1286 (+1.4 ppm error). 
Lab book reference: GH-2-49 
 
tert-Butyl N-(2-methyl-1-oxo-1λ⁶-thiolan-1-ylidene)carbamate cis-213 and trans-
213 
 
Using general procedure A, N-Boc sulfoximine 153 (110 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide (0.06 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with 1:1 and then 4:1 EtOAc-hexane as eluent gave an 
approx. 90:10 mixture (by 13C NMR spectroscopy) of methyl sulfoximines cis-213 and 
trans-213 (66 mg, 57%) as a clear oil, RF (EtOAc) 0.47; IR (ATR) 2975, 2935, 1651 
(C=O), 1366, 1280, 1248, 1213, 1153, 1135, 1097, 1082, 893, 862, 790, 765 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 3.79–3.71 (m, 1H, SCH), 3.59–3.28 (m, 1H, SCH), 3.20–3.07 
(m, 1H, SCH), 2.44–2.33 (m, 1H, CH), 2.30–2.17 (m, 1H, CH), 2.11–1.97 (m, 1H, CH), 
1.90–1.78 (m, 1H, CH), 1.52–1.38 (m, 12H, CMe3,SCHMe); 13C NMR (100.6 MHz, 
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CDCl3) δ 159.5 (C=O, cis-213), 159.1 (C=O, trans-213) 80.56 (CMe3, cis-213), 60.3 
(SCH, trans-213), 58.3 (SCH, cis-213), 52.8 (SCH2, cis-213), 51.8 (SCH2, trans-213), 
31.8 (CH2, cis-213), 31.2 (CH2, trans-213), 28.2 (CMe3, cis-213), 21.4 (CH2, cis-213), 
20.9 (CH2, trans-213), 13.45 (SCHMe, trans-213), 13.37 (SCHMe, cis-213) (one CMe3 
and one CMe3 resonance not resolved); MS (ESI) m/z 256 (M + Na)
+; HRMS (ESI) m/z 
calcd for C10H19NO3S (M + Na)
+ 256.0978, found 256.0983 (‒2.0 ppm error). The 
stereochemistry of sulfoximines cis-213 and trans-213 was assigned by analogy with 
related examples.  
Lab book reference: GH-2-7 
 
tert-Butyl N-(2-methyl-1-oxo-1λ⁶-thian-1-ylidene)carbamate cis-214 and trans-214 
 
Using general procedure A, N-Boc sulfoximine 154 (117 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide (0.06 ml, 
1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained a 55:45 mixture 
(by 1H NMR spectroscopy) of sulfoximines. Purification by flash column 
chromatography on silica with 9:1 to 1:1 hexane-EtOAc as eluent gave a 55:45 mixture 
of methyl sulfoximines trans-214 and cis-214 (75 mg, 61%), RF (1:1 hexane-EtOAc) 
0.27; IR (ATR) 2981, 2935, 1656 (C=O), 1278, 1250, 1159, 894 cm-1; 1H NMR (400 
MHz, CDCl3) δ 4.17–4.07 (m, 0.55H, SCH), 3.81 (ddd, J = 14.0, 4.5, 4.5 Hz, 0.45H, 
SCH), 3.44–3.34 (m, 0.45H, SCH), 3.29–3.14 (m, 1H, SCH), 3.00 (ddd, J = 14.0, 11.0, 
3.5 Hz, 0.55H, SCH), 2.14–1.77 (m, 5H, CH), 1.65–1.58 (m, 1H, CH), 1.49 (s, 4.95H, 
CMe3), 1.48 (s, 4.05H, CMe3), 1.45 (d, J = 7.0 Hz, 1.65, CHMe), 1.43 (d, J = 7.0 Hz, 
1.35H CHMe); 13C NMR (100.6 MHz, CDCl3) δ 159.2 (C=O, trans-214), 158.9 (C=O, 
cis-214), 80.4 (CMe3, trans-214), 80.3 (CMe3, cis-214), 55.9 (SCH), 49.7 (SCH2, cis-
214), 49.1 (SCH2, trans-214), 31.4 (CH2, trans-214), 30.4 (CH2, cis-214), 28.38 (CMe3, 
trans-214), 28.35 (CMe3, cis-214), 24.0 (CH2, trans-214), 23.2 (CH2, cis-214), 23.1 (CH2, 
cis-214), 20.4 (CH2, trans-214), 12.3 (CHMe, trans-214), 12.1 (CHMe, cis-214) (one 
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SCH resonance not resolved); MS (ESI) m/z 270 (M + Na)+; HRMS (ESI) m/z calcd for 
C11H21NO3S (M + Na)
+ 270.1134, found 270.1134 (0.0 ppm error). 
Lab book reference: GH-1-66-2 
 
1-Imino-2-methyl-1λ⁶-thian-1-one cis-215a and trans-215 
 
TFA (0.20 ml, 2.5 mmol, 9.75 eq.) was added dropwise to a stirred solution of an 
unknown mixture of N-Boc methyl sulfoximines cis-215 and trans-215 (65 mg, 0.25 
mmol, 1.0 eq.) in CH2Cl2 (1.3 mL). The resulting solution was stirred at rt for 24 h. The 
solvent was evaporated under reduced pressure and water (1.3 mL) and saturated 
Na2CO3(aq) (2.6 mL) were added. The aqueous layer was extracted with CH2Cl2 (3 × 20 
mL) and the combined organic layers were dried (Na2SO4) and evaporated under reduced 
pressure to give the crude product which contained a 60:40 mixture (by 1H NMR 
spectroscopy) of NH sulfoximines trans-215 and cis-215. Purification by flash column 
chromatography on silica with 95:5 and then 9:1 EtOAc-MeOH as eluent gave NH 
sulfoximine trans-215 (16 mg, 42%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.18; IR 
(ATR) 3535 (NH), 3266 (NH), 2933, 2861, 1648 (C=O), 1453, 1238, 1194, 1177, 1098, 
986, 722, 469 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.17 (ddd, J = 14.0, 3.5, 3.5 Hz, 1H, 
SCH), 3.12–3.01 (m, 1H, SCH), 2.95–2.86 (m, 1H, SCH), 2.24 (br s, 1H, NH), 2.12–2.01 
(m, 2H, CH), 1.99–1.89 (m, 1H, CH), 1.90–1.78 (m, 1H, CH), 1.78–1.67 (m, 1H, CH), 
1.54–1.42 (m, 1H, CH), 1.32 (d, J = 7.0 Hz, 3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) 
δ 58.8 (SCH), 53.7 (SCH2), 32.7 (CH2), 25.2 (CH2), 24.6 (CH2), 11.6 (Me); MS (ESI) m/z 
148 (M + H)+; HRMS (ESI) m/z calcd for C6H13NOS (M + H)
+ 148.0791, found 148.0790 
(+0.3 ppm error) and NH sulfoximine cis-215 (13 mg, 34%) as a yellow oil, RF (9:1 
EtOAc-MeOH) 0.12; IR (ATR) 3527 (NH), 3267 (NH), 2934 , 2861, 1654 (C=O), 1454, 
1233, 1202, 1173, 992, 715 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.20–3.07 (m, 1H, SCH), 
3.03–2.87 (m, 2H, SCH), 2.60 (br s, 1H, NH), 2.10–2.00 (m, 2H, CH), 2.00–1.93 (m, 1H, 
CH), 1.90–1.74 (m, 2H, CH), 1.52–1.42 (m, 1H, CH), 1.34 (d, J = 7.0 Hz, 3H, CHMe); 
13C NMR (100.6 MHz, CDCl3) δ 59.1 (SCH), 53.3 (SCH2), 31.55 (CH2), 24.5 (CH2), 23.7 
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(CH2), 11.4 (Me); MS (ESI) m/z 148 (M + H)
+; HRMS (ESI) m/z calcd for C6H13NOS (M 
+ H)+ 148.0791, found 148.0787 (+2.4 ppm error).  
Lab book reference: GH-1-70-3 
 
2-(Hydroxydiphenylmethyl)-1-(methylimino)-1λ⁶-thiolan-1-one cis-216 
 
Using general procedure A, N-Me sulfoximine 155 (67 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF) in THF (5 mL) gave the crude product. Purification by 
flash column chromatography on silica with 9:1 and then 1:1 hexane-EtOAc as eluent 
gave alcohol cis-216 (129 mg, 82%) as a white solid, mp 144–146 °C, RF (1:1 hexane-
EtOAc) 0.12; IR (ATR) 3428 (OH), 3064, 2942, 2871, 2802, 1493, 1449, 1253, 1224, 
1091, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.74–7.69 (m, 2H, Ph), 7.46–7.42 (m, 2H, 
Ph), 7.36–7.30 (m, 2H, Ph), 7.30–7.24 (m, 2H, Ph), 7.24–7.18 (m, 1H, Ph), 7.18–7.13 (m, 
1H, Ph), 5.06 (s, 1H, COH) 4.33 (dd, J = 9.5, 8.5 Hz, 1H, SCH), 3.42–3.34 (m, 1H, SCH), 
2.89 (ddd, J = 12.5, 11.5, 6.5 Hz, SCH), 2.49 (s, 3H, NMe), 2.37–2.25 (m, 1H, CH), 2.17–
2.07 (m, 1H, CH), 2.01–1.85 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 145.8 (ipso-
Ph), 145.0 (ipso-Ph), 128.6 (Ph), 128.5 (Ph), 127.4 (Ph), 126.9 (Ph), 126.0 (Ph), 125.1 
(Ph), 78.1 (COH), 68.9 (SCH), 53.3 (SCH2), 30.0 (NMe), 27.7 (CH2), 20.9 (CH2); MS 
(ESI) m/z 316 (M + H)+; HRMS (ESI) m/z calcd for C18H21NO2S (M + H)
+ 316.1366, 
found 316.1367 (‒0.3 ppm error). The stereochemistry of alcohol cis-216 was assigned 
by analogy with related examples. 
Lab book reference: GH-1-69-2 
 
2-(Hydroxydiphenylmethyl)-1-(methylimino)-1λ⁶-thian-1-one cis-217 and trans-217 
Chapter Four: Experimental 
 
 
132 
 
 
Using general procedure A, N-Me sulfoximine 156 (74 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product 
which contained a 50:50 mixture (by 1H NMR spectroscopy) of alcohols cis-217 and 
trans-217. Purification by flash column chromatography on silica with 8:2 hexane-EtOAc 
and then 1:1 as eluent gave alcohol 217a (60 mg, 36%) as a white solid, mp 148–150 °C 
RF (1:1 hexane-EtOAc) 0.26; IR (ATR) 3063, 2929, 2880, 1492, 1448, 1230, 1211, 1132, 
1096, 831, 750, 705, 691 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.74 (s, 1H, COH) 7.72–
7.68 (m, 2H, Ph), 7.54–7.49 (m, 2H, Ph), 7.33–7.26 (m, 4H, Ph), 7.21–7.14 (m, 2H, Ph), 
3.95 (dd, J = 12.0, 3.0 Hz, 1H, SCH), 3.47–3.38 (m, 1H, SCH), 2.93–2.83 (m, 1H, SCH), 
2.64 (s, 3H, NMe), 2.39–2.23 (m, 1H, CH), 2.01–1.73 (m, 4H, CH), 1.52–1.37 (m, 1H, 
CH); 13C NMR (100.6 MHz, CDCl3) δ145.45 (ipso-Ph), 145.37 (ipso-Ph), 128.56 (Ph), 
127.61 (Ph), 127.0 (Ph), 126.8 (Ph), 126.2 (Ph), 124.9 (Ph), 79.1 (SCHCOH), 66.5 (SCH), 
50.5 (SCH2), 27.8 (NMe), 27.6 (CH2), 25.1 (CH2), 24.5 (CH2); MS (ESI) m/z 330 (M + 
H)+; HRMS (ESI) m/z calcd for C19H23NO2S (M + H)
+ 330.1522, found 330.1515 (+2.2 
ppm error) and sulfoximine 217b (70 mg, 43%) as a white solid, mp 150–152 °C, RF (1:1 
hexane-EtOAc) 0.14; IR (ATR) 3058, 2929, 2807, 1446, 1237, 1216, 1107, 864, 730, 699 
cm-1; 1H NMR (400 MHz, CDCl3) δ 7.58–7.53 (m, 2H, Ph), 7.44–7.40 (m, 2H, Ph), 7.38–
7.21 (m, 6H, Ph), 3.99 (dd, J = 12.0, 2.0 Hz, 1H, SCH), 3.28–3.19 (m, 1H, SCH), 2.88–
2.77 (m, 1H, SCH), 2.53 (s, 3H, NMe), 2.26–2.14 (m, 1H, CH), 2.03–1.84 (m, 4H, CH), 
1.49–1.35 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 144.7 (ipso-Ph), 142.2 (ipso-
Ph), 128.4 (Ph), 127.6 (Ph), 127.4 (Ph), 127.1 (Ph), 80.7 (SCHCOH), 70.1 (SCH), 53.8 
(SCH2), 28.2 (NMe), 27.0 (CH2), 26.0 (CH2), 23.5 (CH2) (two Ph resonances not 
resolved); MS (ESI) m/z 330 (M + H)+; HRMS (ESI) m/z calcd for C19H23NO2S (M + H)
+ 
330.1522, found 330.1521 (+0.5 ppm error).  
Lab book reference: GH-1-76 
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2-[Hydroxy(phenyl)methyl]-1-(methylimino)-1λ⁶-thiolan-1-one cis,anti-218 and 
cis,syn-218 
 
Using general procedure A, N-Me sulfoximine 155 (67 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.22 mL of a 2.5 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde (0.10 
mL, 1.0 mmol, 2.0 eq.) in THF (5 mL) gave the crude product which contained a 75:25 
mixture (by 1H NMR spectroscopy) of alcohols cis,anti-218 and cis,syn-218. Purification 
by flash column chromatography on silica with EtOAc as eluent gave alcohol cis,anti-
218 (68 mg, 60%) as a white solid, mp 134–136 °C, RF (9:1 EtOAc-MeOH) 0.33; IR 
(ATR) 3455 (OH), 3186, 2946, 2878, 2802, 1451, 1216, 1138, 1101, 842, 702 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.41–7.33 (m, 4H, Ph), 7.31–7.26 (m, 1H, Ph), 5.46 (s, 1H, 
CHOH), 3.87 (d, J = 2.5 Hz, 1H, CHOH), 3.42–3.30 (m, 2H, SCH,SCH2), 2.98–2.89 (m, 
1H, SCH), 2.89 (s, 3H, NMe), 2.47–2.34 (m, 1H, CH), 2.26–2.16 (m, 1H, CH), 1.95–1.80 
(m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 140.3 (ipso-Ph), 128.7 (Ph), 127.9 (Ph), 
125.7 (Ph), 70.0 (PhCHOH), 66.8 (SCH), 52.2 (SCH2), 30.5 (NMe), 22.8 (CH2), 21.4 
(CH2); MS (ESI) m/z 240 (M + H)
+; HRMS (ESI) m/z calcd for C12H17NO2S (M + H)
+ 
240.1053, found 240.1053 (‒0.2 ppm error) and an 85:15 mixture of alcohols cis,syn-218 
and cis,anti-218 (24 mg, 20 mg (17%) of cis,syn-218 and 4 mg (3%) of cis,anti-218) as a 
white solid, mp 136–138 °C, RF (9:1 EtOAc-MeOH) 0.28; IR (ATR) 3440 (OH), 3061, 
2928, 2808, 1453, 1228, 1140, 1108, 863, 841, 703 cm-1; 1H NMR (400 MHz, CDCl3) 
for cis,syn-218 δ 7.40–7.32 (m, 5H, Ph), 4.83 (d, J = 9.5 Hz, 1H, CHOH), 3.91 (s, 1H, 
CHOH), 3.43–3.33 (m, 2H, SCH), 3.02 (ddd, J = 12.5, 10.5, 7.5 Hz, 1H, SCH), 2.84 (s, 
3H, NMe), 2.16–2.06 (m, 1H, CH), 1.98–1.87 (m, 1H, CH), 1.84–1.76 (m, 2H, CH); 13C 
NMR (100.6 MHz, CDCl3) for cis,syn-218 δ 140.5 (ipso-Ph), 128.9 (Ph), 128.7 (Ph), 
126.9 (Ph), 73.9 (PhCHOH), 67.8 (SCH), 53.8 (SCH2), 30.6 (NMe), 28.5 (CH2), 21.4 
(CH2); MS (ESI) m/z 240 (M + H)
+; HRMS (ESI) m/z calcd for C12H17NO2S (M + H)
+ 
240.1053, found 240.1050 (+0.9 ppm error). The stereochemistry of alcohol cis,anti-218 
was assigned by X-ray crystallography and that of alcohol cis,syn-218 was assigned by 
analogy with related examples. 
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Crystal structure determination of cis,anti-218 
C12H17NO2S, M = 239.32, monoclinic, a = 8.7992(3), b = 18.9535(6), c = 7.1301(2) Å, β 
= 99.909(4)°, U = 1171.38(7) Å3, T = 110.00(10) K, space group P21, Z = 4, μ(Mo-Kα) = 
2.336 mm-1, 3823 reflection measured, 2087 unique (Rint = 0.0269) which were used in 
calculation. The final R1 was 0.0371 (I≥2σ) and wR2 was 0.0969 (all data). 
Lab book reference: GH-1-71 
 
2-[Hydroxy(phenyl)methyl]-1-(methylimino)-1λ⁶-thian-1-one trans,syn-219 and 
219a 
 
Using general procedure A, N-Me sulfoximine 156 (74 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde (0.10 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 75:25 
mixture (by 1H NMR spectroscopy) of alcohols trans,syn-219 and 219a. Purification by 
flash column chromatography on silica with 8:2 and then 1:1 hexane-EtOAc as eluent 
gave alcohol trans,syn-219 (70 mg, 55%) as a white solid, mp 136–138 °C, RF (EtOAc) 
0.58; IR (ATR) 3245 (OH), 2925, 2860, 1452, 1240, 1227, 1213, 1166, 1137, 1098, 1063, 
869, 825, 768, 713, 699, 667, 461 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.41–7.32 (m, 4H, 
Ph), 7.29–7.24 (m, 1H, Ph), 5.95 (s, 1H, PhCHOH), 5.77 (s, 1H, PhCHOH), 3.63–3.54 
(m, 1H, SCH), 2.88–2.78 (m, 2H, SCH), 2.78 (s, 3H, NMe), 2.27–2.13 (m, 1H, CH), 
2.02–1.92 (m, 1H, CH), 1.90–1.76 (m, 2H, CH), 1.75–1.66 (m, 1H, CH), 1.31–1.16 (m, 
1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 140.3 (ipso-Ph), 128.5 (Ph), 127.6 (Ph), 126.2 
(Ph), 67.9 (PhCHOH), 67.0 (SCH), 48.4 (SCH2), 28.0 (NMe), 24.4 (CH2), 24.3 (CH2), 
22.6 (CH2); MS (ESI) m/z 254 (M + H)
+; HRMS (ESI) m/z calcd for C13H19NO2S (M + 
H)+ 254.1209, found 254.1210 (‒0.1 ppm error) and alcohol 219a (10 mg, 8%) as a white 
solid, mp 130–132 °C, RF (1:1 hexane-EtOAc) 0.58; IR (ATR) 3215 (OH), 2926, 2861, 
1453, 1233, 1214, 1167, 1138, 1106, 1058, 865, 769, 702 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 7.42–7.27 (m, 5H, Ph), 5.13 (d, J = 9.0 Hz, 1H, PhCHOH), 3.55–3.48 (m, 1H, 
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SCH), 3.17 (ddd, J = 9.0, 7.5, 3.0 Hz, 1H, SCH), 2.86 (s, 3H, NMe), 2.75–2.65 (m, 1H, 
SCH), 2.06–1.91 (m, 2H, CH), 1.80–1.70 (m, 1H, CH), 1.67–1.55 (m, 1H, CH), 1.31–
1.20 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 139.6 (ipso-Ph), 128.7 (Ph), 128.5 
(Ph), 127.6 (Ph), 72.7 (SCH), 65.8 (PhCHOH), 50.5 (SCH2), 28.5 (NMe), 26.0 (CH2), 
24.7 (CH2), 23.3 (CH2); MS (ESI) m/z 254 (M + H)
+; HRMS (ESI) m/z calcd for 
C13H19NO2S (M + H)
+ 254.1209, found 254.1208 (+0.5 ppm error). The stereochemistry 
of alcohol trans,syn-219 was assigned by X-ray crystallography. 
Crystal structure determination of trans,syn-219 
C13H19NO2S, M = 253.35, monoclinic, a = 15.4721(5), b = 5.42359(16), c = 30.2011(7) 
Å, β = 90 °, U = 2534.31(12) Å3, T = 110.05(10) K, space group P21, Z = 8, μ(Mo-Kα) = 
2.188 mm-1, 4998 reflection measured, 3147 unique (Rint = 0.0220) which were used in 
calculation. The final R1 was 0.0357 (I≥2σ) and wR2 was 0.0937 (all data). 
Lab book reference: GH-2-5 
 
2-Benzyl-1-(methylimino)-1λ⁶-thiolan-1-one cis-220 
 
Using general procedure A, N-Me sulfoximine 155 (67 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide (0.12 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 99:1 EtOAc-MeOH as eluent 
gave benzyl sulfoximine cis-220 (42 mg, 38%) as a clear oil, RF (9:1 EtOAc-MeOH) 0.37; 
IR (ATR) 2929, 2800, 1496, 1454, 1223, 1137, 1098, 859, 754, 726, 701, 529, 463 cm-1; 
1H NMR (400 MHz, CDCl3) δ 7.34–7.28 (m, 2H, Ph), 7.26–7.21 (m, 3H, Ph), 3.40–3.25 
(m, 3H, SCH, PhCH), 2.93 (ddd, J = 13.0, 10.0, 7.5 Hz, 1H, SCH), 2.79–2.71 (m, 1H, 
PhCH), 2.74 (s, 3H, NMe), 2.22–2.12 (m, 2H, CH), 1.99–1.79 (m, 2H, CH); 13C NMR 
(100.6 MHz, CDCl3) δ 137.8 (ipso-Ph), 129.2 (Ph), 128.9 (Ph), 127.0 (Ph), 63.5 (SCH), 
51.7 (SCH2), 35.2 (PhCH2), 30.5 (NMe), 30.3 (CH2), 21.5 (CH2); MS (ESI) m/z 224 (M 
+ H)+; HRMS (ESI) m/z calcd for C12H17NOS (M + H)
+ 224.1104, found 224.1103 (+0.4 
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ppm error). The stereochemistry of benzyl sulfoximine cis-220 was assigned by analogy 
with related examples. 
Lab book reference: GH-2-16 
 
2-Benzyl-1-(methylimino)-1λ⁶-thian-1-one 221a and 221b 
 
Using general procedure A, N-Me sulfoximine 156 (74 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide (0.12 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 50:50 
mixture (by 1H NMR spectroscopy) of benzyl sulfoximines 221a and 221b. Purification 
by flash column chromatography on silica with EtOAc as eluent gave benzyl sulfoximine 
221a (35 mg, 30%) as a clear oil, RF (9:1 EtOAc-MeOH) 0.45; IR (ATR) 3027, 2923, 
2872, 2801, 1454, 1443, 1239, 1224, 1131, 1098, 872, 826, 756, 699, 462 cm-1; 1H NMR 
(400 MHz, CDCl3) δ 7.33–7.27 (m, 2H, Ph) 7.26–7.21 (m, 1H, Ph), 7.21–7.16 (m, 2H, 
Ph), 3.51 (dd, J = 13.5, 3.0 Hz, 1H, PhCH), 3.47–3.39 (m, 1H, SCH), 3.05–2.95 (m, 1H, 
SCH) , 2.89–2.79 (m, 1H, SCH), 2.83 (s, 3H, NMe), 2.69 (dd, J = 13.5, 11.5 Hz, 1H, 
PhCH), 2.02–1.84 (m, 3H, CH), 1.84–1.71 (m, 2H, CH) 1.36–1.22 (m, 1H, CH); 13C 
NMR (100.6 MHz, CDCl3) δ 137.5 (ipso-Ph), 129.5 (Ph), 128.8 (Ph), 126.9 (Ph), 64.5 
(SCH), 48.5 (SCH2), 31.8 (PhCH2), 29.9 (CH2), 28.5 (NMe), 24.5 (CH2), 24.4 (CH2); MS 
(ESI) m/z 238 (M + H)+; HRMS (ESI) m/z calcd for C13H19NOS (M + H)
+ 238.1260, 
found 238.1263 (‒1.2 ppm error) and benzyl sulfoximine 221b (30 mg, 25%) as a clear 
oil, RF  (9:1 EtOAc-MeOH) 0.41; IR (ATR) 3027, 2929, 2870, 2802, 1454, 1237, 1209, 
1163, 1135, 1104, 866, 755, 701, 463, cm-1; 1H NMR (400 MHz, CDCl3) δ 7.33–7.27 (m, 
2H, Ph) 7.25–7.20 (m, 1H, Ph), 7.20–7.16 (m, 2H, Ph), 3.61 (dd, J = 13.5, 3.0 Hz, 1H, 
PhCH), 3.33–3.25 (m, 1H, SCH), 3.17–3.08 (m, 1H, SCH), 2.90 (s, 3H, NMe), 2.85–2.76 
(m, 1H, SCH), 2.66 (dd, J = 13.5, 12.0 Hz, 1H, PhCH), 2.06–1.85 (m, 2H, CH), 1.87–
1.66 (m, 3H, CH) 1.39–1.25 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 137.2 (ipso-
Ph), 129.5 (Ph), 128.8 (Ph), 126.7 (Ph), 63.0 (SCH), 50.3 (SCH2), 32.0 (PhCH2), 29.1 
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(NMe), 27.4 (CH2), 23.8 (CH2), 23.7 (CH2); MS (ESI) m/z 238 (M + H)
+; HRMS (ESI) 
m/z calcd for C13H19NOS (M + H)
+ 238.1260, found 238.1259 (+0.4 ppm error).  
Lab book reference: GH-1-83 
 
2-Methyl-1-(methylimino)-1λ⁶-thiolan-1-one cis-222 and trans-222 
 
Using general procedure A, N-Me sulfoximine 155 (67 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide (0.06 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 90:10 
mixture (by 1H NMR spectroscopy) of methyl sulfoximines cis-222 and trans-222. 
Purification by flash column chromatography on silica with EtOAc and then 9:1 EtOAc-
MeOH as eluent gave a 90:10 mixture of methyl sulfoximines cis-222 and trans-222 (46 
mg, 63%) as a clear oil, RF (9:1 EtOAc-MeOH) 0.18; IR (ATR) 2935, 2800, 1451, 1413, 
1217, 1136, 1098, 1056, 1020, 867, 839, 707 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.34–
3.26 (m, 1H, SCH), 3.20–3.10 (m, 1H, SCH), 2.88–2.78 (m, 1H, SCH), 2.80 (s, 3H, 
NMe), 2.35–2.26 (m, 1H, CH), 2.21–2.11 (m, 1H, CH), 2.02–1.88 (m, 1H, CH), 1.79–
1.67 (m, 1H, CH), 1.33 (d, J = 7.0 Hz, 2.7H, SCHMe), 1.31 (d, J = 7.0 Hz, 0.3H, SCHMe); 
13C NMR (100.6 MHz, CDCl3) δ 57.2 (SCH, cis-222), 56.4 (SCH, trans-222), 51.3 
(SCH2, trans-222), 50.2 (SCH2, cis-222), 31.9 (CH2, cis-222), 30.5 (NMe, cis-222), 29.2 
(CH2, trans-222), 28.5 (NMe, trans-222), 23.8 (CH2, trans-222), 21.4 (CH2, cis-222), 14.6 
(SCHMe, trans-222), 13.8 (SCHMe, cis-222); MS (ESI) m/z 148 (M + H)+; HRMS (ESI) 
m/z calcd for C6H13NOS (M + H)
+ 148.0791, found 148.0788 (+1.9 ppm error). The 
stereochemistry of methyl sulfoximine cis-222 was assigned by synthesis from N-TBDPS 
sulfoximine cis-172. 
Lab book reference: GH-2-17 
 
2-Methyl-1-(methylimino)-1λ⁶-thiolan-1-one cis-222 
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TBAF (1.76 mL of a 1 M solution in THF, 1.76 mmol, 2.0 eq.) was added dropwise to a 
stirred solution of N-TBDPS methyl sulfoximine cis-172 (327 mg, 0.88 mmol, 1.0 eq.) in 
THF (7 mL) at rt under Ar. The resulting solution was stirred at rt for 24 h. The solvent 
was evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with EtOAc and then 99:1 EtOAc-MeOH as eluent 
gave NH sulfoximine cis-223 (112 mg, 95%) as a yellow oil, RF (9:1 EtOAc-MeOH) 0.16; 
1H NMR (400 MHz, CDCl3) δ 3.20 (ddd, J = 12.5, 8.5, 4.0 Hz, 1H, SCH), 3.14–3.02 (m, 
2H, SCH), 2.41–2.32 (m, 1H, CH) 2.23–2.12 (m, 1H, CH), 2.12–2.00 (m, 1H, CH), 1.85–
1.73 (m, 1H, CH), 1.34 (d, J = 7.0 Hz, 3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) δ 
59.3 (SCH), 55.3 (SCH2), 32.0 (CH2), 21.3 (CH2), 12.7 (SCHMe). A solution of 
paraformaldehyde (30 mg, 1.0 mmol, 1.2 eq.) and NH sulfoximine cis-223 (112 mg, 0.84 
mmol, 1.0 eq.) in formic acid (2 mL) was stirred and heated at 120 °C for 36 h. The 
solution was allowed to cool to rt and the solvent was evaporated under reduced pressure. 
The residue was dissolved in 2 M H2SO4(aq) (5 mL) and the aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The aqueous layer was basified by the addition of 2 M NaOH(aq) 
until pH 12 was reached. The aqueous mixture was extracted with CH2Cl2 (3 × 30 mL). 
The combined organic layers were dried (MgSO4) and evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica with 
EtOAc and then 9:1 EtOAc-MeOH as eluent gave methyl sulfoximine cis-222 (100 mg, 
81%) as a clear oil, RF (9:1 EtOAc-MeOH) 0.18; IR (ATR) 2934, 2873, 1451, 1267, 1217, 
1178, 1135, 1098, 1057, 1020, 867, 838 cm-1; 1H NMR (400 MHz, CDCl3) δ 3.34–3.26 
(m, 1H, SCH), 3.20–3.10 (m, 1H, SCH), 2.88–2.78 (m, 1H, SCH), 2.80 (s, 3H, NMe), 
2.35–2.26 (m, 1H, CH), 2.21–2.11 (m, 1H, CH), 2.02–1.88 (m, 1H, CH), 1.79–1.67 (m, 
1H, CH), 1.33 (d, J = 7.0 Hz, 3H, SCHMe); 13C NMR (100.6 MHz, CDCl3) δ 57.2 (SCH), 
50.2 (SCH2), 31.9 (CH2), 30.5 (NMe), 21.4 (CH2), 13.8 (CHMe); MS (ESI) m/z 148 (M 
+ H)+; HRMS (ESI) m/z calcd for C6H13NOS (M + H)
+ 148.0791, found 148.0787 (+2.7 
ppm error).  
Lab book reference: GH-2-52 
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2-Methyl-1-(methylimino)-1λ⁶-thian-1-one 224 and 2,6-dimethyl-1-(methylimino)-
1λ⁶-thian-1-one 225 
 
Using general procedure A, N-Me sulfoximine 156 (74 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and methyl iodide (0.06 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with EtOAc then 9:1 EtOAc-MeOH as eluent gave a 
complex mixture of sulfoximine 156, methyl sulfoximine 224 and dimethyl sulfoximine 
225 (40 mg) as a colourless oil. It was not possible to determine the ratio from the 1H 
NMR spectrum. Evidence for methyl sulfoximine 224 and dimethyl sulfoximine 225 was 
provided by MS data. 
Lab book reference: GH-2-8 
 
{[2-(Hydroxydiphenylmethyl)-1-oxo-1λ⁶-thiolan-1-ylidene]amino}formonitrile cis-
226 and trans-226 and {[2,5-Bis(hydroxydiphenylmethyl)-1-oxo-1λ⁶-thiolan-1-
ylidene]amino}formonitrile cis,cis-227 and trans,cis-227  
 
Using general procedure A, N-CN sulfoximine 68 (72 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone (0.25 
mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. 
Purification by flash column chromatography on silica with 8:2 hexane-EtOAc and then 
EtOAc as eluent gave a 70:30 mixture of disubstituted sulfoximines cis,cis-227 and 
trans,cis-227 (30 mg, 12%) as a white solid, RF (4:1 EtOAc-hexane) 0.59; IR (ATR) 3524 
(OH), 3060, 2925, 2192 (CN), 1492, 1449, 1235, 1160, 1049, 1033, 907, 729, 697, 523 
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cm-1; 1H NMR (400 MHz, CDCl3) δ 7.70 (d, J = 7.5 Hz, 0.6H, Ph), 7.66 (d, J = 7.5 Hz, 
2.8H, Ph), 7.59 (d, J = 7.5 Hz, 0.6H, Ph), 7.49–7.40 (m, 4H, Ph), 7.40–7.15 (m, 12H, Ph), 
4.91 (s, 0.3H, COH), 4.89–4.82 (m, 1.7H, SCH), 4.37 (dd, J = 12.0, 6.0 Hz, 0.3H, SCH), 
3.87 (s, 0.3H, COH), 3.72 (s, 1.4H, COH), 2.72–2.56 (m, 1.4H, CH), 2.47–2.37 (m, 0.6H, 
CH), 2.05–1.86 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 144.0 (ipso-Ph, trans,cis-
227), 143.72 (ipso-Ph, cis,cis-227), 143.66 (ipso-Ph, cis,cis-227), 143.4 (ipso-Ph, 
trans,cis-227), 142.9 (ipso-Ph, trans,cis-227), 142.4 (ipso-Ph, trans,cis-227), 129.5 (Ph, 
trans,cis-227), 129.2 (Ph, trans,cis-227), 129.1 (Ph, cis,cis-227), 128.85 (Ph, cis,cis-227), 
128.82 (Ph, trans,cis-227), 128.79 (Ph, trans,cis-227), 128.7 (Ph, trans,cis-227), 128.40 
(Ph, trans,cis-227), 128.35 (Ph, trans,cis-227), 128.3 (Ph, cis,cis-227), 127.74 (Ph, 
trans,cis-227), 127.68 (Ph, cis,cis-227), 125.8 (Ph, trans,cis-227), 125.4 (Ph, trans,cis-
227), 125.12 (Ph, cis,cis-227), 125.07 (Ph, cis,cis-227), 125.0 (Ph, trans,cis-227), 124.8 
(Ph, trans,cis-227), 111.8 (CN, cis,cis-227), 110.3 (CN, trans,cis-227), 79.8 (COH, 
cis,cis-227), 78.6 (COH, trans,cis-227), 77.6 (COH, trans,cis-227), 73.5 (SCH, trans,cis-
227), 72.7 (SCH, trans,cis-227), 72.1 (SCH, cis,cis-227), 25.6 (CH2, cis,cis-227) 23.7 
(CH2, trans,cis-227), 22.9 (CH2, trans,cis-227); MS (ESI) m/z 509 (M + H)
+; HRMS 
(ESI) m/z calcd for C31H28N2O3S (M + H)
+ 509.1893, found 509.1902 (‒1.7 ppm error) 
and a 90:10 mixture of monosubstituted sulfoximines cis-226 and trans-226 (18 mg, 
11%) as a white solid, mp 180–182 °C, RF (4:1 EtOAc-hexane) 0.41; IR (ATR) 3533 
(OH), 2928, 2192, 1494, 1449, 1235, 1180, 1061, 1033, 908, 807, 787, 730, 703 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 7.71–7.66 (m, 1.8H, Ph), 7.64–7.60 (m, 0.2H, Ph), 7.45–7.36 
(m, 3.7H, Ph), 7.35–7.27 (m, 3.2H, Ph), 7.23–7.17 (m, 1.1H, Ph), 4.69 (dd, J = 10.0, 8.0 
Hz, 0.9H, SCH), 4.50 (dd, J = 10.0, 8.0 Hz, 0.1H, SCH), 3.78 (dd, J = 13.0, 6.0 Hz, 0.9H, 
SCH), 3.72 (s, 0.9H, COH), 3.58–3.47 (m, 0.2H, SCH), 3.21 (ddd, J = 13.0, 6.5, 6.5 Hz, 
0.9H, SCH), 2.54–2.40 (m, 1H, CH), 2.38–2.24 (m, 1H, CH), 2.14–1.94 (m, 2H, CH); 
13C NMR (100.6 MHz, CDCl3) δ 143.9 (ipso-Ph, cis-226), 143.2 (ipso-Ph, cis-226), 
129.21 (Ph, cis-226), 129.17 (Ph, trans-226), 129.08 (Ph, trans-226), 128.8 (Ph, cis-226), 
128.4 (Ph, cis-226), 127.6 (Ph, cis-226), 125.5 (Ph, trans-226), 125.4 (Ph, cis-226), 125.0 
(Ph, cis-226), 124.9 (Ph, trans-226), 112.1 (CN, cis-226) 78.54 (COH, cis-226), 71.1 
(SCH, trans-226), 69.1 (SCH, cis-226), 56.6 (SCH2, trans-226), 55.1 (SCH2, cis-226), 
27.6 (CH2, cis-226), 27.1 (CH2, trans-226), 20.8 (CH2, trans-226), 20.7 (CH2, cis-226) 
(two ipso-Ph, two Ph, one CN and one COH signal not resolved for sulfoximine trans-
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226); MS (ESI) m/z 327 (M + H)+; HRMS (ESI) m/z calcd for C18H18N2O2S (M + H)
+ 
372.1162, found 372.1163 (‒0.5 ppm error). 
Lab book reference: GH-1-90 
 
({2-[Hydroxy(phenyl)methyl]-1-oxo-1λ⁶-thiolan-1-ylidene}amino)formonitrile 228 
 
Using general procedure A, N-CN sulfoximine 68 (72 mg, 0.5 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde (0.10 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with 8:2 and then 1:1 hexane-EtOAc as eluent gave one 
unassigned diastereomer of sulfoximine 228a (25 mg, 20%) as a white solid, mp 114–
116 °C, RF (EtOAc) 0.61; IR (ATR) 3350 (OH), 2952, 2188 (CN), 1240, 1186, 1067, 817, 
736, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.41–7.36 (m, 4H, Ph), 7.35–7.30 (m, 1H, 
Ph), 5.54 (dd, J = 4.0, 2.0 Hz, 1H, PhCH), 3.71–3.57 (m, 2H, SCH), 3.28 (ddd, J = 13.0, 
10.5, 8.0 Hz, 1H, SCH), 3.19 (d, J = 4.0 Hz, 1H, CHOH), 2.58–2.45 (m, 1H, CH), 2.45–
2.35 (m, 1H, CH), 2.13–1.98 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 139.1 (ipso-
Ph), 129.0 (Ph), 128.5 (Ph), 125.6 (Ph), 112.7 (CN), 69.1 (PhCH), 67.3 (SCH), 52.7 
(SCH2), 22.0 (CH2), 20.6 (CH2); MS (ESI) m/z 273 (M + Na)
+; HRMS (ESI) m/z calcd 
for C12H14N2O2S (M + Na)
+ 273.0668, found 273.0669 (‒0.1 ppm error) and a 60:20:15:5 
mixture of sulfoximines 228b, 228c, 228d and 228a (42 mg, 34%) as a white solid, mp 
116–118 °C, RF (EtOAc) 0.53; IR (ATR) 3361 (OH), 2946, 2193 (CN), 1243, 1192, 823, 
772, 730, 703 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.43–7.34 (m, 4H, Ph), 7.33–7.27 (m, 
1H, Ph), 5.55 (dd, J = 3.5, 2.5 Hz, 0.15H, PhCH, 228d), 5.52 (dd, J = 4.0, 2.0 Hz, 0.05H, 
PhCH, 228a), 5.10 (dd, J = 10.0, 4.0 Hz, 0.2H, PhCH, 228c), 4.98 (dd, J = 10.0, 4.0 Hz, 
0.6H, PhCH, 228b), 3.81–3.41 (m, 2.6H, SCH,CHOH), 3.64 (d, J = 4.0 Hz, 0.2H, 
CHOH), 3.52 (d, J = 4.0 Hz, 0.6H, CHOH), 3.29 (ddd, J = 13.5, 11.0, 7.5 Hz, 0.6H, SCH), 
2.51–2.34 (m, 0.4H, CH), 2.30–1.97 (m, 1.8H, CH), 1.92–1.71 (m, 1.8H, CH); 13C NMR 
(100.6 MHz, CDCl3) δ 139.7 (ipso-Ph, 228c, 228d), 139.5 (ipso-Ph, 228c, 228d), 139.3 
(ipso-Ph, 228b), 129.3 (Ph, 228b), 129.2 (Ph, 228b), 128.9 (Ph, 228c, 228d), 128.46 (Ph, 
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228c, 228d), 128.42 (Ph, 228c, 228d), 126.9 (Ph, 228b), 126.7 (Ph, 228c, 228d), 125.8 
(Ph, 228c, 228d), 125.7 (Ph, 228c, 228d), 112.9 (CN, 228c, 228d), 112.5 (CN, 228b), 
112.2 (CN, 228c, 228d), 72.9 (SCH, CHOH, 228c, 228d), 72.7 (SCH, CHOH, 228c, 
228d), 72.3 (CHOH, 228b), 71.6 (SCH, 228b), 70.1 (SCH, 228c, 228d), 68.2 (CHOH, 
228c, 228d), 54.8 (SCH2, 228b), 54.5 (SCH2, 228c, 228d), 53.4 (SCH2, 228c, 228d), 28.3 
(CH2, 228b), 27.7 (CH2, 228c, 228d), 22.4 (CH2, 228c, 228d), 21.2 (CH2, 228b), 20.7 
(CH2, 228c, 228d), 20.5 (CH2, 228c, 228d) (signals for 228a not resolved); MS (ESI) m/z 
252 (M + H)+; HRMS (ESI) m/z calcd for C12H15N2O2S (M + H)
+ 251.0849, found 
251.0850 (‒0.5 ppm error). 
Lab book reference: GH-2-6 
 
[(2-Benzyl-1-oxo-1λ⁶-thiolan-1-ylidene)amino]formonitrile cis-229 and trans-229 
and [(2,5-Dibenzyl-1-oxo-1λ⁶-thiolan-1-ylidene)amino]formonitrile cis,cis-230 and 
trans,cis-230 
 
Using general procedure A, N-CN sulfoximine 68 (72 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide (0.12 
mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with 1:1 EtOAc-hexane and then 4:1 EtOAc-hexane as 
eluent gave an unknown mixture of disubstituted sulfoximines cis,cis-230 and trans,cis-
230 (55 mg, 34%) as a clear gel, RF (4:1 EtOAc-hexane) 0.70; IR (ATR) 3037, 2930, 2188 
(CN), 1496, 1455, 1233, 1177, 832, 756, 699, 540, 464 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.38–7.26 (m, 6H, Ph), 7.25–7.19 (m, 4H, Ph), 3.83–3.35 (m, 4H, SCH/PhCH), 2.90–
2.60 (m, 2H, PhCH), 2.29–1.92 (m, 3H, CH), 1.84–1.65 (m, 1H, CH); 13C NMR (100.6 
MHz, CDCl3) δ 135.69 (ipso-Ph), 135.64 (ipso-Ph), 135.49 (ipso-Ph), 135.42 (ipso-Ph), 
129.22 (Ph), 129.18 (Ph), 129.17 (Ph), 129.12 (Ph), 129.02 (Ph), 127.69 (Ph), 127.66 
(Ph), 127.61 (Ph), 112.46 (CN), 112.37 (CN), 68.18 (SCH, trans,cis-230), 65.08 (SCH, 
trans,cis-230), 64.86 (SCH, cis,cis-230), 34.63 (PhCH2, trans,cis-230), 33.95 (PhCH2, 
trans,cis-230), 33.79 (PhCH2, cis,cis-230), 28.03 (CH2, trans,cis-230), 27.81 (CH2, 
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trans,cis-230), 26.52 (CH2, cis,cis-230); MS (ESI) m/z 325 (M + H)
+ HRMS (ESI) m/z 
calcd for C19H20N2OS (M + H)
+ 325.1369, found 325.1369 (‒0.1 ppm error) and a 70:30 
mixture (by 1H NMR spectroscopy) of monosubstituted sulfoximines cis-229 and trans-
229 (37 mg, 32%) as a clear gel, RF (4:1 EtOAc-hexane) 0.39; IR (ATR) 2938, 2188 (CN), 
1496, 1455, 1233, 1192, 819, 755, 702, 540 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.38–
7.26 (m, 3H, Ph), 7.25–7.20 (m, 2H, Ph), 3.76–3.68 (m, 0.7H, SCH), 3.68–3.57 (m, 1H, 
SCH), 3.55–3.37 (m, 1.6H, PhCH, SCH), 3.26 (ddd, J = 13.5, 10.0, 8.0 Hz, 0.7H, SCH), 
2.90 (dd, J = 15.0, 11.0 Hz, 0.3H, PhCH), 2.80 (dd, J = 14.0, 10.0 Hz, 0.7H, PhCH), 2.41–
2.23 (m, 2H, CH), 2.23–1.86 (m, 2H, CH); 13C NMR (100.6 MHz, CDCl3) δ 135.8 (ipso-
Ph, trans-229), 135.5 (ipso-Ph, cis-229), 129.21 (Ph, cis-229), 129.18 (Ph, trans-229), 
129.09 (Ph, cis-229), 129.01 (Ph, trans-229), 127.69 (Ph, cis-229), 127.63 (Ph, trans-
229), 112.50 (CN, trans-229), 112.46 (CN, cis-229), 67.05 (SCH, trans-229), 64.76 
(SCH, cis-229), 53.64 (SCH2, cis-229), 52.42 (SCH2, trans-229), 33.86 (PhCH2, cis-229), 
33.00 (PhCH2, trans-229), 29.94 (CH2, cis-229), 29.12 (CH2, trans-229), 21.22 (CH2, cis-
229), 20.44 (CH2, trans-229); MS (ESI) m/z 235 (M + H)
+; HRMS (ESI) m/z calcd for 
C12H14N2OS (M + H)
+ 235.0900, found 235.0899 (+0.1 ppm error).   
Lab book reference: GH-1-89 
 
[(2-Methyl-1-oxo-1λ⁶-thiolan-1-ylidene)amino]formonitrile 231 and [(2,5-Dimethyl-
1-oxo-1λ⁶-thiolan-1-ylidene)amino]formonitrile 232 
 
Using general procedure A, N-CN sulfoximine 68 (72 mg, 0.50 mmol, 1.0 eq.), n-BuLi 
(0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and then methyl iodide 
(0.06 mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product. Purification by flash 
column chromatography on silica with 4:1 EtOAc-hexane and then EtOAc as eluent gave 
a complex mixture of diastereomeric monosubstituted sulfoximines 231 and disubstituted 
sulfoximines 232 (25 mg) as a clear oil, RF (EtOAc) 0.33; IR (ATR) 2940, 2185 (CN), 
1451, 1225, 1186, 817, 724, 539 cm-1; MS (ESI) m/z 181 [(M + Na)+] HRMS (ESI) m/z 
calcd for C6H10N2OS (M + Na)
+ 181.0406, found 181.0410 (‒2.4 ppm error); MS (ESI) 
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m/z 195 [(M + Na)+] HRMS (ESI) m/z calcd for C7H12N2OS (M + Na)
+ 195.0568, found 
195.0567 (‒1.0 ppm error).   
Lab book reference: GH-1-91-7 
Attempted synthesis of 2-Benzyl-1-[(tert-butyldiphenylsilyl)imino]-2-(pyridine-3-
carbonyl)-1λ⁶-thiolan-1-one 237 
 
LHMDS (0.55 mL of a 1 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of N-TBDPS keto-sulfoximine cis-183 (231 mg, 0.5 mmol, 1.0 eq.) 
in THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 20 
min. Then, benzyl bromide (0.12 mL, 1.0 mmol, 2.0 eq) was added dropwise. The 
resulting solution was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Then water 
(5 mL) was added and the two layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 7:3 and then 1:1 hexane-EtOAc as eluent gave no 
identifiable products and no starting material (by 1H NMR spectroscopy). 
Lab book reference: GH-2-13 
 
Attempted synthesis of 1-[(tert-Butyldiphenylsilyl)imino]-2-(pyridine-3-carbonyl)-
1λ⁶-thiolan-1-one 238 
 
LHMDS (0.55 mL of a 1.0 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of N-TBDPS keto-sulfoximine cis-183 (231 mg, 0.50 mmol, 
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1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C 
for 20 min. Then, benzaldehyde (0.10 mL, 1.0 mmol, 2.0 eq) was added dropwise. The 
resulting solution was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Then, water 
(5 mL) was added and the two layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product which contained a 75:25 
mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-183 and trans-183. 
Purification by flash column chromatography on silica with 7:3 and then 1:1 hexane-
EtOAc as eluent gave keto-sulfoximine trans-183 (50 mg, 22%) as a white solid, mp 112–
115 °C, RF (1:1 hexane-EtOAc) 0.35; IR (ATR) 3070, 3049, 2930, 2891, 2856, 1687 
(C=O), 1586, 1427, 1300, 1256, 1154, 1108, 998, 821, 731, 699, 603, 500, 487 cm-1; 1H 
NMR (400 MHz, CDCl3) δ 9.13 (d, J = 1.5 Hz, 1H, Ar), 8.75–8.70 (m, 1H, Ar), 8.11–
8.04 (m, 1H, Ar), 7.78–7.67 (m, 4H, Ph), 7.43–7.34 (m, 6H, Ph), 7.23 (dd, J = 8.0, 5.0 
Hz, 1H, Ar), 4.64 (dd, J = 8.0, 5.5 Hz, 1H, SCH), 3.00–2.90 (m, 1H), 2.88–2.80 (m, 1H), 
2.76–2.68 (m, 1H), 2.34–2.26 (m, 1H, CH), 2.22–2.09 (m, 2H, CH), 1.08 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 191.3 (C=O), 153.9 (Ar), 150.5 (Ar), 136.6 (Ar), 135.68 
(Ar), 135.63 (Ar), 135.48 (ipso-Ar), 135.44 (ipso-Ar), 132.2 (ipso-Ar), 129.7 (Ar), 127.89 
(Ar), 127.84 (Ar), 123.5 (Ar), 69.3 (SCH), 56.5 (SCH2), 27.1 (CMe3), 25.5 (CH2), 21.4 
(CH2), 19.4 (CMe3) (one Ar resonance not resolved); MS (ESI) m/z 463 (M + H)
+; HRMS 
(ESI) m/z calcd for C26H30N2O2SSi (M + H)
+ 463.1870, found 463.1877 (‒1.6 ppm error) 
and keto-sulfoximine cis-183 (157 mg, 68%) as a white solid. The stereochemistry of 
keto-sulfoximines cis-183 and trans-183 was assigned by analogy with related examples. 
Lab book reference: GH-2-19 
 
Attempted synthesis of 2-benzoyl-2-benzyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-
thiolan-1-one 242 and 2,5-dibenzoyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-thiolan-
1-one trans,cis-239  
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LHMDS (0.55 mL of a 1.0 M solution in hexanes, 0.55 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of N-TBDPS sulfoximine cis-180 (231 mg, 0.50 mmol, 1.0 
eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒78 °C for 
20 min. Then, benzyl bromide (0.12 mL, 1.0 mmol, 2.0 eq) was added dropwise. The 
resulting solution was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Then, water 
(5 mL) was added and the two layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) and 
evaporated under reduced pressure to give the crude product which contained a 70:20:10 
mixture (by 1H NMR spectroscopy) of monosubstituted sulfoximine trans-180, 
disubstituted sulfoximine trans,cis-239 and monosubstituted sulfoximine cis-180. 
Purification by flash column chromatography on silica with 95:5 and then 9:1 hexane-
EtOAc as eluent gave a 50:50 mixture of sulfoximines cis-180, and trans,cis-239 (43 mg, 
19 mg (8%) of cis-180 and 22 mg (8%) of trans,cis-239) as a white solid, RF (8:2 hexane-
EtOAc) 0.36; IR (ATR) 3069, 2930, 2856, 1682, 1327, 1299, 1154, 1108, 728, 701, 603, 
501 cm-1; 1H NMR (400 MHz, CDCl3) for trans,cis-239 δ 8.17–8.10 (m, 2H, Ph), 7.69–
7.64 (m, 2H, Ph), 7.63–7.29 (m, 12H, Ph), 7.25–7.14 (m, 4H, Ph), 5.16 (dd, J = 8.0, 8.0 
Hz, 1H, SCH), 4.62 (dd, J = 8.0, 3.5 Hz, 1H, SCH), 3.11–3.01 (m, 1H, CH), 2.68–2.52 
(m, 2H, CH), 2.46–2.35 (m, 1H, CH), 0.80 (s, 9H, CMe3); 13C NMR (100.6 MHz, CDCl3) 
for trans,cis-239 δ 193.1 (C=O), 190.1 (C=O), 136.6 (ipso-Ph), 136.4 (ipso-Ph), 135.8 
(Ph), 135.7 (Ph), 134.9 (ipso-Ph), 134.1 (Ph), 133.6 (Ph), 129.8 (Ph), 129.6 (Ph), 129.1 
(Ph), 128.8 (Ph), 128.7 (Ph), 127.8 (Ph), 127.7 (Ph), 69.0 (SCH), 68.7 (SCH), 26.2 
(CMe3), 24.0 (CH2), 23.7 (CH2), 19.3 (CMe3) (two Ph resonances not resolved); MS (ESI) 
m/z 566 (M + H)+; HRMS (ESI) m/z calcd for C34H35NO3SSi (M + H)
+ 566.2180, found 
566.2183 (‒0.7 ppm error) and sulfoximine trans-180 (109 mg, 47%) as a white solid 
Lab book reference: GH-2-22 
 
Attempted synthesis of 2,5-Dibenzoyl-1-[(tert-butyldiphenylsilyl)imino]-1λ⁶-
thiolan-1-one 242 
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KHMDS (1.1 mL of a 0.5 M solution in toluene, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of a 75:25 mixture of N-TBDPS keto-sulfoximines cis-180 and trans-
180 (231 mg, 0.50 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting 
solution was stirred at ‒78 °C for 20 min. Then, benzyl bromide (0.12 mL, 1.0 mmol, 2.0 
eq) was added dropwise. The resulting solution was stirred at ‒78 °C for 1 h and then 
allowed to warm to rt. Then, water (5 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product 
which contained only keto-sulfoximine trans-242 (by 1H NMR spectroscopy).  
Lab book reference: GH-2-33 
 
Attempted synthesis of 2-Benzoyl-1-[(tert-butyldiphenylsilyl)imino]-2-methyl-1λ⁶-
thiolan-1-one 243 
 
LHMDS (0.55 mL of a 1.0 M solution in THF, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of a 75:25 mixture of N-TBDPS keto-sulfoximines cis-180 and trans-
180 (231 mg, 0.50 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting 
solution was stirred at ‒78 °C for 20 min. Then, methyl iodide (0.06 mL, 1.0 mmol, 2.0 
eq) was added dropwise. The resulting solution was stirred at ‒78 °C for 1 h and then 
allowed to warm to rt. Then, water (5 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 98:2 and then 95:5 hexane-
EtOAc as eluent gave a single unassigned diastereomeric sulfoximine 243 (14 mg, 6%) 
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as a white solid, RF (8:2 hexane-EtOAc) 0.35; IR (ATR) 3069, 2956, 2928, 2855, 1680 
(C=O), 1427, 1306, 1263, 1142, 1109, 737, 702, 502 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 8.15–8.09 (m, 2H, Ph), 7.82–7.77 (m, 3H, Ph), 7.46–7.32 (m, 10H, Ph), 3.24–3.14 (m, 
1H, SCH), 2.92–2.82 (m, 1H, SCH), 2.69–2.58 (m, 1H, CH), 2.22–2.08 (m, 1H, CH), 
1.97–1.85 (m, 1H, CH), 1.79–1.69 (m, 1H, CH), 1.74 (s, 3H, Me), 1.17 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 196.1 (C=O), 136.3 (ipso-Ph), 135.9 (Ph), 135.8 (Ph), 
135.7 (ipso-Ph), 134.9 (Ph), 132.5 (Ph), 130.1 (Ph), 129.52 (Ph), 129.51 (Ph), 128.2 (Ph), 
127.78 (Ph), 127.76 (Ph), 74.1 (SCMe), 57.8 (SCH2), 36.6 (SCMe), 27.3 (CMe3), 25.0 
(CH2), 20.1 (CH2), 19.8 (CMe3) (one ipso-Ph resonance not resolved); MS (ESI) m/z 476 
(M + H)+; HRMS (ESI) m/z calcd for C28H33NO2SSi (M + H)
+ 476.2074, found 476.2083 
(‒1.9 ppm error), a 60:40 mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-
180 and trans,cis-239 (70 mg, 39 mg (17%) of cis-180 and 31 mg (11%) of trans,cis-239) 
and keto-sulfoximine trans-180 (130 mg, 56%). 
Lab book reference: GH-2-36 
 
KHMDS (1.1 mL of a 0.5 M solution in toluene, 0.55 mmol, 1.1 eq.) was added dropwise 
to a stirred solution of a 75:25 mixture of N-TBDPS keto-sulfoximines cis-180 and trans-
180 (231 mg, 0.50 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting 
solution was stirred at ‒78 °C for 20 min. Then, methyl iodide (0.06 mL, 1.0 mmol, 2.0 
eq) was added dropwise. The resulting solution was stirred at ‒78 °C for 1 h and then 
allowed to warm to rt. Then, water (5 mL) was added and the two layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 97:3 and then 95:5 hexane-
EtOAc as eluent gave a single unassigned diastereomeric sulfoximine 243 (12 mg, 5%) 
as a white solid and a 70:30 mixture (by 1H NMR spectroscopy) of keto-sulfoximines cis-
180 and trans,cis-239 (69 mg, 45 mg (20%) of cis-180 and 24 mg (8%) of trans,cis-239) 
and keto-sulfoximine trans-180 (135 mg, 58%). 
Lab book reference: GH-2-37 
 
NaHMDS (0.28 mL of a 2.0 M solution in toluene, 0.55 mmol, 1.1 eq.) was added 
dropwise to a stirred solution of a 75:25 mixture of N-TBDPS keto-sulfoximines cis-180 
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and trans-180 (231 mg, 0.50 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The 
resulting solution was stirred at ‒78 °C for 20 min. Then, methyl iodide (0.06 mL, 1.0 
mmol, 2.0 eq) was added dropwise. The resulting solution was stirred at ‒78 °C for 1 h 
and then allowed to warm to rt. Then, water (5 mL) was added and the two layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 97:3 and then 
95:5 hexane-EtOAc as eluent gave a single unassigned diastereomeric sulfoximine 243 
(2 mg, 1%) as a white solid, and a 65:25:10 mixture (by 1H NMR spectroscopy) of keto-
sulfoximines trans-180, cis-180, and trans,cis-239 (189 mg, 120 mg (52%) of trans-180, 
46 mg (20%) of cis-180 and 22 mg (8%) of trans,cis-239).   
Lab book reference: GH-2-38 
 
NaH (0.022g of 60% in mineral oil, 0.55 mmol, 1.1 eq.) was added to a stirred solution 
of a 75:25 mixture of N-TBDPS keto-sulfoximines cis-180 and trans-180 (231 mg, 0.50 
mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. The resulting solution was stirred at ‒
78 °C for 20 min. Then, methyl iodide (0.06 mL, 1.0 mmol, 2.0 eq) was added dropwise. 
The resulting solution was stirred at ‒78 °C for 1 h and then allowed to warm to rt. Then, 
water (5 mL) was added and the two layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were dried (MgSO4) 
and evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 97:3 and then 95:5 hexane-EtOAc as eluent gave 
a single unassigned diastereomeric sulfoximine 243 (10 mg, 4%) as a white solid, and a 
65:25:10 mixture (by 1H NMR spectroscopy) of keto-sulfoximines trans-180, cis-180 and 
trans,cis-239 (200 mg, 127 mg (55%) of trans-180, 49 mg (21%) of cis-180 and 24 mg 
(8%) of trans,cis-239).   
Lab book reference: GH-2-39 
 
n-BuLi (0.65 mL of a 2.3 M solution in hexane, 1.5 mmol, 1.0 eq) was added dropwise 
to a stirred solution of diisopropylamine (0.21 mL, 1.5 mmol, 1.0 eq) in THF (1 mL) at 0 
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°C under Ar. The resulting solution was stirred at 0 °C for 30 min. This gave a freshly 
prepared solution of LDA in THF. 
Freshly prepared LDA (0.68 mL of a 0.8 M solution in THF, 0.55 mmol, 1.1 eq.) was 
added dropwise to a stirred solution of a 75:25 mixture of N-TBDPS keto-sulfoximines 
cis-180 and trans-180 (231 mg, 0.50 mmol, 1.0 eq.) in THF (5 mL) at ‒78 °C under Ar. 
The resulting solution was stirred at ‒78 °C for 20 min. Then, methyl iodide (0.06 mL, 
1.0 mmol, 2.0 eq) was added dropwise. The resulting solution was stirred at ‒78 °C for 1 
h and then allowed to warm to rt. Then, water (5 mL) was added and the two layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 20 mL). The combined 
organic layers were dried (MgSO4) and evaporated under reduced pressure to give the 
crude product which contained an 85:15 mixture (by 1H NMR spectroscopy) of keto-
sulfoximines trans-180 and cis-180  
Lab book reference: GH-2-60 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(hydroxydiphenylmethyl)-5-methyl-1λ⁶-
thiolan-1-one cis,cis-244 
 
Using general procedure A, N-TBDPS sulfoximine cis-172 (186 mg, 0.50 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzophenone 
(0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude 
product. Purification by flash column chromatography on silica with 98:2 hexane-EtOAc 
as eluent gave disubstituted sulfoximine cis,cis-244 (197 mg, 71%) as a white solid, mp 
58–60 °C; RF (9:1 hexane-EtOAc) 0.5; IR (ATR) 3433 (OH), 3068, 2930, 2855, 2194, 
1449, 1427, 1310, 1240, 1107, 730, 700, 644, 605, 501 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 7.83–7.77 (m, 2H, Ph), 7.77–7.73 (m, 2H, Ph), 7.61–7.56 (m, 2H, Ph), 7.50–7.36 (m, 
6H, Ph), 7.36–7.25 (m, 6H, Ph), 7.25–7.14 (m, 2H, Ph), 5.20 (s, 1H, COH), 4.43 (dd, J = 
8.5, 8.5 Hz, 1H, SCH), 2.78–2.66 (m, 1H, SCH), 2.26–2.05 (m, 2H, CH), 1.85–1.68 (m, 
2H, CH), 1.07 (s, 9H, CMe3), 0.95 (d, J = 7.0 Hz, 3H, CHMe); 
13C NMR (100.6 MHz, 
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CDCl3) δ 145.66 (ipso-Ph), 145.57 (ipso-Ph), 136.3 (ipso-Ph), 136.1 (ipso-Ph), 135.8 
(Ph), 135.7 (Ph), 129.32 (Ph), 129.26 (Ph), 128.41 (Ph), 128.37 (Ph), 127.7 (Ph), 127.5 
(Ph), 127.1 (Ph), 126.7 (Ph), 126.3 (Ph), 125.1 (Ph), 78.5 (COH), 71.7 (SCHCOH), 62.3 
(SCHMe), 29.0 (CH2), 27.1 (CMe3), 24.3 (CH2), 19.3 (CMe3), 13.5 (SCHMe); MS (ESI) 
m/z 554 (M + H)+; HRMS (ESI) m/z calcd for C34H39NO2SSi (M + H)
+ 554.2544, found 
554.2552 (‒1.6 ppm error). The stereochemistry of disubstituted sulfoximine cis,cis-244 
was assigned by analogy with related examples. 
Lab book reference: GH-1-87-2 
 
1-[(tert-Butyldiphenylsilyl)imino]-2-(hydroxydiphenylmethyl)-6-methyl-1λ⁶-thian-
1-one cis,cis-245 
 
Using general procedure A, N-TBDPS methyl sulfoximine cis-174 (193 mg, 0.5 mmol, 
1.0 eq.), n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and 
benzophenone (0.25 mL of a 4 M solution in THF, 1.0 mmol, 2.0 eq) gave the crude 
product. Purification by flash column chromatography on silica with 95:5 hexane-EtOAc 
as eluent gave disubstituted sulfoximine cis,cis-245 (231 mg, 81%) as a white solid, mp 
108–110 °C, RF (9:1 hexane-EtOAc) 0.47; IR (ATR) 3286 (OH), 3055, 2932, 2856, 1255, 
1155, 1106, 909, 729, 698, 610, 492 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.82–7.69 (m, 
6H, Ph), 7.45–7.22 (m, 14H, Ph), 3.88 (dd, J = 12.0, 1.5 Hz, 1H, SCH), 2.94–2.82 (m, 
1H, SCH), 2.30–2.15 (m, 1H, CH), 1.93–1.85 (m, 1H, CH), 1.81–1.64 (m, 3H, CH), 1.41–
1.28 (m, 1H, CH), 0.91 (s, 9H, CMe3), 0.49 (d, J = 7.0 Hz, 3H, SCHMe); 
13C NMR (100.6 
MHz, CDCl3) δ 145.4 (ipso-Ph), 142.1 (ipso-Ph), 136.2 (ipso-Ph), 136.0 (Ph), 135.7 (Ph), 
135.40 (ipso-Ph), 129.33 (Ph), 129.25 (Ph), 128.9 (Ph), 128.3 (Ph), 127.69 (Ph), 127.66 
(Ph), 127.5 (Ph), 127.4 (Ph), 127.3 (Ph), 82.2 (COH), 74.7 (SCHCOH), 64.4 (SCHMe), 
33.2 (CH2), 28.6 (CH2), 26.9 (CMe3), 26.5 (CH2), 19.6 (CMe3), 12.7 (SCHMe) (one Ph 
resonance not resolved); MS (ESI) m/z 568 (M + H)+; HRMS (ESI) m/z calcd for 
C35H41NO2SSi (M + H)
+ 568.2700, found 568.2687 (+2.4 ppm error).   
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Lab book reference: GH-2-64-2 
 
2-Benzyl-1-[(tert-butyldiphenylsilyl)imino]-5-methyl-1λ⁶-thiolan-1-one cis,cis-246 
 
Using general procedure A, N-TBDPS sulfoximine cis-172 (186 mg, 0.50 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq) gave the crude product. Purification by flash column 
chromatography on silica with 95:5 and then 9:1 hexane-EtOAc as eluent gave 
disubstituted sulfoximine cis,cis-246 (198 mg, 86%) as a clear viscous oil, RF (8:2 hexane-
EtOAc) 0.63; IR (ATR) 3068, 2930, 2855, 1322, 1247, 1145, 1107, 821, 736, 701, 605, 
500 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.80–7.72 (m, 4H, Ph), 7.41–7.32 (m, 6H, Ph), 
7.25–7.14 (m, 3H, Ph), 6.94–6.88 (m, 2H, Ph), 3.07–2.88 (m, 3H, SCH, PhCH), 2.57–
2.47 (m, 1H, PhCH), 2.07–1.95 (m, 1H, CH), 1.88–1.77 (m, 1H, CH), 1.75–1.58 (m, 2H, 
CH), 1.17 (d, J = 7.0 Hz, 3H, SCHMe), 1.08 (s, 9H, CMe3); 
13C NMR (100.6 MHz, 
CDCl3) δ 138.3 (ipso-Ph), 136.86 (ipso-Ph), 136.80 (ipso-Ph), 135.78 (Ph), 135.75 (Ph), 
129.23 (Ph), 129.20 (Ph), 129.1 (Ph), 128.6 (Ph), 127.63 (Ph), 127.61 (Ph), 126.6 (Ph), 
65.1 (SCHCH2Ph), 60.0 (SCHMe), 33.9 (PhCH2), 28.0 (CH2), 27.3 (CMe3), 25.7 (CH2), 
19.4 (CMe3), 12.8 (SCHMe); MS (ESI) m/z 462 (M + H)
+; HRMS (ESI) m/z calcd for 
C28H35NOSSi (M + H)
+ 462.2281, found 462.2285 (‒0.7 ppm error). The stereochemistry 
of disubstituted sulfoximine cis,cis-246 was assigned by analogy with related examples. 
Lab book reference: GH-2-28 
 
2-Benzyl-1-[(tert-butyldiphenylsilyl)imino]-6-methyl-1λ⁶-thian-1-one cis,cis-247 
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Using general procedure A, N-TBDPS sulfoximine cis-174 (193 mg, 0.5 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzyl bromide 
(0.12 mL, 1.0 mmol, 2.0 eq) gave the crude product. Purification by flash column 
chromatography on silica with 95:5 hexane-EtOAc as eluent gave disubstituted 
sulfoximine cis,cis-247 (202 mg, 85%) as a white solid, mp 110–112 °C, RF (9:1 hexane-
EtOAc) 0.39; IR (ATR) 3068, 2931, 2854, 1346, 1277, 1159, 1106, 759, 733, 701, 648, 
603, 493 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.90–7.81 (m, 4H, Ph), 7.45–7.33 (m, 6H, 
Ph), 7.24–7.14 (m, 3H, Ph), 6.84–6.77 (m, 2H, Ph), 3.36 (dd, J = 13.5, 2.5 Hz, 1H, PhCH), 
2.94–2.79 (m, 2H, SCH), 2.46 (dd, J = 13.0, 12.0 Hz, 1H, PhCH), 1.87–1.59 (m, 5H, CH), 
1.35–1.22 (m, 1H, CH), 1.18 (d, J = 7.0 Hz, 3H, SCHMe), 1.10 (s, 9H, CMe3); 13C NMR 
(100.6 MHz, CDCl3) δ 137.9 (ipso-Ph), 136.9 (ipso-Ph), 136.5 (ipso-Ph), 135.79 (Ph), 
135.74 (Ph), 129.5 (Ph), 129.1 (Ph), 128.5 (Ph), 127.61 (Ph), 127.55 (Ph), 126.5 (Ph), 
67.2 (SCH), 61.6 (SCH), 32.8 (CH2), 31.5 (PhCH2), 29.0 (CH2), 27.3 (CMe3), 25.0 (CH2), 
19.9 (CMe3), 12.2 (SCHMe) (one Ph resonance not resolved); MS (ESI) m/z 476 (M + 
H)+; HRMS (ESI) m/z calcd for C29H37NOSSi (M + H)
+ 476.2438, found 476.2428 (+2.0 
ppm error). The stereochemistry of disubstituted sulfoximine cis,cis-247 was assigned by 
analogy with related examples. 
Lab book reference: GH-2-65-2 
 
1-{[Diphenyl(trimethylsilyl)methyl]imino}-2-[hydroxy(phenyl)methyl]-5-methyl-
1λ⁶-thiolan-1-one cis,cis,anti-248 and cis,cis,syn-248 and 1-phenyl-1-pentanol 249 
 
Using general procedure A, N-TBDPS sulfoximine cis-172 (186 mg, 0.50 mmol, 1.0 eq.), 
n-BuLi (0.24 mL of a 2.3 M solution in hexanes, 0.55 mmol, 1.1 eq.) and benzaldehyde 
(0.10 mL, 1.0 mmol, 2.0 eq) in THF (5 mL) gave the crude product which contained a 
60:25:15 mixture (by 1H NMR spectroscopy) of alcohols cis,cis,anti-248, cis,cis,syn-248 
and 1-phenyl-1-pentanol 249 i.e. a 70:30 mixture of alcohols cis,cis,anti-248 and 
cis,cis,syn-248. Purification by flash column chromatography on silica with 97:3 and then 
95:5 hexane-EtOAc as eluent gave an 85:15 mixture of alcohol cis,cis,anti-248 and 1-
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phenyl-1-pentanol 249 (161 mg, 152 mg (64%) of cis,cis,anti-248 and 9 mg (10%) of 1-
phenyl-1-pentanol 249) as a white solid, mp 80–82 °C, RF (9:1 hexane-EtOAc) 0.26; IR 
(ATR) 3479 (OH), 3068, 2930, 2855, 1451, 1427, 1313, 1244, 1132, 1103, 821, 733, 699, 
607, 499 cm-1; 1H NMR (400 MHz, CDCl3) for cis,cis,anti-248 δ 7.82–7.78 (m, 2H, Ph), 
7.77–7.74 (m, 2H, Ph), 7.34–7.34 (m, 6H, Ph), 7.25–7.18 (m, 3H, Ph), 6.96–6.92 (m, 2H, 
Ph), 5.07 (brs, 1H, PhCHOH), 4.04 (d, J = 2.0 Hz, 1H, PhCHOH), 3.05–2.94 (m, 2H, 
SCH), 2.24–2.13 (m, 1H, CH), 2.11–2.01 (m, 1H, CH), 1.79–1.67 (m, 1H, CH), 1.64–
1.53 (m, 1H, CH), 1.26 (d, J = 7.0 Hz, 3H, SCHMe), 1.11 (s, 9H, CMe3); 
13C NMR (100.6 
MHz, CDCl3) for cis,cis,anti-248 δ 140.5 (ipso-Ph), 136.34 (ipso-Ph), 136.31 (ipso-Ph), 
135.68 (Ph), 135.63 (Ph), 129.46 (Ph), 129.38 (Ph), 128.3 (Ph), 127.77 (Ph), 127.71 (Ph), 
127.3 (Ph), 125.5 (Ph), 69.0 (SCH), 68.5 (PhCHOH), 61.1 (SCH), 28.8 (CH2), 27.2 
(CMe3), 19.5 (CH2), 19.3 (CMe3), 11.7 (SCHMe); MS (ESI) m/z 478 (M + H)
+; HRMS 
(ESI) m/z calcd for C28H35NO2SSi (M + H)
+ 478.2231, found 478.2237 (‒1.4 ppm error) 
and alcohol cis,cis,syn-248 (53 mg, 22%) as a white solid, mp 140–142 °C, RF (9:1 
hexane-EtOAc) 0.18; IR (ATR) 3472 (OH), 3068, 2930, 2855, 1454, 1427, 1310, 1242, 
1136, 1107, 821, 767, 732, 700, 606, 500 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.79–7.74 
(m, 4H, Ph), 7.44–7.35 (m, 6H, Ph), 7.34–7.27 (m, 3H, Ph), 7.24–7.20 (m, 2H, Ph), 4.83 
(dd, J = 9.5, 3.0 Hz, 1H, PhCHOH), 4.06 (d, J = 3.0 Hz, 1H, PhCHOH), 3.26–3.18 (m, 
1H, SCH), 2.96–2.86 (m, 1H, SCH), 2.09–1.99 (m, 1H, CH), 1.74–1.56 (m, 3H, CH), 
1.13 (d, J = 7.0 Hz, 3H, SCHMe), 1.10 (s, 9H, CMe3); 
13C NMR (100.6 MHz, CDCl3) δ 
140.4 (ipso-Ph), 136.29 (ipso-Ph), 136.23 (ipso-Ph), 135.8 (Ph), 129.4 (Ph), 128.7 (Ph), 
128.4 (Ph), 127.7 (Ph), 127.6 (Ph), 127.1 (Ph), 74.6 (PhCHOH), 70.5 (SCH), 62.1 (SCH), 
29.1 (CH2), 27.2 (CMe3), 24.7 (CH2), 19.3 (CMe3), 13.3 (SCHMe) (two Ph resonances 
not resolved); MS (ESI) m/z 478 (M + H)+; HRMS (ESI) m/z calcd for C28H35NO2SSi (M 
+ H)+ 478.2231, found 478.2234 (‒0.7 ppm error). The stereochemistry of sulfoximines 
cis,cis,anti-248 and cis,cis,syn-248 was assigned by analogy with related examples.  
Diagnostic signals for 1-phenyl-1-pentanol 249 1H NMR (400 MHz, CDCl3) δ 4.67 (ddd, 
J = 7.5, 6.0, 3.5 Hz, 1H, PhCHOH) 0.89 (t, J = 7.0 Hz, 3H, CH2Me); 
13C NMR (100.6 
MHz, CDCl3) δ 145.1 (ipso-Ph), 128.5 (Ph), 127.5 (Ph), 126.0 (Ph), 74.7 (PhCOH), 39.0 
(PhCOHCH2), 28.1 (MeCH2CH2), 22.7 (MeCH2), 14.1 (Me). Spectroscopic data are 
consistent with those reported in the literature.72 
Lab book reference: GH-2-18
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Abbreviations 
Ar argon  
BINAP 2,2′-bis(diphenylphosphino)-1,1′-binaphthalene  
Boc tert-butoxycarbonyl  
Bu butyl  
Bz benzoyl  
CPME cyclopentyl methyl ether  
d doublet  
DCE 1,2-dichloroethane  
dba Dibenzylideneacetone  
DME 1,2-Dimethoxyethane  
DPH O-(2,4-dinitrophenyl)hydroxylamine  
dr diastereomeric ratio  
E+ electrophile  
esp α,α,α′,α′-Tetramethyl-1,3-benzenedipropionic acid  
eq. equivalent  
HMDS hexamethyldisilizane  
HMPA hexamethylphosphoramide  
HOBt hydroxybenzotriazole  
Hz Hertz  
IR infra-red  
J coupling constant in Hz  
KHMDS potassium hexamethyldisilazide  
LHMDS lithium hexamethyldisilazide  
m multiplet  
M molar  
mCPBA 3-chloroperbenzoic acid  
M+ molecular ion  
Me methyl  
min minute  
MP melting point  
MS mass spectrometry  
Abbreviations 
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MSH O-mesitylsulfonylhydroxylamine  
m/z mass to charge ratio 
NBS N-bromosuccinimide 
NCS N-chlorosuccinimide 
NFSI N-fluorobenzenesulfonimide 
NMR nuclear magnetic resonance 
Ns para-nitrobenzenesulfonyl 
Ph phenyl 
PIDA (diacetoxyiodo)benzene 
PMB p-methoxybenzyl 
rt room temperature 
s singlet 
SES trimethylsilylethylsulfonyl 
TBAF tetrabutylammonium fluoride 
TBDPS tert-butyldiphenylsilyl 
TBHP tert-butyl hydroperoxide 
TFE tetrafluoroethylene 
TMS trimethylsilyl 
Ts tosyl 
X-Phos 2-dicyclohexylphosphino-2′,4′,6′-
triisopropylbiphenyl 
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